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The tautomerase superfamily (TSF) provides an excellent model system to study 
enzyme specificity, catalysis, and divergent evolution.  trans-3-Cholroacrylic acid 
dehalogenase (CaaD), cis-3-chloroacrylic acid dehalogenase (cis-CaaD), and malonate 
semialdehyde decarboxylase (MSAD) are three TSF members that catalyze the final 
reactions in the degradation of the nematocide, 1,3-dichloropropene.  All three enzymes 
have the TSF characteristic --fold and catalytic amino terminal proline (Pro-1).  Both 
CaaD and cis-CaaD dehalogenate their respective isomers of 3-chloroacrylic acid 
yielding malonate semialdehyde.  Subsequently, MSAD decarboxylates malonate 
semialdhyde resulting in acetaldehyde and CO2.    Their catalytic and substrate 
specificities are exquisite considering they share three key and positionally conserved 
residues.  As part of an effort to understand how such specificity evolved, a pre-steady-








fluorescent mutant of CaaD was constructed that had minimal kinetic differences from 
the wild-type.  The mutant was validated as an accurate fluorescent reporter of change in 
enzyme state that allowed for the reaction to be followed using stopped-flow methods.  
Stopped-flow fluorescence, rapid chemical quench data and ultraviolet spectroscopy were 
globally fit by computational simulation.  The fit resulted in a kinetic mechanism for 
CaaD affording detailed information about the reaction, including measuring the rate of  
product release, the rate of chemistry, a previously unknown partially rate-limiting step 
associated with a conformational change, and the definition of binding constants for both 
products (MSA and Br-).  In addition to the dehalogenation reaction, the reaction of the 
fluorescent mutant with a mechanism-based inhibitor, 3-bromopropiolate, was 
characterized.  The values for the apparent rate of inhibition and potency were defined 
and estimates were determined for the values of the rate of chemistry and the release of 
bromide.  The information gathered during these inhibition experiments was used to 
further refine the CaaD dehalogenation mechanism eliminating ambiguities present in the 
initial data set.   
  Finally, the reactions of a cis-CaaD homologue, Cg10062 from Corynebacterium 
glutamicum were characterized.  Cg10062 shares high sequence similarity (53%) and the 
same six critical active site residues as cis-CaaD, but Cg10062 has poor cis-CaaD 
activity.  Moreover, Cg10062 dehalogenates both 3-chloroacrylic acid isomers.  The 








investigated.   Cg10062 functions as a hydratase/decarboxylase using propiolate 
generating malonate semialdehyde and acetaldehyde.  Cg10062 catalyzes a hydration-
dependent decarboxylation of propiolate as exogenously added malonate semialdehyde is 
not decarboxylated.  With 2,3 butadienoate and 2-butynoate, Cg10062 functions as a 
hydratase and yields only acetoacetate.  Mutations to the activating residues Glu114 and 
Tyr103 produced a range of results from a reduction in wild-type activity to a switch of 
activity.  Possible intermediates for the hydration and decarboxylation products can be 
trapped as covalent adducts to Pro-1 when NaCNBH3 is incubated with certain 
combinations of substrate and mutant enzymes.  Three mechanisms are presented to 
explain these findings along with the strengths and weaknesses of each mechanism in 
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Chapter 1:  Introduction 
1.1 EVOLUTION OF AN ENZYME  
Why enzymology?  For thousands of years, we have made advantageous use of 
enzymes in various processes.  About 150 years ago, humans began to study these 
enzymes.  The Danish chemist Christian Hansen is credited with the first preparations of 
a purified enzyme for industrial use.1   In 1874, he extracted rennet, an enzyme found in 
the stomach of mammals, from dried calves’ stomachs using saline solution.1  Rennet is a 
group of protease-like enzymes used in the process of creating cheese from milk.  The 
use of rennet for this purpose is estimated to date back about 8,000 years.2  Enzymes also 
play a critical role in other old processes as baking bread and the production of alcohol by 
fermentation.1 The enzymes used in these two processes are both found in yeast.  In 1876, 
Wilhelm Kuhne coined the term “enzyme” to describe the isolation of the ferments from 
the host organism.1  The word “enzyme” literally translates as “in yeast”, derived from 
the Greek “en” meaning “in” and “zyme” meaning yeast.1  Early enzymology was 
founded on a desire to understand the simple transformations that were observed in these 
processes.   
In 1894, the study of enzymes and how they work accelerated because of a 
hypothesis provided by Emil Fischer.1  Fischer proposed a model explaining enzyme 






Figure 1.1:  Emil Fischer’s Lock and Key Model   
Some form of the “lock and key” model is still found today as an elementary 
introduction to enzymes and their properties.  Although a simplistic view of an enzyme, 
this model asks a core question in enzymology: how does an enzyme develop a “lock” 
which is a match for a “key”?  This question remains a topic of many heated discussions.   
A simple answer to this question, ‘the enzyme evolved the lock to fit the key’, 
prompts another question: how does the evolution of an enzyme occur?  One simple 
method for an enzyme to evolve is by mutation and selection.3  A point mutation occurs 
when the coding DNA is altered and, as a consequence, the amino acid sequence is 
altered.  If the point mutation provides a selective advantage for the host, the host will 
have a greater chance of survival and more opportunity to pass its genes to another 
generation.  This is essentially the theory of evolution proposed by Charles Darwin4, but 
applied at the microscopic level.  However, beneficial point mutations are rare; while 
most often point mutations are silent or deleterious.  Point mutations in the DNA that lead 
to loss of regulatory control over a protein’s expression levels, gene duplication events, 
and horizontal gene transfer can all play a role in the evolution of an enzyme.3   
Enzymes usually function as part of a metabolic pathway.  Metabolic pathways 
use multiple enzymes and generally operate in sequence to achieve a specific end 




organism.  Metabolic pathways are vital in all known forms of life.  Several of these 
pathways, including those from carbohydrate, lipid, and energy metabolism, are 
maintained, in some form, across all three domains of life.5  Thinking about the function 
of a single enzyme can be difficult, but understanding that function as a part of a 
metabolic pathway with multiple enzymes and how the enzyme and the pathway has 
evolved can be overwhelming.  Fortunately, there is a strong foundation of past research 
to help.  
To begin, consider the evolution of a single enzyme.  The ability to evolve or 
“evolvability” of an enzyme refers to the likelihood of a particular enzyme to develop and 
maintain a new activity.3  A highly evolvable enzyme suggests that it can develop a new 
activity rather easily.  The resulting activity can be recruited to carry out its new task for 
the benefit of the host organism.  The evolvability of a particular enzyme is primarily 
determined by two aspects: stability and potential for functional innovation.3  Simply 
stated, the more stable and functionally malleable a particular enzyme is, the higher the 
chance it can quickly evolve a new activity that will benefit the host.   
Stability means potentially critical point mutations will not destabilize the overall 
protein.  A new function could require several mutations, so that a stable backbone 
scaffold is critical.  Stability does come at a cost: flexibility in an enzyme, especially 
around the active site, can play an important role in an enzyme’s functionality.3  
Movements of loop domains or closures of cap domains can be very important for protein 
activity.  Maintaining a balance between stability and flexibility is critical for a scaffold 
with high evolvability.   
The ability of an enzyme to alter its function, or functional innovation, also plays 
a critical role in the evolvability of an enzyme.3,6  At the extremes of functional 




enzyme to alter its substrate specificity while keeping the chemistry the same.  Many 
enzymes are believed to follow this route including, malate and lactate dehydrogenase 
and the protease enzymes, trypsin and chymotrypsin.7  Alternatively, an enzyme can alter 
the chemistry it performs while maintaining substrate binding.8  It has been suggested 
that the primary choice of Nature for the evolution of an enzyme is to alter the substrate 
specificity because having the right chemistry in place is more difficult than binding an 
alternate substrate.7,8  Many enzymes that diverged from a common evolutionary ancestor 
likely used a combination of these two methods to optimize binding of alternative 
substrates and the chemistry that is being carried out.   
One way Nature can get an evolutionary “head start” is to use a promiscuous 
enzyme.  A promiscuous enzyme is one that shows interactions or activities with alternate 
substrates.  Promiscuity is observed in two distinct forms: catalytic promiscuity and 
substrate ambiguity.3,9  Catalytic promiscuity refers to the ability of an enzyme to process 
different substrates to give different products.  The reactions generally share a common 
intermediate or a mechanistic strategy.  Substrate ambiguity refers to the ability of an 
enzyme to catalyze the same chemical reaction on series of different substrates.  The role 
promiscuity plays in developing enzymes with new functions is one of the topics  
addressed by the work in this dissertation.  
There are two main theories to explain the evolution of metabolic pathways. One 
theory involves enzyme recruitment.10  Enzyme recruitment is the process by which a 
catalyst with a new activity is utilized by the host for a purpose that was not originally 
evolved.3,10  A new activity can be acquired by a beneficial genetic alteration (e.g., point 
mutation).  If this activity provides a selective advantage to the host organism, the 
mutation has a higher probability of being passed on to the next generation.  In 1976,     




Jenson suggested that ancient enzymes might have had poor substrate specificity 
allowing them to process a greater variety of substrates.  A relatively small number of 
enzymes with high promiscuity would enable a simple organism to operate at maximum 
function.  Presumably, however, these enzymes would catalyze reactions poorly and 
provide the driving force for improvement.   
Jensen proposed that by coupling gene duplication events with random point 
mutations, an ancient, non-specific, promiscuous enzyme could improve its catalytic 
efficiency and evolve to catalyze one specific reaction.3,10  The product of this new 
reaction, if stable, can then become the target for another promiscuous enzyme which 
could then undergo another evolution event.  Recruiting these new enzymes to process a 
series of chemical reactions as a part of a metabolic pathway would then become a 
relatively straightforward task.  When new potential substrates become available to an 
organism, enzymes with promiscuous activities could then be improved and new 
metabolic pathways develop.  If this is the preferred method of metabolic expansion, one 
would expect different enzymes to compose a metabolic pathway.  In general, this is what 
is found in metabolic pathways: not all the enzymes in the pathway are similar in 
sequence and structure.  Many contemporary enzymes exhibit some promiscuity.3   
  There is one caveat to this theory of evolution of metabolic pathways: it requires 
the existence of at least a few ancient, promiscuous enzymes.  The origin of these 
enzymes is not explained by Jensen.10  One possibility for the origin of these initial 
enzymes was suggested by N. H. Horowitz, in 1945, as part of his retrograde theory of 
evolution of metabolic pathway.11  Although Horowitz’s retrograde theory is less favored 
due to a growing body of evidence against it, it does provide an explanation for the 




Horowitz’s theory of retrograde evolution is based on another theory proposed by 
two independent evolutionary theorists, J. B. S. Haldane and A. I. Oparin, in the 
1930s.11,12   The “Oparin-Haldane theory” suggested that early forms of life lived in a 
“rich, primordial soup” full of all the necessary components for life.12  Horowitz 
suggested that this type of environment would allow for early organisms to be mostly 
heterotrophic, and these organisms could develop a few enzymes which would carry out 
simple one step biosynthetic processes.11  As life began to thrive, the “rich, primordial 
soup” became depleted.  This applied pressure on organisms to develop the ability to 
synthesize essential compounds.  By changing the genome through gene duplication or 
gene fusion or by gaining new genes through horizontal gene transfer, the small number 
of enzymes available to make these compounds could quickly multiply.  This sets the 
stage for the available enzymes to evolve according to Jensen’s theory of metabolic 
recruitment.  A picture of what these “ancestral” enzymes might have looked like can be 
formed by studying the enzymes in the context of an enzyme superfamily.   
     
1.2 THE ENZYME SUPERFAMILY 
During the 1990’s, advances in protein structure crystallography, genome 
sequencing, polymerase chain reaction (PCR) techniques, and computational power 
allowed researchers to quickly acquire a lot of detailed information about thousands of 
enzymes.    It quickly became obvious that many enzymes with similar sequences share 
similar structures.13-17  However, enzymes that share both sequence and structure 
similarity do not always possess the same functionality (e.g. mandelate racemase and 
muconate lactonizing enzyme are two examples).15  These observations stimulated the 




was developing a method to classify groups of enzymes which accounted for both the 
similarities in structure and function.  Homologous enzymes are defined as those that 
descend from a common ancestor and therefore are structurally similar.15  The term 
“superfamily”, as defined by J. A. Gerlt, P. C. Babbit, and others, is used to describe a 
group of homologous enzymes that catalyze the same chemical reaction with different 
substrate specificity or that catalyze a different overall reaction, but share a common 
mechanistic feature enabled by a conserved active site architecture.  13-15 
Conservative estimates predict that there are around a few thousand protein folds 
in nature.14  This relatively small number suggests that in more complex species (species 
with 10,000 or more theoretical gene products), enzymes with similar structures must 
carry out different reactions.14  The enolase superfamily (ESF) is one of the most 
functionally diverse superfamilies known to date, catalyzing at least 14 different 
reactions.  The name comes from the glycolytic enzyme, enolase.  Mandelate racemase 
(Figure 1.2) and muconate lactonizing enzyme, are two members of the ESF.16,17   All the 
reactions catalyzed by this superfamily share a common mechanistic strategy.  A general 
base at the active site abstracts theproton of the carboxylate moiety on the substrate to 
form an enolate intermediate, which is stabilized by a divalent metal ion.13-17  The active 
sites of the enolase superfamily members are positioned inside of a (-barrel with 






Figure 1.2:  Structure of Mandelate Racemase, an ESF Member 
The crystal structure of mandelate racemase.  The -helices and the -sheets 
of the (-barrel are colored in red and yellow, respectively.  Shown in 
blue is the cap domain.  The active site metal, manganese (Mn2+), is shown 
as an orange sphere.  PDB code: 2MNR 
 
The barrel is “hard-wired” to carry out the chemistry, although the exact 
chemistry varies among superfamily members, leading to its diversity.  The cap may be 
responsible for the substrate specificity and/or the exclusion of bulk solvent from the 
active site.16,17  This structural design modulates the active site, so that new activities can 
be developed and optimized rather easily utilizing the same scaffold and same general 
reaction strategy.  The -barrel fold is observed in several enzyme superfamilies, 
lending credence to its evolvability. 
Studying the evolution of enzymes and their promiscuity, achieves multiple aims.  




assist protein engineering efforts and design, which have a range of applications from 
bioremediation to general synthesis of pharmaceuticals and other important chemicals.3  
Understanding how enzymes evolve can be used to design more diverse molecules.  
These molecules include antibiotics that might evade resistance, better pharmaceuticals 
with limited side effects, and environmentally friendly compounds.     
In the tautomerase superfamily (TSF), a diverse set of chemical reactions is 
observed.  All reactions are catalyzed by enzymes that use the same simple structural 
motif (--) and an amino-terminal proline.18,19  The reactions include tautomerization, 
hydration, dehalogenation, and decarboxylation.  There are recent reports that more 
complex reactions are catalyzed such as carbon-carbon bond formation.20  Members of 
the TSF might have undergone several evolution events from a progenitor enzyme.  Gene 
duplication and gene fusion events are evident in the family.  An example of this is 
present in a comparison of the sequence lengths.  The sequences are either “short” or 
“long” in length.  The “long” sequences likely arose from a fusion of two “short” 








Figure 1.3:  --Structure, the Characteristic Motif of the Tautomerase Superfamily 
The crystal structures of the two enzymes in the tautomerase superfamily.  
A) The “short” chain structure of 4-oxalocrotonate tautomerase consisting of 
a single --unit (PDB code: 4OTA).  B) The “long” chain structure of 
cis-3-chloroacrylic acid dehalogenase consisting of two linked --units  
(PBD code: 2FLZ).  Shown in spheres in both is the catalytic amino-
terminal proline.   
 
Several enzymes in the TSF show a high degree of catalytic promiscuity, most 
notably 4-oxalocrotonate tautomerase (4-OT).  These observations make the tautomerase 
superfamily a good model system to study the mechanism of enzyme evolution, 
specifically the features defining enzyme specificity and catalysis.  Tautomerase 
superfamily members have been studied extensively.  The work in this dissertation 




1.3 OVERVIEW OF THE TAUTOMERASE SUPERFAMILY 
The tautomerase superfamily (TSF) is a collection of structurally homologous 
enzymes that are characterized by two features, a  protein fold and a catalytic 
amino-terminal proline.18,19  There are five known subfamilies in the superfamily, which 
are titled for the first characterized member: 4-oxalocrotonate tautomerase (4-OT), 5-
(carboxymethyl)-2-hydroxymuconate isomerase (CHMI), macrophage migration 
inhibitory factor (MIF), cis-3-chloroacrylic acid dehalogenase (cis-CaaD), and malonate 
semialdehyde decarboxylase (MSAD).19   
4-OT, from Pseudomonas putida mt-2, was first identified as a part of the meta-
fission pathway, which is responsible for the degradation of simple aromatic 
hydrocarbons.19  In this pathway, benzene or toluene is first converted to catechol or a 
catechol derivative by a series of enzymatic reactions.  Subsequently, catechol or the 
catechol-derivative can be processed through the meta-fission pathway (Scheme 1.1).19  
The end products of the pathway are pyruvate and acetaldehyde.  The latter is converted 
to acetyl-CoA.  Both products can be shuttled into the Kerbs cycle. 
Scheme 1.1: meta-Fission Pathway for Degradation of Aromatic Hydrocarbons 
 
4-OT catalyzes the 1,5-keto-enol tautomerization of 2-hydroxymuconate to 2-
oxo-3-hexendioate.18  4-OT consists of monomers made up of 62 amino acids in length 
and exists as a hexamer (Figure 1.4A).  The amino-terminal proline, which is critical for 
efficient catalysis, has an unusually low pKa value of 6.4.




amine of proline has a pKa of about 10.6.  This low pKa value in 4-OT allows it to 
function as a catalytic base (under physiological conditions at pH 7.3).  The lone pair on 
Pro1 of 4-OT is proposed to help shuttle a proton in the 1-5 keto-enol tautomerization 
reaction.18,19   
In addition to 4-OT’s biological tautomerization reaction, the enzyme shows a 
high degree of catalytic promiscuity.  It has been shown that 4-OT catalyzes at least 5 
other reactions including hydration that can result in dehalogenation19, decarboxylation, 
enamine formation,20 isomerization,21 and aldol condensation20.  It has also been shown 
that single point mutations in the active site can improve the efficiency of these reactions.  
Most of the known reactions catalyzed by 4-OT appear to be a result of the unique pKa of 
the amino-terminal proline.20  
Another enzyme in the TSF, CHMI participates in the degradation of aromatic 
amino acids as part of the homoprocatechuate pathway in Escherichia coli strain C.18  
CHMI consists of monomers that are 125 amino acids in length and exists as a trimer 
(Figure 1.4B).  CHMI functions similar to 4-OT, but uses 5-(carboxymethyl)-2-
hydroxymuconate as its substrate.  MIF is a pro-inflammatory cytokine where each 
monomer is made up 115 amino acids and is a trimer.  MIF is unique among the known 
superfamily members because it only contains the catalytic Pro1 and no other conserved 
active site residues.19  MIF catalyzes the tautomerization of phenylenolpyruvate to 
phenylpyruvate, but this activity has no known biological relevance.19  Pro1 in MIF and 






Figure 1.4:  4-OT and CHMI Oligomers 
A) The 4-OT hexamer.  Shown in spheres are the six amino-terminal 
prolines.  B) The CHMI trimer.  Shown in spheres are the three amino-
terminal proline residues.   
 
The amino-terminal proline can also act as a general acid catalyst.  Three enzymes 
that are part of the 1,3-dichloropropene catabolic pathway, CaaD, cis-CaaD (Figure 
1.3B), and MSAD, all use Pro1 as a general acid catalyst.  These three enzymes and a 
homologue, designated Cg10062, and the reactions they catalyze will be the focus of the 
work presented in this dissertation, as they represent model systems to better understand 
enzyme specificity, functionality, promiscuity, and the roles they play in the evolution of 
enzymes.   
1.4 1,3-DICHLOROPROPENE CATABOLIC PATHWAY 
1,3-Dichloropropene is a synthetic compound introduced into the environment in 




marketed as nematicides used to protect crops from nematodes.  During the late 1960’s 
and early 1970’s, soil bacteria were identified that degraded 1,3-dichloropropene.22  In 
1998, Janssen et al identified and characterized a specific pathway for its degradation 
(Scheme 1.2) in Pseudomonas cichorii 170.22 
Scheme 1.2: 1,3- Dichloropropene Catabolic Pathway  
 
In the first step, 1,3-dichloropropene is converted to 3-chloroallyl alcohol (not 
shown) by a hydrolytic dehalogenase, known as DhaA, which catalyzes the 
dehalogenation reaction using a covalent intermediate between the enzyme and 
substrate.22  An active site aspartate acts as a nucleophile and attacks the substrate 
causing the displacement of a halide ion.23  Water hydrolyzes the covalent intermediate to 
yield free enzyme and the haloalcohol.  DhaA is structurally unrelated to the two other 
dehalogenases in the 1,3-dichloropropene pathway.   
After the formation of the haloalcohol, an alcohol dehydrogenase and an aldehyde 
dehydrogenase oxidize the alcohol moiety to yield trans- and cis-3-chloroacrylates (1 and 
2, respectively).22  The enzymes, trans-3-chloroacrylic acid dehalogenase and cis-3-
chloroacrylic acid dehalogenase process their respective isomers to yield malonate 
semialdehyde (3).22,24,25  Malonate semialdehyde decarboxylase processes 3 to yield 
acetaldehyde (4).26  Subsequently, 4 can be shuttled into the Krebs Cycle (although the 





1.5 trans-3-CHLOROACRYLIC ACID DEHALOGENASE 
trans-3-Chloroacrylic acid dehalogenase (CaaD) catalyzes the hydration of 1 to 3.  
CaaD is a heterohexamer composed of three  subunits and three subunits.18,24  One 
can consider CaaD as trimer of heterodimers. Sequence analysis, mutational analysis, and 
the relatively small subunits (70 and 75 amino acids, respectively) of CaaD placed it into 
the 4-OT family of the tautomerase superfamily.24  Both the  and  subunits contain an 
N-terminal proline.  However, only the Pro1 is catalytically active.24   
A single active site of CaaD is comprised of residues from one  subunit and one 
 subunit with secondary residues from a second, adjacent  subunit.  In addition to 
Pro1, CaaD contains three other catalytically crucial residues: two arginine residues, 
Arg8 and Arg11, and a glutamate residue, Glu52.  Direct 15N NMR titration studies 
of CaaD using 15N-labeled enzyme and pH rate profiles showed that the pKa of the Pro1 
is 9.2, a relatively normal pKa for the secondary amine, but 3 orders of magnitude higher 
than that of 4-OT (6.4).27  This led to the conclusion that the N-terminal Pro1 of CaaD 
acts as a general acid catalyst as it would be mostly cationic at biological pH.  The results 
of kinetic, mutagenesis, mass spectrometry, and X-ray crystallography studies suggested 
the current catalytic mechanism for CaaD, shown in Scheme 1.3.24,27   





The two arginines help bind and position the substrate, 1 via its carboxylate 
moiety. The glutamate residue deprotonates the active site water molecule and the water 
molecule undergoes a Michael addition to 1 at the C3 position to form an enolate 
intermediate.  Formation of this intermediate and stabilization is facilitated by the two 
arginine residues. Two plausible pathways can form the product. In path A, the proline 
donates a hydrogen atom to the C2 position forming an unstable halohydrin, which can 
then directly expel the halide to form 3.  In path B, the intermediate undergoes an , 
elimination, losing the halide and forming the enol form of 3. The enol is then 
tautomerized to form 3.  CaaD also catalyzes the ketonization of phenylenolpyruvate (5)  
to phenylpyruvate (6) .28  It can be inferred from this observation that CaaD likely 
follows path B.  Therefore, path B is preferred over path A in the mechanism for CaaD. 
Like 4-OT, CaaD also shows promiscuity.  It catalyzes the tautomerization of 
phenylenolpyruvate, but it does not ketonize 2-hydroxymuconate.18,29  It will also 
catalyze the hydration of 2-oxo-3-pentynoate (2-OP, 7) to form acetopyruvate (8).  
Conversely, 7 completely inactivates 4-OT by forming a covalent adduct with Pro1 
(Scheme 1.4).18,29  This dichotomy of reactions with 7 reflects the difference in the pKa 
values for the Pro1 residues of CaaD and 4-OT.   
The higher pKa of Pro1 in CaaD makes it cationic at physiological pH and allows 
for the hydration of 7.19  On the contrary, the lower pKa of Pro1 in 4-OT allows the Pro1 
to function as a nucleophile and attack C4 of 7, causing it to become covalently bonded 
to the enzyme.19  These pKa differences in Pro1 may, in part, explain why CaaD performs 
a hydration reaction instead of a tautomerization reaction.  This also illustrates the ability 
of 7 to be used as a mechanistic probe for the pKa of Pro1 in the TSF.  From these results 
one can conclude that although their structures are similar, CaaD and 4-OT catalyze very 




Scheme 1.4: Reactions of 2-oxo-3-Pentynoate (7) with CaaD and 4-OT 
 
Another set of acetylene compounds, 3-chloro- and 3-bromopropiolate (9), were 
designed to be used as mechanistic probes of hydration activity.29  The halopropiolates 
covalently and irreversibly modify CaaD and similar enzymes in the family at the Pro1 
position like 7 does with 4-OT.  The mechanism of inhibition is not known definitely, but 
the likely modes of inhibition are outlined in Scheme 1.5.29 






The halopropiolates are proposed to act like classic suicide inhibitors. The initial 
addition of water catalyzed by the enzyme generates two possible highly reactive species 
that can irreversibly add to Pro1.  The reactive species is unknown.  A crystal structure 
with the covalently modified Pro-1 residue of CaaD was solved to 2.3 Å.  This structure 
was used in the docking studies presented in Chapter 2.      
 
1.6 cis-3-CHLOROACRYLIC ACID DEHALOGENASE 
The TSF member, cis-3-chloroacrylic acid dehalogenase (cis-CaaD), also 
participates in the degradation of 1,3-dichloropropene.22,25  Like CaaD, cis-CaaD 
catalyzes the hydration of 2 to yield 3.  However, unlike CaaD, cis-CaaD is a homotrimer 
composed of three 149 amino acid monomers.25  The active site of cis-CaaD has the same 
critical residues found in CaaD: Pro1, Arg70, Arg73, and Glu114.  cis-CaaD contains two 
two critical residues that are not found in CaaD: His28 and Tyr103.25  A single cis-CaaD 
monomer contains most of the critical residues that compose a single active site (5 out of 
6).  However, Tyr103 is located on a -sheet from the adjacent monomer.30  Based on 
structural and mutagenesis studies, the proposed mechanism is the same as that proposed 
for CaaD (Scheme 1.6).  The source of the proton that is donated at C2 is less clear as 
two potential proton donors are available (Pro1 and His28).  
The additional residues are proposed to act as follows.  His28 might help the two 
Arg residues (Arg70 and Arg73) in substrate binding, polarization, and enolate 
stabilization.  Tyr103 is positioned to assist Glu114 in water activation.  cis-CaaD also 
shows catalytic promiscuity using  5 and 7.28,31  However, cis-CaaD processes these 
substrates significantly less efficiently than CaaD.  cis-CaaD is also covalently modified 




Scheme 1.6: Proposed Mechanism for cis-CaaD using cis-3-Chloroacrylate (2) 
 
 
To uncover more details about the mechanism of cis-CaaD, the reaction of cis-
CaaD with cis-3-bromoacrylate (10) was subjected to a thorough steady-state and pre-
steady-state kinetic analysis.32,33  cis-CaaD processes 10 and 2 with similar steady-state 
parameters, but the released bromide ion is more accurately quantified than the chloride 
ion.32  cis-CaaD contains a tryptophan residue, Trp-101, at the back of the active site 
pocket.30  This tryptophan residue enables the reactions of cis-CaaD to be monitored 
using stopped-flow fluorescence by following the native enzyme fluorescence at 340 
nm.33  Stopped-flow methods provide accurate data with minimal background about the 
reaction at very early time points during the reaction.  The data gathered in this pre-
steady-state phase of the reaction can provide information about individual rate constants 
for each kinetically significant step of the reaction.33  Similarly, rapid-quench 
experiments can provide information about individual rates constants and potentially, the 
rate-limiting step in catalysis.33,34  In contrast, a steady-state kinetic analysis provides 
only kcat and Km, which are a function of the individual rate constants and only give vague 
information about the overall reaction.33  Global data fitting by simulation allows all of 
the data to be simultaneously fit to a single kinetic model.35,36  Fitting data in this manner 




assumptions.35-37  A more detailed discussion of data fitting by simulation can be found in 
Chapter 3.  On the basis of these experiments (and data fitting), a kinetic model for the 
catalysis of 10 by cis-CaaD was proposed and published.32  However, the proposed 
model fails to account for data acquired after publication.  Simple refinement of the old 
model could not account for the new data.  This led to an investigation of alternative 
substrates with cis-CaaD, which might provide a simpler model and possibly lead to a 
correct model (i.e., accounts for all of the data) for cis-CaaD with 10. 
In the course of the investigation of cis-CaaD with the alternative substrate, 2,3-
butadienoate (11), an allene compound, a previously unknown reaction mechanism for 
cis-CaaD was uncovered.38  Like 10, cis-CaaD adds water to 11 to yield acetoacetate 
(12).  The steady-state parameters with 11 are similar to those of 10.38  However, the 
stopped-flow fluorescence traces show a rate that is at least 20-fold less than kcat as 
measured by steady-state kinetic experiments.  It is not possible to account for this data 
with an in-line kinetic model.  However, a kinetic model that uses multiple pathways to 
yield the formation of a single product can account for both the observed rate of turnover 
(kcat) and the slow formation of the intermediate.   
Along with the stopped-flow experiments, trapping studies were carried out with 
11 and cis-CaaD.38  These studies showed that cis-CaaD is covalently modified by 11 
exclusively at the Pro1 position when the reducing agent, sodium cyanoborohydride, is 
added.  Moreover, turnover studies showed that cis-CaaD is covalently modified by 11 
(in the presence of NaCNBH3) with 1.3 equivalents per active site.
38  This result 
suggested that cis-CaaD processes 11 almost exclusively through a covalent catalytic 
mechanism.  The covalent enamine intermediate was also directly observed by UV 
spectroscopy after deconvolution of time-dependent wavelength spectra using singular 




proposed and used to globally fit the full set of kinetic data.  This resulted in the estimates 
of six individual rate constants, along with a fluorescence factor for the enzyme and an 
extinction coefficient for a secondary enamine.38  The data resulting from this study led 
to the proposal of a different type of mechanism by which cis-CaaD processes 11 to 12 
(Scheme 1.7).  These studies also uncovered mechanistic details of cis-CaaD, which were 
previously unknown.  We believe this covalent catalysis mechanism might occur during 
the catalytic cycle of cis-CaaD using 10.   





Despite having very similar active site architectures, cis-CaaD and CaaD can only 
dehalogenate their respective isomers.  To date, there is no known compound that the 
enzymes process equivalently, except for 9, which results in covalent modification and 
inhibition.  A fascinating question is, “how do CaaD and cis-CaaD achieve such exquisite 
specificity?”  Following the kinetic approach outlined above, the kinetic mechanism of 
CaaD was investigated and the results are reported in Chapters 2 and 3.   
 
1.7 MALONATE SEMIALDEHYDE DECARBOXYLASE 
Malonate semialdehyde decarboxylase (MSAD) is the last enzyme in the 1,3 
dichloropropene catabolic pathway.22  MSAD catalyzes the decarboxylation of 3 to 4, 
where 4 can be shuttled into the Krebs cycle.  MSAD is a homotrimer where each 
monomer is composed of 129 amino acids.26  In this way, it is similar to cis-CaaD.  
MSAD contains the amino-terminal proline and the two arginine residues (Arg70 and 
Arg 73).  Like CaaD and cis-CaaD, but unlike many other decarboxylases, MSAD uses 
no metals or cofactors to catalyze the decarboxylation reaction.  A 15N NMR titration of 
MSAD  vs. pH showed that the pKa of Pro1 is 9.2, similar to that of CaaD.
39  MSAD 
catalyzes the hydration of 7, although slowly (as assessed by kcat/Km).
39  The purpose of 
this hydration activity is unknown.  It could be a promiscuous activity carried over from a 
progenitor enzyme or it could be functional.  One possibility is that the hydration activity 
is a rescue function.  It would allow MSAD to remove covalent adducts formed on Pro1 
by reaction with the aldehyde moieties in the substrate or product.  Based on all of these 
observations and the crystal structure, a mechanism for the decarboxylation of 3 was 





Scheme 1.8: Proposed Mechanism for Decarboxylation by MSAD 
 
The crystal structure, along with mutagenesis studies, showed that Asp37 is 
critical for both the decarboxylation and the hydration activities.40  Asp37 might act with 
Pro1 to coordinate an active site water molecule.   This may help facilitate the 
decarboxylation of 3 to form 4 and could help stabilize the enolate intermediate.  Asp37 
might also be responsible for maintaining the pKa value of Pro1. For the hydration 
activity, Asp37 could deprotonate the water molecule allowing it to add (in a Michael 
addition) to the acetylene moiety of 7 (Scheme 1.9).  The difference between these two 
proposed functions of Asp37 could stem from a difference in binding of 3 and 7, as 7 is 
two carbons longer than 3 and has limited flexibility.  
Scheme 1.9: Proposed Hydration of 2-oxo-3-Pentynoate (7) by MSAD 
 
One major difference between the active site architecture of MSAD and the 
dehalogenases (cis-CaaD or CaaD) is the presence of a large hydrophobic wall in MSAD.  




arginines, which are located at the back, right side of the active site.  In the dehalogenase 
enzymes, this region of the active site is occupied by the water activating residues (e.g., 
Glu52 in CaaD and Glu114 and Tyr103 in cis-CaaD).   The hydrophobic wall is made up 
of 5 residues: Tyr39, Trp114, Phe116, Phe124, and Leu128.  The role of this large 
hydrophobic wall is unclear, but it is conserved across other MSADs.  The substrate for 
MSAD, 3, exists as a mixture of the free aldehyde and hydrate.  The equilibrium of the 
mixture is about 73% hydrate and 27% free aldehyde and is maintained at a nearly 
diffusion-controlled rate.41  It is not known if the hydrate binds to the active site or 
MSAD only catalyzes the free aldehyde, as shown in Scheme 1.8.  One role for the 
hydrophobic wall might be to dehydrate the hydrate, thereby generating the free aldehyde 
at the active site for decarboxylation.  Another interesting feature about MSAD is that it 
does not show saturation kinetics with 3 (up to 20 mM).  It is unclear saturation is not 
able to be achieved with 3, but the hydrate could play a role.     
A MSAD homologue, designated FG41 MSAD, was cloned from the Coryneform 
bacterium strain FG41.  FG41 MSAD is a homotrimer where each monomer is 136 
amino acids.  The homologue was annotated as a decarboxylase due to the high sequence 
identity (~37%) with MSAD.  In fact, FG41 MSAD decarboxylates 3 at a rate 
comparable to that of the P. pavonaceae MSAD.42  However, the FG41 MSAD has a 
significantly lower hydration activity using 7.42  Interestingly, FG41 MSAD has one of 
the critical arginine residues (Arg76), while the other one is replaced by Gln73.   
Once the crystal structure was solved, two other residues, Thr72 and Tyr123 were 
identified as possible substitutes for the missing arginine residue.42  Subsequent 
mutagenesis studies confirmed the importance of these residues in maintaining the 
decarboxylation activity.  Roles for these residues were tentatively assigned, as shown in 




Scheme 1.10: Decarboxylation and Hydration Reactions of FG41 MSAD 
 
Thr72 and Tyr123, along with Gln73, are proposed to form multiple hydrogen 
bond interactions with 3 to help facilitate decarboxylation.42  When Gln73 is changed to  
Arg73 in FG41 MSAD, the decarboxylation activity doesn’t improve significantly.  
However, the hydration activity of this mutant using 7 increases 9-fold over that of wild-
type FG41 MSAD (as assessed by kcat/Km).
42  There are at least three other characterized 
MSAD homologues.  Some of these homologues, such as YrdN from B. subtilis strain 
168 (53% sequence identity to MSAD), only contain a single arginine residue at position 
76 or the equivalent position. This observation suggests that this second arginine residue 
might not be necessary for decarboxylation in other MSAD homologues, but the 
significance of this observation remains unclear.  This set of MSADs illustrates how a 
single reaction can be catalyzed using different groups in a similar reaction strategy. 
 
1.8 Cg10062 FROM CORYNEBACTERIUM GLUTAMICUM 
A BLASTP search using the cis-CaaD amino acid sequence as the query 
identified a gene labeled cg10062 from Corynebacterium glutamicum.  Unlike the 
enzymes of the 1,3-dichloropropene catabolic pathway, the cg10062 gene has no clear 
genomic context.  A sequence alignment with Cg10062 and cis-CaaD shows 53% 




crucial residues as cis-CaaD: Pro1, His28, Arg73, Arg75, Try103, and Glu114.  A crystal 
structure of the homotrimeric Cg10062 shows an active site architecture that is nearly 
superimposable on that of cis-CaaD.43  A pH rate profile suggested that the pKa of Pro1 is 
about 9.2, similar to those of cis-CaaD and CaaD.44  Cg10062 catalyzes the hydration of 
7, although poorly (with a similar kcat/Km to that of cis-CaaD, 50 M
-1 s-1 versus 10 M-1 s-1, 
respectively)43    Cg10062 is also covalently modified at Pro1 by 9.  These observations 
are consistent with a high pKa value of Pro1 and that Cg10062 is, in fact, a hydratase.
43  
Due to the high sequence similarities with cis-CaaD, Cg10062 was placed in the cis-
CaaD subfamily. 
However, an examination of Cg10062’s activity with cis-3-chloro- (2) and cis-3-
bromoacrylate (10), it was found that Cg10062 is a poor cis-CaaD.43  It shows about a 
1,000-fold reduction in specificity (kcat/Km) with 10 than cis-CaaD, primarily due to the 
high Km value ( >50 mM versus the 160 µM for cis-CaaD).
43,45  More intriguing, 
Cg10062 dehalogenates trans-3-chloroacrylate (1), albeit poorly.  However, cis-CaaD 
and all known cis-CaaD mutants do not process 1.  This is intriguing because the active 
sites appear nearly identical.   
Another pair of compounds provided more evidence that more significant 
differences exist between the cis-CaaD and Cg10062 than the active site crystal structure 
and sequences might suggest.  The enantiomeric epioxide compounds (R)-oxirane-2-
carboxylate and (S)-oxirane-2-carboxylate were studied as potential covalent inhibitors of 
cis-CaaD and Cg10062.  cis-CaaD is irreversibly inactivated by only the (R)-oxirane-2-
carboxylate.44  However, Cg10062 is inactivated by both epoxide compounds with a 
preference for the (R) isomer.44  These observations parallel the observations made for 
the 3-haloacrylates.  The mechanism by which these compounds inactivate these enzymes 




intriguing and has implications for the exquisite substrate specificity exhibited by cis-
CaaD. 
 One possible source of the specificity differences between cis-CaaD and Cg10062 
was identified while comparing the crystal structures of the modified and unmodified 
structures of both enzymes.  A loop near the active site is observed in different positions 
in cis-CaaD and Cg10062 (Figure 1.5A and 1.5B, respectively).45  In the non-liganded 
structure of cis-CaaD, the loop is in an “open” conformation (Figure 1.5A, light green).  
In the covalently modified structure (dark green), the loop appears in a “closed” 
conformation.  However, in Cg10062, the loop is observed in the “open” conformation in 
both the non-liganded and modified structures (Figure 1.5B).  
These observations led to a hypothesis and subsequent investigation into the loop 
residues.  Two of these residues in cis-CaaD (Thr32 and Thr34) were individually 
mutated to their counterparts in Cg10062 (Ala32 and Ala34).  These individual mutations 
do have a significant effect on the Km values using 10.
45  The Km values raise 
approximately 20-fold and 4-fold, respectively.  However, changing Gln35 in cis-CaaD 
to Pro35, dropped the observed Km value ~10-fold (suggesting tighter binding).  Also, 
changing Ala32 and Ala34 in Cg10062 to Thr residues does not result in a similar 
improvement in the Km values.  This led to the conclusion that if the loop is playing a role 
in specificity, there are probably multiple factors leading to the observed changes in Km 







Figure 1.5: Loop Residues in cis-CaaD and Cg10062 
A) Shown in dark green are the residues that make up the loop of cis-CaaD 
in the modified crystal structure.  In the light green are the loop residues in 
the non-liganded structure.  The gray arrow indicates the anticipated 
direction of movement from the “open” to the “closed” form of the enzyme 
(PDB codes: 3MF7 (dark green) and 3MF8 (light green).  B) Shown in 
maroon are the residues of the loop in Cg10062 (PDB code: 3N4G).  
Cg10062 does not show this same movement upon modification of the 
proline residue. Shown in the spheres are the proline residues of both cis-
CaaD and Cg10062.     
  
In the course of the investigation of the roles of the loop residues, the allene 
substrate, 11, was examined with Cg10062.  It was found to be the best known substrate 
for Cg10062 (as assessed by kcat/Km).  The kcat/Km value is comparable to that of cis-CaaD 
(5.1 × 103 versus 8.7 × 10




importantly, the Km values are the same, within experimental error (690 ± 30 µM for cis-
CaaD and 780 ± 130 µM for Cg10062).45  However, cis-CaaD processes 11 though a 
covalent intermediate using Pro1.  This was confirmed by trapping the substrate on the 
enzyme with NaCNBH3. When the same experiment was carried out with 11 and 
Cg10062, the enzyme is not inactivated and no covalently modified enzyme could be 
detected.45  Cg10062 processes approximately 80 mM of 11 in the presence of either 
sodium borohydride or sodium cyanoborohydride.  On this basis, it was concluded that 
Cg10062 does not use covalent catalysis like cis-CaaD, but rather does a direct hydration 
on 11.   
Subsequently, the T34A mutant of cis-CaaD was examined to see if it processed 
11 through a covalent intermediate like wild-type cis-CaaD.45  It was found that the T34A 
mutant of cis-CaaD goes through a covalent intermediate about 1 in every 5 turnovers of 
the enzyme.  In other words, about 80% of the time, the T34A mutant carries out a direct 
hydration in contrast to the almost exclusive formation of the covalent intermediate in 
wild-type cis-CaaD.  This observation suggests that the T34A mutant of cis-CaaD is more 
Cg10062-like in the mechanism it uses to process 11. 
 Another unique feature of 11 is its ability to report the stereochemistry of the 
proton addition atom at C-2.38,45.  cis-CaaD and Cg10062 were shown to add a proton 
stereospecifically at C2 on opposite faces of 11.45  The T34A mutant of cis-CaaD retains 
the same stereochemistry as wild-type cis-CaaD, even though it catalyzes the reaction by 
a different mechanism.45  The implications of these results remain unclear, but again they 
highlight differences between the two enzymes (cis-CaaD and Cg10062), which were 





Enzymes are essential for life.  Moreover, understanding how enzymes function is 
essential for advancing human health.  Not only are enzymes the targets for many 
pharmaceuticals, but the ability to harness the power of enzymes has other benefits 
including bioremediation and synthesis of pharmaceuticals and other important 
chemicals.  This process begins with an understanding of the exact features that define 
the specificity of an enzyme and how it catalyzes its reaction.  
If we revisit the “lock and key” model of an enzyme proposed by Emil Fischer, it 
becomes obvious that this model is a drastic oversimplification.  The rigidity suggested 
by the “lock and key” model is unrealistic.  However, the “lock and key” model does 
provoke questions about the evolution of the “lock”.  By classifying enzymes into 
superfamilies and characterizing them, one gains a better understanding of how each 
individual enzyme functions and what is similar and different about them.  In doing so, 
one gains a better understanding about the evolution of enzymes.  The tautomerase 
superfamily is a model system to understand enzyme function and evolution.  Within the 
TSF, the enzymes of the 1,3-dicholopropene catabolic pathway and their homologues 
show various catalytic strategies on a variety of different substrates while using very 
similar architectures.  They provide a good model system to study divergent evolution 
and the features that define specificity and catalysis.   
Specifically, the features that dictate the specificities of CaaD and cis-CaaD are 
unclear.  The work presented in Chapter 2 and 3 focus on our mechanistic understanding 
of the dehalogenation reaction catalyzed by CaaD.  This sets the stage for future work 
which may be able to elucidate the distinguishing features that define specificities in the 




A cis-CaaD homologue, Cg10062 has shown little specificity with several 
substrates tested.  Also, its lack of significant genomic context raises questions about its 
role in the organism.  In Chapter 4, a substrate with high specificity is identified for 
Cg10062. Upon further investigation with this substrate and other acetylene compounds, 
it was determined that Cg10062 catalyzes a previously unknown reaction.  These results 
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Chapter 2:  Design of a Fluorescent Mutant of trans-3-Chloroacrylic 
Acid Dehalogenase 
2.1 INTRODUCTION  
 A mixture of cis- and trans-1,3-dichloropropene (1, Scheme 2.1) constitutes the 
active ingredient in nematicides marketed as Telone II® and Shell D-D®.1  The 
effectiveness of 1 in soil is limited by its rapid degradation due, in part, to the bacterial 
1,3-dichloropropene catabolic pathway.1-3  In three enzyme-catalyzed steps, the isomeric 
mixture is processed to the trans- and cis-isomers of 3-chloroacrylic acid (2 and 3, 
respectively).2,4  Subsequently, these compounds are processed by the isomer-specific 
dehalogenases trans- and cis-3-chloroacrylic acid dehalogenase (CaaD and cis-CaaD, 
respectively) to malonate semialdehyde (4).4-6  Malonate semialdehyde decarboxylase 
(MSAD) converts 4 to acetaldehyde (5), which is channeled into the Krebs cycle.7  The 
three enzymes are members of the tautomerase superfamily, a group of structurally 
homologous enzymes characterized by a  building block and a catalytic amino-
terminal proline (Pro-1).8,9  These three enzymes provoke interesting mechanistic, 
structural, and evolutionary questions including how they became part of the same 




Scheme 2.1: 1,3-Dichloropropene Catabolic Pathway  
 
 Sequence analysis coupled with mechanistic and structural studies identified Pro-
1, from the -subunit, and Arg-8, Arg-11, and Glu-52, from the –subunit, as key 
catalytic residues in the heterohexameric CaaD.4,5,10,11  In the current working hypothesis 
for the mechanism (Scheme 2.2), Glu-52 functions as a general base catalyst to activate 
a water molecule for attack at C-3 of 2.10,11  The two arginines (Arg-8 and Arg-11) 
interact with the C-1 carboxylate group to align the substrate in the active site and draw 
electron density away from C-3, which facilitates the addition of water to C-3 to produce 
the enediolate species, 6.  In one scenario (Scheme 2.2, route A), Pro-1 (pKa ~9.2) 
protonates C-2 to complete the conjugate addition of water and form a chlorohydrin 
intermediate (7).  The chemical or enzyme-catalyzed decay of 7 then yields 4.  In a 
second scenario (Scheme 2.2, route B), 6 rearranges to enol 8, which is coupled with the 
elimination of the chloride (i.e., an -elimination of HCl), and subsequent ketonization 






Scheme 2.2: Catalytic Mechanism of CaaD using trans-3-Chloroacrylic Acid (2)__ 
 
 Given the similarities in the overall active site organization, it was initially 
thought that the mechanisms of CaaD and cis-CaaD were largely the same, with 
differences in the primary (70 and 75 amino acids for the - and -subunits of CaaD vs 
149 amino acids in cis-CaaD) and quaternary structures (heterohexamer vs trimer), and 
the corresponding isomer specificities.6  However, in light of additional results, it became 
apparent that there are at least three major differences in the catalytic mechanisms.  First, 
two extra residues, His-28 and Tyr-103, are involved in the dehalogenation of the cis-
isomer.12  The positions of these residues in a crystal structure suggest that His-28 aligns 
with the arginine pair and Tyr-103 assists a glutamate residue (Glu-114) in the activation 
of water.  There are no obvious counterparts for these residues in CaaD.  Second, a loop 
may be involved in cis-CaaD catalysis, where substrate binding induces loop closure, 
facilitating catalysis.13  A similar event has not been discovered in the catalytic cycle of 
CaaD.  Third, there is very recent evidence that cis-CaaD utilizes a covalent intermediate 
(via Pro-1) to process an alternate substrate, 2,3-butadienoate, and that some fraction of 




 Potential roles for the loop and the covalent intermediate in the cis-CaaD 
mechanism were suggested in part from pre-steady-state kinetic experiments.13,14  The 
experiments reported here were part of a larger effort to delineate similarities and 
difference between CaaD, cis-CaaD, and their mutants, and to establish a basis for their 
catalytic differences.  In this chapter, we use trans-3-bromoacrylate (9) as the substrate 
because the release of bromide can be accurately quantified, as shown in our previous 
studies on cis-CaaD.13 The stopped-flow fluorescence experiments on cis-CaaD relied on 
a signal provided by a single tryptophan residue (Trp-101) in the active site cavity.13  
CaaD does not have a significant native fluorophore: it only contains 2 tyrosine residues 
(αTyr-9 and αTyr-60), one of which (αTyr-60) is located near the active site.10  Hence, a 
tryptophan residue was introduced to provide a stronger signal for stopped-flow 
fluorescence experiments.  Here, we show how in silico docking studies guided our 
selection of a point mutation to introduce a tryptophan residue to provide a strong 
fluorescence signal to monitor enzyme states during catalysis. Mutation at this position 
had a minimal effect on the observable CaaD reaction, as assessed by the steady-state 
kinetic parameters, rapid quench experiments, and bromide inhibition studies.  This 
mutant sets the stage for more in-depth kinetic studies to be carried out in an effort to 
gain more information about the features that distinguish CaaD from other family 




2.2 MATERIALS AND METHODS 
 Materials.  Chemicals, biochemicals, buffers, and solvents were purchased from 
Sigma-Aldrich Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Pittsburgh, PA), 
Fluka Chemical Corp. (Milwaukee, WI) or EMD Chemicals, Inc (Gibbstown, NJ).  The 
reagents used in the ion chromatography (IC) and rapid quench experiments were 
acquired from sources reported elsewhere.13,14 The centrifugal filter devices (3,000 MW 
cutoff) were obtained from PALL Life Sciences (Ann Arbor, MI).  Column resins were 
obtained from Sigma-Aldrich. 
 Bacterial Strains, Plasmids, and Growth Conditions.  Escherichia coli strain 
BL21-Gold(DE3) was obtained from Stratagene (La Jolla, CA).  The E. coli DH5 cells 
were obtained from Invitrogen (Carlsbad, CA).  The construction of the pET-24a(+) 
vector (EMD Chemicals, Inc.) containing caad1 and caad2 (the α- and β-subunits of  
CaaD, respectively) is described elsewhere.4,5,15  Cells were grown at 37 °C in Luria-
Bertani (LB) media that contained kanamycin (Kn, 30 µg/mL).  
 General Methods. The PCR amplification of DNA sequences was conducted in a 
GeneAmp 2700 thermocycler (Applied Biosystems, Carlsbad, CA).  Techniques for 
restriction enzyme digestion, ligation, transformation, and other standard molecular 
biology manipulations were based on methods described elsewhere.16 DNA sequencing 
was performed by the DNA Core Facility in the Institute for Cellular and Molecular 
Biology (ICMB) at the University of Texas at Austin.  Mass spectrometer (MS) data 




CA) housed in the ICMB Protein and Metabolite Analysis Facility at the University of 
Texas.  Steady-state kinetic assays were performed on an Agilent 8453 diode-array 
spectrophotometer at 22 °C.5  Non-linear regression data analysis was performed using 
the program Grafit (Erithacus Software Ltd., Staines, U.K.).  Protein concentrations were 
determined according to the method of Waddell.17 Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) was carried out on denaturing gels 
containing 15% or 20% polyacrylamide.18   
2.2.1 Docking Studies 
 In order to identify and optimize positions for a tryptophan residue in the CaaD 
active site, docking studies were carried out using PyMOL with Autodock Vina.19,20  To 
minimize differences in the active sites of the different CaaD crystal structures, 21 active 
sites in four reported crystal structures were compared (PDB codes: 1S0Y1, 3EJ3, 3EJ7, 
3EJ9). [Each heterohexamer contains 3 active sites.  One crystal structure (PDB code 
3EJ9) contains a single heterohexamer, whereas those for PDB codes 1S0Y, 3EJ3, and 
3EJ7 contain two heterohexamers.  This gives a total of 21 active sites.]  The crystal 
structures include those with covalent (malonic acid, 1S0Y) and non-covalent ligands 
(acetate and phosphate, 3EJ3), and those without any ligands (3EJ7 and 3EJ9).  The side 
chains of Glu-52 and Leu-57 adopt different rotomers depending on the bound ligand 
limiting the available active site space.  The active site with the covalently bound 
malonyl adduct was chosen as the receptor for docking studies (Figure 2.1A).  The 




3-bromo or 3-chloropropiolate, as described elsewhere.5,10  The adduct was removed 
before docking experiments were performed (Figure 2.1B).  A 10 Å  15 Å  10 Å box 
centered on the βPro-1 residue was selected as the origin of docking. The side chains of 
Glu-52 and Leu-57 were designated as flexible during docking routines. 
 
Figure 2.1: Active Site of CaaD  
Two views of the active site of CaaD.  A) The key catalytic residues of 
CaaD shown as sticks with Pro-1 covalently attached to malonate after 
reaction with 3-bromopropiolate.10  B) The approximate active site volume 
as predicted in Pymol is shown in mesh after the malonate moiety has been 
removed from the active site.  The mesh area below E52 shows 





2.2.2 Construction of the CaaD Mutants 
Four CaaD mutants were constructed using a pET-24a(+) vector containing both 
caad1 and caad2 genes as the template. Mutations were introduced at the appropriate 
position using the QuikChange Site-Directed Mutagenesis Kit from Agilent (Santa Clara, 
CA) following the manufacturer's instructions.  Briefly, the amplification mixtures (50 
µL) contained 10X QuikChange buffer, 200 µM of each dNTP, 250 nM of each primer, 
25-50 ng of template DNA, and 2.5 U of Pfu turbo Hot Start polymerase.  Typically, the 
cycling parameters were 95°C for 2 min followed by 18 cycles of 95°C for 30 s, 55°C for 
30 s and 68°C for 6 min with a final elongation step of 68°C for 10 min.  The annealing 
temperature could be varied between 55°C and 75°C, which is approximately 5°C below 
the standard melting temperature of the primers.  The extension time could also vary 
between 6 and 12 min.  Oligonucleotide primers (coding and complementary) with the 
desired change to make the αY60W, αM7W, αL57W, and βI37W CaaD mutants were 
obtained from Sigma-Aldrich. The forward and reverse primers used to introduce the 
mutations were respectively: 5'-CTGCCGGACTGGGTGCCAG-3' and 5'-
CTGGCACCCAGTCCGGCAG-3' (αY60W); 5'-CTTGCGACTGGCGCTATGGGAG-3' 
and 5'-CTCCCATAGCGCCAGTCGCAAG-3' (αM7W); 5'-
CGAGCATTGGCCGGACTAC-3' and 5'-GTAGTCCGGCCAATGCTCG-3' (αL57W); 
and 5'-CGACCCCAAGTGGATCAATG-3' and 5'-CATTGATCCACTTGGGGTCG-3' 
(βI37W).  After amplification , 1 U of the restriction enzyme, Dpn1, was added reaction 




thereby removing most of the template from the reaction mixture.  The DNA products 
were purified using the MiniElute PCR Purification Kit (Qiagen, Valencia, Ca.) and 
transformed into E. coli DH5 cells for plasmid preparation.  Single colonies were used 
to inoculate 20 mL of LB/Kn media. The cultures were grown overnight at 37 °C and 
plasmids were isolated using the GenElute Plasmid Miniprep Kit (Sigma-Aldrich).   
2.2.3 Expression and Purification of CaaD and CaaD Mutants 
 CaaD was grown and expressed in E. coli BL21-Gold(DE3) cells and purified by 
a variation of published protocols.5,15  An overnight starter culture (40 mL) was grown at 
37 °C from a single colony and used to inoculate five 2 L Erlenmeyer flasks (each 
containing 500 mL of   LB/Kn media).  The cultures were incubated for ~2 h at 37 °C.  
Protein expression was induced with isopropyl β-D-thiogalactopyranoside (1 mM, final 
concentration), followed by a 4-5 h induction period at 37 °C. Cells were harvested by 
centrifugation (4,000 × g), to yield ~7 g of cells and stored at -80 °C. Cells were 
suspended in 10 mM Na2HPO4 buffer, pH 8 (Buffer A) and lysed by sonication.  The 
resulting solution was centrifuged for 30 min (23,500 × g) and the supernatant was 
subjected to an additional 30 min of centrifugation (330,000 × g).  Solid (NH4)2SO4 (for 
a final concentration of 1.6 M) was slowly added (over 10 min) to the supernatant and 
the resulting solution was stirred on ice for 1 h, and then centrifuged for 15 min (23,500 
× g).  The clarified supernatant was filtered (0.2 µM pore) and loaded onto a Phenyl-
Sepharose 6 Fast Flow column (0.5 × 10 cm, ~4 mL resin) pre-equilibrated with Buffer 




mL of Buffer B followed by a linear salt gradient [1.6-0 M (NH4)2SO4].  Protein typically 
elutes 45-60 min after initiation of the salt gradient.  Protein purity in the individual 
fractions was evaluated by SDS-PAGE and activity assays.  Fractions with the highest 
activity and purity were pooled and exchanged into Buffer C (50 mM Na2CO3 buffer, pH 
10.5) using an Amicon stirred-cell concentrator (10,000 MW cutoff).  Exchanged protein 
was then loaded onto a Q-Sepharose 6 Fast Flow column (~7 mL of resin) pre-
equilibrated with Buffer C and washed (~1 mL/min) with Buffer C (5 mL), followed by 
elution using a linear salt gradient (0-0.1 M Na2SO4).  Protein typically elutes 15-45 min 
after the start of the salt gradient.  The appropriate fractions, assessed as described above, 
were pooled.  The combined fractions were exchanged into 100 mM Na2HPO4 buffer, pH 
8, using an Amicon stirred-cell concentrator (10,000 MW cutoff) and concentrated to 
~16 mg/mL (~1 mM).  Yields were typically ~75 mg of homogenous protein from 2.5 L 
of culture.  
2.2.4 Mass Spectral Analysis and CaaD and CaaD Mutants 
 The monomer molecular masses of CaaD and the CaaD mutants were determined 
by electrospray ionization mass spectrometry (ESI-MS) using LCQ electrospray ion-trap 
mass spectrometer.  Samples for ESI-MS analysis were made 1 mg/mL and prepared as 
reported.5  The observed molecular mass (MH+) for the α- and β-subunits of CaaD are 
8343 Da and 7505 Da, respectively.  The α-subunits of Y60W, M7W, and L57W-CaaD 




CaaD shows a molecular mass of 7578 Da.  These masses agree with the calculated 
masses (within experimental error). 
2.2.5 Steady-State Kinetics 
 The steady-state kinetic parameters for CaaD and the four CaaD mutants were 
measured using trans-3-bromoacrylate (9).5  The assays were carried out at 22 °C in 100 
mM Na2HPO4 buffer, pH 8.1, using a 2 µM enzyme solution (based on the α-β dimer 
molecular mass).   Enzyme solutions were equilibrated for 1 h prior to use.  The assay 
was initiated by the addition of 9 from a 20 mM stock solution (made up in 100 mM 
phosphate buffer, final pH 8.1). The decrease in absorbance at 224 nm, corresponding to 
the hydration of 9 (ε224= 9100 M
-1 cm-1), was monitored over a 60 s time period, with 
readings recorded every 3 s.  Initial rates were plotted vs. substrate concentration and fit 
to the Michaelis-Menten equation using Grafit to determine kcat
 and Km.  Data for full 
time course experiments (300 s) were collected using five concentrations of 9 (20, 50, 80, 
100, and 150 µM).   
2.2.6 Stopped-Flow Experiments 
 The stopped-flow experiments were carried out on a SF 2004 series stopped-flow 
apparatus (KinTek Corp).  Wild-type, αY60W- and αM7W-CaaD, were separately made 
up in 100 mM Na2HPO4 buffer, pH 8.1, to final concentrations of 20 µM (based on the 
α-β dimer molecular mass), and allowed to equilibrate at 22 °C for 1 h.  Various 
concentrations of 9 (0-20,000 µM) were made up in 100 mM Na2HPO4 buffer, pH 8.1.  




were then mixed in the stopped-flow apparatus at 22 ºC.  The fluorescence was excited at 
280 nm and emission was observed using a 340 nm band pass filter (Semrock, Rochester, 
NY).  The slit width on the monochromator and the light filter were set at 0.6 mm.  
Traces represent an average of at least five runs at each substrate concentration.  The 
time courses range between 1-300 s with 1000 data points collected for each trace.  
Stopped-flow fluorescence traces were fit initially to defined exponential functions by 
non-linear regression using the KinTek stopped-flow software.  Data were fit either to a 
single exponential (Eq. 2.1) or double exponential function (Eq 2.2).  










t)C                            (Eq. 2.2) 
The concentration dependence of the rate was fit to a hyperbola (Eq. 2.3) using non-










rev         (Eq. 2.3) 
Light transmittance (280 nm) was also monitored in the stopped-flow apparatus with 




2.2.7 Rapid-Quench Experiments 
 The rapid-quench experiments were carried out at 22 °C on a RFQ-3 quench-flow 
apparatus (KinTek Corp).  The experimental procedure followed previously published 
ones with the modifications noted below.13  To correct for dilution errors introduced by 
sample preparation and the rapid quench apparatus, tartrate was included as an internal 
standard.  Tartrate is well-resolved from other peaks (e.g. bromide, phosphate, and 
sulfate), readily quantified by ion chromatography (IC), and does not inhibit CaaD at 
concentrations of 4 mM (data not shown).   Typically, ~8 mM tartrate (4 mM final 
concentration) was added to a concentrated enzyme solution (400-1000 µM) in 100 mM 
Na2HPO4 buffer, pH 8.1, and allowed to equilibrate for 1 h.  For each experiment, one 
syringe was loaded with enzyme solution (400-1000 µM) containing 8 mM tartrate and a 
second syringe was loaded with freshly prepared 9 (from a 20 mM stock solution, pH 
8.1).  The reaction mixture (~15 µL enzyme and ~15 µL substrate)  was quenched at 
intervals ranging from 3 ms to 1.5 s (depending on the kcat of the enzyme) with 0.6 M 
H2SO4 (~90 µL). The individually quenched reaction mixtures (~110 µL) were then 
transferred to a PALL centrifugal filter device (3,000 MW cutoff), and centrifuged at 
11,000 rpm for 30 min to remove enzyme.  The effluent was saved (~80 µL) and used for 
bromide and tartrate quantification.  An aliquot of the effluent (~25 µL) was diluted into 
475 µL of 20 mM NaHCO3 buffer, pH 9.0, to give a final volume of 500 µL, pH ~3.0.  
To quantify the amount of tartrate added to the concentrated enzyme solutions, an 
unreacted enzyme control sample (~100 µL) was filtered (as above) to remove enzyme 




to give a final volume of 500 µL.  These control samples were made up in triplicate and 
the tartrate concentration was quantified by IC analysis.  A dilution factor for each 
sample was determined by dividing the final tartrate concentration by the average initial 
tartrate concentration added to the enzyme solution.  The bromide ion concentration was 
determined using IC on an ICS-1500 instrument as previously described with the 
following modifications.13  The contents of the mixture elute over a 18 min period.  
Bromide ion was detected by suppressed conductivity with an applied current of 25 mA 
and quantified as described.13  A linear plot of the peak area vs. the concentration of 
bromide gives a slope of 0.018 ± 0.002 µS × min-1 × ppm-1 (correlation coefficient ~ 
0.995), where  µS is microsiemens and ppm is parts per million. The calibration curve for 
tartrate was constructed using a stock solution of 100 mM sodium tartrate in 20 mM 
NaHCO3 buffer, pH 9.0.  Seven serial dilutions (0.08-50 mM) were made from the 100 
mM sodium tartrate solution stock.  A linear plot of the peak area vs. the concentration 
gave a slope of 0.0020 ± 0.0001 µS × min × mM-1 (correlation coefficient ~ 0.995). 
 Data were fit to the burst equation (Eq. 2.4) to estimate the rate () and amplitude 
(A) of the reaction followed by steady-state turnover (kss): 
(1 exp( )) ssY A t k t              (Eq. 2.4) 




2.3 RESULTS  
2.3.1 In silico Docking Experiments  
 In order to provide a larger signal for stopped-flow fluorescence experiments on 
CaaD, we introduced a tryptophan residue at a position near the active site. We evaluated 
several potential sites based upon minimal impact on the reaction kinetics and enzyme 
structure.  Inspection of the available crystal structures of CaaD (1S0Y, 3EJ3, 3EJ7, 
3EJ9) and cis-CaaD (2FLZ) combined with a series of docking studies, identified six 
potential sites for the insertion of the tryptophan (Phe-39, Phe-50, Leu-57,Ile-37, 
Met-7, Tyr-60).  Docking studies were carried out in silico with wild-type CaaD and 
six tryptophan mutants (F39W, F50W, M7W, Y60W, L57W, and I37W 
generated by in silico using the PyMOL mutagenesis wizard) and 9 (Figure 2.2A).20  
With the exception of the F39W and L57W  in silico mutants, (the tryptophan side 
chain of the L57W mutant was held fixed during the docking studies) the consensus 
binding orientation for 9, as assessed by the lowest predicted free energies of binding 
(Table 2.1), places the carboxylate group near the two arginine residues and the bromide 
moiety buried near the back of the active site, facing a potential halide binding pocket 
consisting primarily of Phe-39 and Phe-50.  Interestingly, in this consensus binding 
mode, the side chains of Glu-52 and Leu-57 adopt rotomers that increase the size of 
the active site pocket (Figure 2.2B).  This increase in the active site volume (shown in 




























Wild-type -4.8 -3.5 
Y60W -5.1 -3.6 
M7W -4.8 - 
L57W -4.0 -  
I37W -4.8 - 
F39W -4.9
 - 
F50W -5.0 - 
aThe ΔG value for binding as 
predicted by AutoDock Vina for the 
binding of 9 to CaaD and mutants 
(Figure 2.2A).19   
bThe ΔG for the binding of 9 to CaaD 
in which the points into the 
active site such that it can carry out 







Figure 2.2:  Substrate Docking Studies 
A) Six docking poses of 9 in the CaaD active site having the lowest energies 
of binding (G values can be found in Table 2.1 after each residue (shown 
in color) was independently replaced with a tryptophan (in silico).  Four 
poses of 9 are superimposable, whereas the poses of 9 in the ’F39W (cyan) 
and L57W (pink) enzymes are slightly different.  All lowest energy poses 
move E52 (as found in cystal structure to solid sticks) as illustrated by the 
arrow.  B) Docking of 9 (spheres) into wild-type CaaD.19  Shown in mesh is 
the in silico active site pocket volume.  The movement of E52 to expand 
the active site volume is shown by the arrow.  C)  An alternative docking 
mode for 9 with E52 in a position to perform the proposed chemistry with 
the newly predicted active site volume shown in mesh. The figure was 




 At first glance, Phe-39 and Phe-50, seemed to be the most promising sites for a 
tryptophan substitution: Phe-39 superimposes on Trp-101 in cis-CaaD (monitored in 
stopped-flow experiment on cis-CaaD,13 and Phe-50 aligns with a tryptophan in two 
other tautomerase superfamily members [i.e., a heterohexamer 4-oxalocrotonate 
tautomerase  and a 4-OT homologue in the tomaymycin biosynthetic pathway designated 
TomN].21,22  However, in silico mutagenesis of these residues indicates that the CaaD 
active site cannot accommodate the larger indole side chain of the tryptophan residue.  In 
the αF39W in silico mutant, there are steric clashes with nearby residues and a significant 
volume reduction of the putative halide binding pocket.  In the αF50W in silico mutant, 
all rotomers exhibit significant steric clashes including one with the β1 strand containing 
αArg-8.  Moreover, docking studies using 2 and 9 show steric clashes with the halide 
moiety of each substrate.  These results may partially explain the intractable kinetic data 
previously obtained with the F39W mutant of CaaD using 9.23  Hence, the αF39W and 
αF50W positions were no longer considered as possible sites for tryptophan introduction.  
 The Y60W in silico mutant has a predicted energy of binding (with 9) that is 
comparable to wild-type (–5.1 kcal/mol vs. 4.8 kcal/mol).19 Moreover, docking 
conformations in which the side chain of Glu-52 points into the active site (Figure 
2.2C) such that it can carry out the proposed chemistry, (i.e. activation of a water 
molecule for attack at C-3), were observed for both the in silicoY60W mutant and 
wild-type CaaD (each at, -3.5 kcal/mol).  A similar conformation for Glu-52 is 




on Pro-1, perhaps reflecting the position of Glu-52 after the attack of water on 9.  
Based upon our in silico analysis, four mutants, M7W, Y60W, L57W, and I37W 
were constructed and their properties analyzed. 
2.3.2 Steady-state Kinetic Parameters of CaaD and CaaD Mutants 
 Four CaaD mutants, M7W, Y60W, L57W, and I37W, were constructed and 
purified.  Mass spectral analysis shows nearly homogenous proteins (>95%) with the 
predicted subunit molecular masses (monomeric).  The L57W and I37W mutants of 
CaaD showed no activity with 2 or 9.  Exploratory stopped-flow experiments carried out 
with the I37W mutant and 9 suggest that I37W-CaaD binds 9 very weakly with a Kd  > 
40 mM.  Due to the similar locations of I37 and L57 in the active site, it appears that 
both mutants show difficulty with binding the substrate.  One explanation for this 
observation is that the indole side chain of tryptophan is forming a “gate” that prevents 9 
from entering the active site.  No further experiments were carried out on these two 
mutants and their positions were no longer considered as possible sites for tryptophan 
introduction.    
 In contrast, the M7W and Y60W mutants have steady-state kinetic parameters 
(with 9) comparable to those of wild-type enzyme (Table 2.2).  The Km value for M7W-
CaaD was comparable to that of wild-type, whereas the kcat decreased ~4-fold.  As a 




Y60W-CaaD decreased ~1.5-fold compared with wild-type, but the values of kcat and 


























type 120 ± 10 2.5 ± 0.1 1.3 ± 0.1 × 104 
M7W 120 ± 10 0.6 ± 0.1 0.3 ± 0.1 × 104 
Y60W 70 ± 3.5 2.5 ± 0.1 1.2 ± 0.1 × 104 
I37W > 40,000b - - 
aThe kinetic parameters were measured in 100 mM 
Na2HPO4 buffer (pH 8.1) at 22 °C following a 
decrease in absorbance at 224 nm.5  Errors are 
standard deviations.  
bDetermined in a stopped-flow experiment using 9, 




Full progress curves (300 s) were also carried out with these two mutants following the 
disappearance of various concentrations of 9 at 224 nm.  At all concentrations of 9, the 
UV traces for Y60W-CaaD (shown in orange in Figure 2.3) mirror those of wild-type 
CaaD (shown in blue in Figure 2.3), reflecting the similar kcat values.  However, those 
corresponding to the M7W mutant (shown in green in Figure 2.3) exhibit slower rates 
compared with wild-type, reflecting the reduced kcat value. 
 
Figure 2.3:  Full-Time Course Comparison of Wild-Type and Mutants of CaaD with 
trans-3-Bromoacrylate (9)  
A) The UV traces following the disappearance of 9 (18, 42, 63, 83, and 125 
µM) at 224 nm catalyzed by CaaD (blue), the Y60W mutant (orange), and 
the M7W mutant (green).  The full time courses for wild-type and the 
Y60W mutant are comparable.  The full time course for the M7W mutant 




2.3.3 Pre-Steady-state Stopped-Flow Kinetic Experiments 
 The newly-created fluorescent CaaD mutants, M7W and Y60W, were 
examined for their ability to report active site changes during the course of the enzymatic 
reaction.  Changes in the enzyme fluorescence of both mutant proteins were monitored 
during the initial phases (12 s) and full time course (120 s) of the reaction with 9 (Figure 
2.4).  In the first second of the initial time course, the Y60W and M7W mutants 
exhibited 2- and 3.5-fold decreases in fluorescence, respectively (Figures 2.4A and 2.4B).  
The full time course (120 s) shows that this decrease was followed by an increase in 
fluorescence, which eventually plateaus, as the reaction reaches completion (Figures 2.4C 
and 2.4D). Neither mutant shows significant photobleaching under the reaction 
conditions.  Both mutants have similar initial reaction kinetics, which can be 
approximated by a single exponential, ignoring a possible lag at the beginning of the 
trace (The significance of this is discussed in Chapter 3).  However, notable differences 
between the two mutants were observed in the full time course data (Figures 2.4C and 
2.4D). The Y60W-CaaD mutant rapidly returns to a final fluorescence plateau, whereas 
the M7W-CaaD showed a slower return to the final fluorescence value highlighting the 





Figure 2.4: Stopped-Flow Fluorescence Traces of Y60W-CaaD and M7W-CaaD 
A) Y60W-CaaD for 12 s; B) M7W-CaaD for 12 s; C) Y60W-CaaD for 
120 s; and D) M7W-CaaD for 120 s.  The Y60W-CaaD mutant shows 
about a 2-fold decrease in fluorescence, whereas the M7W-CaaD mutant 
shows a 3.5-fold decrease over the first 1 s of the reaction. Note the smaller 




Stopped-flow fluorescence measurements were also performed using wild-type 
CaaD, monitoring the native enzyme fluorescence at 340 nm (with excitation at 280 nm).  
The fluorescence in the wild-type enzyme is likely due to Y60 because of the location 
near the active site and the similarities observed for the wild-type (shown in blue in 
Figure 2.5) and Y60W CaaD mutant (shown in orange in Figure 2.5).  Due to the poor 
quantum yield of tyrosine, the wild-type fluorescence data have a reduced signal-to-noise 
ratio.  However, the data sets from both wild-type and the Y60W-CaaD mutant showed 
the same initial single exponential drop in fluorescence, and conventional analysis of 
both data sets (Table 2.3) yielded the same maximum rates (within error, shown in Figure 
2.6B) when considering only the higher concentrations where the signal with wild-type 
enzyme was sufficient to afford reliable data fitting. Note that in both data sets, traces 
obtained at increasing substrate concentrations were offset due to the absorption of 





Figure 2.5: Stopped-Flow Enzyme Fluorescence of Wild-type and Y60W-CaaD 
mutant        
Stopped-flow enzyme fluorescence (12 s) monitoring the reaction of wild-
type CaaD (blue) and the Y60W-CaaD mutant (orange) with 9.  Both show 
single exponential decay in fluorescence in the first 1 s, but the Y60W 
CaaD mutant shows a significant improvement in the signal-to-noise ratio.  
Note, wild-type data set has been normalized to superimpose it on the 











Table 2.3.  Rates and Equilibrium Constants Obtained from Conventional Analysis of 
Stopped-flow Data using trans-3-bromoacrylate (9) 
 
Data obtained with the Y60W-CaaD mutant gave a significantly larger signal-
to-noise ratio at all concentrations, allowing more extensive analysis as shown in Figure 
2.6.  Initially, the first second of each trace was fit to a single exponential function 
(Figure 2.6A, Eq. 2.1).  The concentration dependence of the rate (obtained from the 
single exponential) was fit to a hyperbola (Figure 2.6B, Eq. 3) suggesting a minimal two-
step model with a rapid equilibrium step (Kd) followed by rate-limiting isomerization 
governed by forward and reverse rate constants (kfor and krev).  Analysis of the 
concentration dependence of the rate defined an apparent Kd = 400 M for initial 














Wild-type 720 3 6 
Y60W-CaaD 400 8 2.5 
M7W-CaaD 7500 12 1 
aRate constants are defined in Eq. 2.3.  bResults from 
fit shown in Figure 2 (raw data shown in Figure 2.5).  
Fit for M7W-CaaD not shown (raw data shown in 




well-defined intercept on the y-axis afforded resolution of a net forward rate (kfor ~ 8 s
-1) 
and an apparent reverse rate (krev ~ 3 s
-1). The numerical values above are summarized in 
Table 2.3.  A more rigorous interpretation and explanation of these results are detailed in 

















Figure 2.6: Conventional Fitting of Stopped-Flow Fluorescence Data with Y60W-
CaaD  
A) The stopped-flow fluorescence traces (0.5 s) showing reaction of 
Y60W-CaaD with 9 were fit to a single exponential (Eq 2.1) shown in 
solid lines.  The concentrations of 9 are: 0, 50, 100, 150, 250, 550, 1000, 
2000, 3000, 4000, 5000, 6000, 8000, 10000 µM.  B) The observed rate 
constant (kobs) from the 1 s stopped-flow data for the wild-type () and the 
Y60W () CaaD plotted versus the concentration of 9.  Error bars for the 
kobs values are representative of the scatter in the data.  Within error, the 
rates at high concentrations are identical.  At lower concentrations, the 
signal to noise is to low too accurately resolve the rate.  The solid line is a fit 




2.3.4 Rapid-Quench Experiments with CaaD and Y60W-CaaD 
 In light of the similarities in the kinetic parameters for wild-type and Y60W 
CaaD, rapid quench experiments were carried out with both enzymes, to provide a more 
rigorous comparison.    Experiments were conducted by mixing equal volumes of various 
concentrations of enzyme (CaaD: 400 M; Y60W-CaaD: 250, 400, and 600 M, after 
mixing) and an excess of 9 (10 mM, after mixing).  At fixed intervals (3-1500 ms), the 
reactions were quenched with acid, and the amount of bromide ion quantified by IC and 
plotted versus time (Figures 2.7A and 2.7B).  A pre-steady-state burst of product 
(bromide) formation was observed for both enzymes in all experiments, with a fast initial 
burst rate followed by a slower steady-state turnover rate.  The observation of a pre-
steady-state burst implies that a step after chemistry is at least partially rate limiting in 
both the CaaD- and Y60W-CaaD-catalyzed reactions.24  Data were fit to the burst 
equation (Eq. 2.4) to yield the kinetic parameters summarized in Tables 2.4 and 2.5, 
defining the rate of the burst as approximately 85 s-1, followed by steady-state turnover of 
3 s-1.  The sum of these observations, along with the steady-state kinetic parameters and 
stopped-flow data presented above, indicated that the Y60W mutant of CaaDwas a 
suitable candidate for subsequent in-depth analysis and use as a model for the wild-type 





Figure 2.7: Pre-steady-state Burst of CaaD and Y60W-CaaD  
Rapid quench experiments using CaaD and Y60W-CaaD fit to the burst 
equation. A) A comparison of the wild-type CaaD  () and the Y60W-
CaaD () showing the burst of bromide followed by steady-state turnover. 
The concentration of enzyme was 400 µM. B) Rapid quench experiment for 
three concentrations of Y60W CaaD: 250 µM (), 400 µM (), and 600 
































Wild-type 90 ± 20c 3 ± 0.5 0.8 
Y60W 86 ± 10 2.5 ± 0.5 0.9 
aThe kinetic parameters were measured in 100 mM 
Na2HPO4 buffer (pH 8.1) at 22 °C with a saturating 
concentration of 9. bCalculated from the burst 
equation.24  c Errors are standard deviations.  










 43 ± 3c 1.8 ± 0.5 0.85 
400 86 ± 20 2.5 ± 0.5 0.9 
600 
107 ± 
15 2.8 ± 0.5 0.94 
aThe kinetic parameters were measured in 100 mM 
Na2HPO4 buffer (pH 8.1) at 22 °C with saturating 
concentration of 9 (10,000 µM).  bCalculated from the burst 





 Enzymes have evolved ingenious catalytic strategies to remove halogens bonded 
to alkane, aromatic, and alkene substrates without the use of metal ions or other 
cofactors.25,26  The haloalkane dehalogenases designated DhlA26-29, 4-chlorobenzoyl-CoA 
dehalogenase30-34, CaaD2-5,10,11,15, and cis-CaaD6,12-14 illustrate the reactions and their 
similarities and differences.  The first two of these enzymes catalyze reactions that 
proceed by a well-characterized covalent ester intermediate25,26, whereas cis-CaaD and 
CaaD do not.5,6,9  Extensive mechanistic, structural, and kinetic studies have defined key 
features of all four enzyme-catalyzed reactions including the catalytic and binding 
residues, rate limiting steps, conformational changes, and the presence or absence of a 
halide-binding pocket.   
 Although cis-CaaD and CaaD have the same core catalytic residues (the amino-
terminal proline, two arginines, and a glutamate), the cis-CaaD reaction appears to be 
more complex than that of CaaD because two additional active site groups (i.e., His-28 
and Tyr-103) are required for activity.12  There is no obvious explanation for the 
additional complexity, and the hydration of the cis-isomer is not expected to be 
energetically more difficult.  As part of an effort to understand the basis for this 
difference and to define the fundamental reaction scheme, a kinetic analysis of both 
enzymes and their mutants is being pursued.  A kinetic mechanism for cis-CaaD has been 
proposed. 13  Although upon further investigation, there is evidence that the kinetic model 
is more complex than initially thought.14  A similar comprehensive analysis of the CaaD 




a signal to define kinetically significant enzyme states.10  This prompted the construction 
of 5 fluorescent mutants of CaaD: Y60W, M7W, F39W,L57W, and I37W.  Two 
of these mutants were inactive, L57W, and I37W.  Two of these mutants, M7W and 
F39W, performed well as a fluorescent reporter, however M7W showed significant 
kinetic deviations from the wild-type enzyme.   
The Y60W mutant of CaaD was validated as an accurate fluorescent reporter of 
active site events and it yielded satisfactorily equivalent kinetic results to wild-type CaaD 
in all experiments.  These experiments include: steady-state kinetics (Table 2.2 and 
Figure 2.3A), stopped-flow enzyme fluorescence (Table 2.3 and Figures 2.5 and 2.6B), 
rapid acid quench (Table 2.4 and Figure 2.7A) and steady-state bromide inhibition studies 
not shown).  The validation of this fluorescent mutant of CaaD allows for further 
experiments to be carried out which might provide insight into the distinguishing 
mechanistic features of the CaaD enzyme.   
In Chapter 3, the Y60W CaaD data shown above (along with more data to be 
shown in Chapter 3) is globally fit to a single kinetic model defining six individual rate 
constants, an equilibrium constant for one product, and values for one of the two possible 
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Chapter 3:  The Kinetic Mechanism of the Y60W Mutant of trans-3-
Chloroacrylic Acid Dehalogenase  
3.1 INTRODUCTION 
 In Chapter 1 of this dissertation, one of the principals of enzymology was 
introduced (Figure 1.1).  Emil Fischer proposed the lock-and-key model hypothesis to 
explain how enzymes work.  In this model, Fischer hypothesized that the binding of a 
substrate to form an enzyme-substrate complex was followed by catalytic turnover to 
reform free enzyme and product.1  This model was the first of several to explain the 
mechanisms of enzyme catalysis.  Analysis of kinetic data provides one platform to 
achieve this goal.     
In 1913, Maud Menten and Leonor Michaelis published work that highlighted the 
importance of analyzing kinetic data in order to gain information about an enzyme-
catalyzed reaction.2,3  Their work focused on the enzyme “invertase” (known today as -
D-fructofuranosidase), which converts sucrose to glucose and fructose (Scheme 3.1).2,3   
Scheme 3.1: Reaction of “Invertase” 
   
 
 Although the kinetic work on “invertase” was started by Victor Henri, Michaelis 




for the interconversion of the - forms of glucose and control of pH)  which prevented 
him from fully testing his theory about the formation of a catalytic enzyme-substrate 
complex.2  By studying changes in initial velocity of substrate (sucrose) depletion as a 
function of increasing sucrose concentrations, Michaelis and Menten developed their now 
famous equation, the Michaelis-Menten equation (sometimes referred to as the Henri-
Michaelis-Menten equation, Eq. 3.1).  By 1925, the arguments were fully developed to 
support the validity of their experiments.  The Michaelis-Menten equation is of the 










         Eq. 3.1 
 Today, enzymologists are quite familiar with this equation and studying initial 
velocities of a reaction to gather information about the kcat and Km of enzymes.  Although 
it is forgotten, Michaelis and Menten were the first to fit full time course kinetic data, not 
just the initial velocities.2,3  They recognized that product inhibition played a significant 
role in the full time course kinetic data.  By taking product inhibition into account, they 
were able to fit full time course data to an integrated form of the rate equation for their 
two-step model.2  By fitting the data for several starting sucrose concentrations, they 
were able to obtain a fit to a family of curves and that yielded a single, reproducible 
“constant value”.2,3  In essence, this was the first global fit of data to a proposed model.  
Interestingly, the “constant value” Michaelis and Menten calculated was actually 
equivalent to kcat/Km, not the Michaelis constant or Km as it is referred to today.
2   
 Even though Michaelis and Menten realized the power in developing a “model” to 
account for all the observable data, this technique is not used nearly as frequently as the 




complexity of enzyme catalysis, which greatly increases the complexity of the 
mathematical functions necessary to describe the reactions.  A common solution to this 
problem is to add assumptions to a model in order to simplify the functions.   
In conventional data fitting, mathematical equations are used to model kinetic 
data.4,5  These equations result from the solution of differential rate equations which give 
the time-dependent concentration for each species for a particular kinetic model.4,6  For 
example, in the analysis of pre-steady-state kinetic data, the data are conventionally fit to 
an equation which is made up by a sum of exponentials (Eq. 3.2): where c is the endpoint, 
Ai is the amplitude, and  is an observed rate (kobs).
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In order to understand the basis for Eq. 3.2, consider the simple reversible one-
step binding of a substrate to an enzyme shown in Scheme 3.2.  Integrating the 
differential rate equation for this simple model relies on the approximation that [S] is 
much larger than [E], results in a single exponential equation describing the concentration 
for each enzyme species over time.6  The concentration of a species over time is a 
function of the observable rate (kobs), which, in turn, is a function of the forward and 
reverse rates (k1[S] and k-1), and a complex amplitude value, which is a function of the 
equilibrium constant for the formation of the ES complex.6  To fit kinetic data that 




solves Eq 3.2 with n equal to 1, resulting in a single observable rate () and amplitude 
(A1).  In general, each kinetically significant step of a model yields one exponential 
term.3-6   
The components that make up the observable rates and amplitudes quickly grow 
in complexity.  For example, for a two step reversible reaction (n = 2 in Eq 3.2) yielding 
two observable rates (1 and 2), the observable rates are the roots of a complex quadratic 
equation (Eq. 3.3).6   
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Eq. 3.3 
One can easily see how the complexity in the mathematical equations usually 
requires to assumptions to simplify them.  To further complicate matters, fitting kinetic 
data to single or double exponential equations, yields only relative values for the 
observable rates and amplitudes, not absolute values of rate constants.4      
As shown above, the observable rates and amplitudes are functions of multiple 
individual rate constants.  In order to determine the actual values of the rate constants that 
make up the observed rates and amplitudes, the observed rates (kobs) and amplitudes are 
subjected to a secondary graphical analysis.4  For example, if we revisit the model in 
Scheme 3.2, the solution of the integrated rate equation suggests that kobs = k1[S] + k-1.
6  
This shows that the observed rates have a positive linear relationship with the substrate 
concentration. The plot of the observed rates as a function of [S], results in a straight line 
with a positive slope and the values for the rate constants, k1 and k-1, are the slope of the 




This secondary plot is one most often described in the literature and used to make  
conclusions.  Many times, data which deviate from the limited analysis provided by 
fitting to the sums of exponential equations are ignored or discarded.4  Moreover, the 
amplitude values are completely ignored even though they contain important equilibrium 
information.  Although fitting by conventional methods can be useful, making 
conclusions solely based on these results is an archaic and error-prone method for data 
analysis.  
 Today, the primary data can be fit directly using computer simulation because of 
the greatly improved computational power.  This method uses numerical integration to 
directly solve the differential rate equations for a user-chosen model and starting 
concentrations.3-5  As a result, the concentration of every species in the model can be 
calculated at any point in time.  The results are presented on a computer screen as a solid 
line which can be optimized to the observed data using statistical regression calculations.  
This solid line is referred to as the simulated trace.  Data fitting by simulation eliminates 
the requirements for assumptions and approximations usually found in conventional data 
analysis.4  Also, the rate constants are determined directly from the primary data set, not 
through secondary means and both rate and amplitude information are included.3-5   
Nonetheless, there are two intrinsically linked limitations to this method of data 
fitting.4  First, the user must enter a model (or the differential equation for the model) that 
accounts for all of the observed kinetic data.  Second, that model cannot be more 
complex than is defined by the data.4,5  Achieving this “Goldilocks” balance is the basis 
for fitting data by computer simulation.  Because entering a model is the first step of 
fitting data and is absolutely required, many become disenchanted and return to the 
conventional methods of fitting.4,5  Fortunately, conventional methods are usually a good 




 The data set collected by Michaleis and Menten a century ago can be fit by 
computer simulation.2,3  First a minimal model which completely accounts for all of the 
observed data must be entered.  To simulate Michaelis and Menten’s initial velocity 
steady state kinetic curves, only a simple model is required (Scheme 3.3).2   
Scheme 3.3: Michaelis-Menten Initial Kinetic Model  
 
This model is sufficient to define the values of kcat and KS (equivalent to Km for their 
special case) for enzymatic turnover, which is all the rate information that can be defined 
by initial velocity steady state data.2,3  In order to fit a more complex data set, like the full 
time course kinetic traces collected by Michaelis and Menten and fit using a 
mathematical equation, a more complete and realistic model is required (Scheme 3.4).3  
This model accounts for the kcat and Km and Kd values for each product.
3    
Scheme 3.4: Expanded Michaelis-Menten Model 
 
In the case of the Michaelis and Menten, they were able to use some assumptions 
to simplify the mathematical rate equation to solve for a “constant value” at several 
different substrate concentrations and reaction times.2,3  These assumptions were: rapid 




accumulate to any significant amount (i.e., it is a short-lived intermediate).  Moreover, 
values for the dissociation constants of the substrate, sucrose, and the products glucose 
and fructose (KS = k-1/k1 , KF = k-5/k5, and KG= k-6/k6) were assumed from previous 
measurements.2,3  Fitting their collected data by computer simulation under the 
assumptions of rapid equilibrium of binding for both the substrate and products, 
irreversible chemistry, and fast decomposition of the ternary complex (i.e., EFG), results 
in values defining the KS (equivalent to Kd or Km, under the conditions of their model), 
kcat (k2), and an average Kd for product inhibition.
3  The Kd for product inhibition is only 
an average because there is no data distinguishing the difference between binding of 
glucose or fructose to the enzyme from full time course data alone.3  However, if the ratio 
of binding constants for glucose and fructose is considered, (KF/KG =1.53, as reported by 
Michaelis and Menten) the value of one (and hence both) can be obtained directly from 
fitting.3  The amount of assumptions here could be reduced with more experiments.  Data 
from transient state kinetic experiments, like stopped-flow, rapid chemical quench, or 
single turnover, could be incorporated resulting in a global fit with fewer assumptions.3,4,6  
As a result, the kon values (or better defined limits) for substrate and products and/or the 
lifetime of the ternary complex, EFG, could be determined.  Experiments providing this 
information would yield values for all 12 rate constants while completely eliminating any 
simplifying assumptions.3     
Today, complex global fits, like the one published by Schroeder et al., contain 
multiple data sets (including transient and steady-state data) with each separate 
experiment containing specific information about one or more individual rate constants of 
the defined model.7  The model ultimately used for global fitting and the resulting values 
for each rate constant were introduced in Chapter 1 (Scheme 1.7).    In this case, models 




It is important to note that even with a well-defined minimal model, a given data 
set may not contain data to sufficient define each individual rate constant of that model.4  
Either additional experiments must be conducted to address limitations of the existing 
dataset or some assumptions must be made.  Unfortunately, restrictions in the enzyme 
system of interest or limitations of instrumentation may prevent the collection of data 
which would provide data defining a particular rate constant.  As discussed above for the 
Michaelis-Menten data set, when fitting the steady-state full time course kinetic data to 
the model in Scheme 3.4, some assumptions were required to achieve well-constrained 
values for the fitted rate constants.  Alternatively, additional experiments could better 
define values for the remaining rate constants.  Therefore, assumptions or simplifications 
may be used to achieve well-defined parameters.  The important distinction here is that 
these assumptions are not required, but they are most often required in conventional 
analysis.4   
As a simple example of the use of assumptions when fitting by computer 
simulation, consider an enzyme that reversibly binds a ligand following the model 
outlined in Scheme 3.2.   When following this simple reaction, the signal should become 
saturated with increasing ligand concentrations (this occurs when k1[S] >> k-1).  If the 
kon of the ligand occurs in the dead time of the instrument, this rate constant can never be 
defined in the data.  However, the equilibrium dissociation constant (Kd) will be defined 
by the experiment.  If one assumes a “fast” kon value, the value for koff is easily defined in 
the dataset, as koff = Kd  kon.  Even though “fast” is a relative and qualitative term to use 
as an assumption to define a numerical value, the experiment suggests that the rate 
constant must be fast enough to occur in the dead time of the instrument.  The dead time 
sets a lower limit on the value for kon, but not an upper limit.  However, the upper limit 




never determine the actual value for kon, limits on its value can be set.  Other methods or 
experiments may be used to determine the value or narrow the range of those limits.  In 
summary, if a dataset does not contain information about each individual rate constant, 
all is not lost because sometimes equilibrium information is defined in the data.   
Assumptions can still be used in conjunction with fitting by computational simulation, 
but are not required, to yield in well-constrained values for parameters.  In general, one 
must clearly state all the assumptions or simplifications that were made to achieve the fit, 
along with the corresponding justification where appropriate.4       
 As mentioned previously, the basis of fitting by simulation is finding the minimal 
model that accounts for the observable data.  Fitting data to an overly complex model 
results in rates that are not defined and have little or no justification for assumed values.4   
As the model has no restraints and is input by us, a problem arises as to how to estimate 
errors on fitted parameters and evaluate goodness of fit resulting from traditional 
regression calculations.4,5,8   
Traditionally, the general method of fitting data by computer simulation is based 
on minimizing the total chi-squared (2) for the dataset.4,8  The squared error is computed 
by squaring the difference between the simulated trace and an observed data point.  
Adding up all these squared error values and dividing by the standard deviation yields the 
chi2.4,5,8  Most fitting algorithms then set out to find the parameters which minimize the 
deviation between the simulated trace and the data as measured by chi2 by nonlinear 
regression.  The problem with this method of fitting is that it drastically underestimates 
the errors associated with the final values leading to a false sense of confidence in their 
accuracy, and it fails to identify any internal relationships among fitted parameters.4,5,8   
KinTek Global Kinetic Explorer (the software used in this work for global data fitting) 




parameter.  With these values, KinTek includes a feature called FitSpace to help 
overcome the problems of traditional fitting and achieves a more realistic estimates of the 
error associated with the individual rate constants.5,8   
FitSpace is an exhaustive calculative method for determining uniqueness of fit 
using graphical plots.  FitSpace is based on minimizing the chi-squared (2) distribution 
of a fit.8  The 2 value is similar to SSE, but is a more accurate statistical measurement of 
“goodness-of-fit”, because it takes into account the standard deviation, or scatter, of 
individual experiments.  If the standard deviation (also known as sigma) for a set of data 
is known or can be estimated, then the 2 can be calculated.8  Initially, FitSpace uses 
traditional nonlinear regression fitting algorithms to find the optimal value each fitted 
parameter.  FitSpace then monitors (calculates) the value of the global 2 (the summed 2 
for each experiment with normalization) while each individual fitted parameter undergoes 
a systematic adjustment from its optimal value.4,8  During this process of adjustment, all 
the other fitted parameters are allowed to be re-optimized in an effort to obtain a minimal 
value of 2.  If by adjusting all other parameters a similarly low 2 can be obtained in the 
searched range of values, the parameter undergoing systematic adjustment is not well-
constrained by the data.  In other words, its optimal value is not unique because deviation 
from its optimum doesn’t change the value of 2.  However, if adjusting all other 
parameters cannot maintain the minimal 2 value, the fitted parameter is well-constrained 
by the data.  This initial process is depicted as a 2-D plot showing how the 2 is affected 
as each parameter is systematically adjusted.  This calculation is then carried out in a 
pair-wise fashion generating a 3-D contour plot of the 2 values for each pair of fitted 
parameters.  This 3-D contour plot depicts the relationship between any two rate 





In summary, global data fitting is a powerful technique that yields a robust 
minimal model that accounts for all of the data from multiple experiments, complete with 
well-constrained estimates for all kinetically relevant parameters (along with reasonable 
error limits).  Moreover, rather than basing data analysis on simplifying assumptions 
(conventional analysis), global fitting identifies which parameters of a given model are 
defined by the data and yields useful limits on their value.  As such, this approach, 
particularly when coupled with transient state kinetic methods, is an invaluable tool for 
the elucidation of enzyme mechanisms.  To this end, we employed this technique to 
investigate the dehalogenation of trans-3-chloroacrylate by CaaD (introduced in Chapter 
2).  The Y60W mutant of CaaD was designed as a fluorescent reporter for the CaaD-
catalyzed dehalogenation of trans-3-bromoacrylate (1) reaction, and shown to be 
kinetically similar to the wild-type CaaD reaction (as reported in Chapter 2).   
Scheme 3.5: Reaction of trans-3-Bromoacrylate (1) with CaaD 
 
In this chapter, all the kinetic data collected (stopped-flow fluorescence, rapid 
chemical quench flow data, and full progress curve) with the Y60W mutant of CaaD 
were globally fit by simulation to a single model.  The global fit also includes data from 
other experiments introduced in this chapter (nine experiments in total), which helped 




with the product, bromide, and the determination of the dissociation constants for 
bromide and malonate semialdehyde (2) to the free Y60W-CaaD (i.e., non-liganded).   
The global fit by simulation to a six-step model resulted in six well-constrained rate 
constants including rates defining chemistry, a proposed conformational change 




3.2 MATERIALS AND METHODS 
 Materials.  Chemicals, biochemicals, buffers, and solvents were purchased from 
Sigma-Aldrich Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Pittsburgh, PA), 
Fluka Chemical Corp. (Milwaukee, WI) or EMD Chemicals, Inc (Gibbstown, NJ).  The 
centrifugal filter devices (3,000 MW cutoff) were obtained from PALL Life Sciences 
(Ann Arbor, MI).   
 General Methods. Steady state kinetic assays were performed on an Agilent 8453 
diode-array spectrophotometer at 22 °C.9  Non-linear regression data analysis was 
performed using the program Grafit (Erithacus Software Ltd., Staines, U.K.).  Protein 
concentrations were determined according to the method of Waddell.10  Global Fitting 
was performed using Kintek Global Kinetic Explorer Version 3.0 or higher.5,8   
3.2.1 Inhibition of αY60W-CaaD by Bromide Ion 
Product inhibition of CaaD by bromide ion was determined under the steady state 
conditions described in Chapter 2.2.5.  Briefly, the assays were carried out at 22 °C in 
100 mM Na2HPO4 buffer, pH 8.1 using a 2 µM enzyme solution.  Aliquots of a sodium 
bromide solution (0.5 M in 100 mM Na2HPO4 buffer, pH 8.1) were added to 1 mL 
portions of enzyme solution to yield a total of six final inhibitor concentrations (0, 5000, 
10000, 15000, 30000, 50000 µM).  The assay was initiated by the addition of six 
different concentrations of 1 (35, 50, 75, 120, 160, and 200 µM), obtained from a 50 mM 




period, recording readings every 3 s.  To avoid, significant signal interference due to 
bromide absorbance at 224 nm, the kinetic traces were followed at 234 nm.   The 
inhibition patterns were determined by plotting the initial rate of the reaction vs. the 
concentration of bromide at different concentrations of 1 in a Dixon plot.11-13 Full time 
courses (220 s) at each inhibitor concentration were recorded under the same conditions 
using 300 µM of 1 (234 = 5200 M
-1 cm-1).   
3.2.2 Binding of Bromide Ion to αY60W-CaaD 
 The binding of bromide ion to the αY60W-CaaD was observed in the stopped-
flow apparatus (SD 2004 series), where the change in fluorescence at 340 nm was 
monitored. The assay was conducted under the conditions described in the Chapter 2, 
Section 2.6 using 10 µM enzyme solution.  To test the binding of bromide, various 
concentrations of bromide (0-50,000 µM) were made up in 100 mM Na2HPO4 buffer, pH 
8.1.  The enzyme (10 µM after mixing) and substrate (0-50,000 µM after mixing) 
solutions were mixed in the stopped-flow apparatus at 22 ºC.  At least five 1 s traces 
were collected and averaged for each concentration of bromide ion.  Stopped-flow 
fluorescence traces were unchanged over 1 s.  Therefore, the data for each trace fit to a 
horizontal line (slope =0) and plotted against the bromide ion concentration.  The data in 
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Stopped-flow traces were also fit by simulation using KinTek Global Kinetic Explorer 
and resulting values were used as constraints during global fitting.5   
3.2.3 Binding of Malonate Semialdehyde (2) to αY60W-CaaD 
 The binding of malonate semialdehyde (2) to αY60W-CaaD was monitored in the 
stopped-flow apparatus (monitoring the change in fluorescence at 340 nm).  The assay 
was conducted as described in the preceding section using a 10 µM enzyme solution.  To 
generate 2, cis-CaaD (20 µM) and propiolic acid (10,000 µM) were mixed in 100 mM 
Na2HPO4 buffer, pH 8.1
 (W.H. Johnson, Jr., J.P. Huddleston, G.K. Schroeder, and C.P. 
Whitman, unpublished observations, 2012).  After 4 min, the mixture was transferred to a 
PALL centrifugal filter device (3,000 MW cutoff), and centrifuged at 11,000 rpm for 10 
min to remove enzyme.  This procedure generates ~10,000 µM of 2 (assuming the 
reaction is quantitative).  Malonate semialdehyde (2) is a mixture of the aldehyde (~25%) 
and hydrate (~75%).14  Various concentrations of 2 (0-10,000 µM) were made up in 100 
mM Na2HPO4 buffer, pH 8.1, immediately before use. The αY60W-CaaD (10 µM after 
mixing) and different concentrations of 2 (0-5,000 µM after mixing) were mixed (1 s) in 
the stopped-flow apparatus at 22 ºC.  Stopped-flow traces were fit to a single exponential 
(Eq 3.2) using the KinTek stopped-flow software.  The kobs and constant values (C) were 
plotted vs. the concentrations of 2.  The plot of C vs. [2] was fit to the hyperbolic 
equation (Eq. 3.4) and kobs vs. [2] was fit to the linear equation (Eq 3.5).
6 




In addition to this conventional analysis, the data were fit by simulation and resulting 
values were used as constraints for global fitting. 
3.2.4 Data and Global Fitting Analysis 
 Conventional data fitting of pre-steady state kinetic data (including concentration 
dependence) by non-linear regression using the program Grafit provided initial estimates 
for rate constants and a minimal number of steps in the overall reaction pathway.  The 
steady state kcat/Km value was used as a lower limit for the rate of substrate binding and 
the kcat
 value provided a lower limit for individual first order rate constants following 
substrate binding and proceeding through product release.6,7  All of the data were then 
globally fit to a single kinetic model using KinTek Global Kinetic Explorer, as described 
elsewhere.5-7,11 During the process of global optimization, the data collected over a series 
of concentrations within a given experiment were scaled using a correction factor (less 
than 5%) for each trace to correct for slight lamp drift between traces.  The simulated 
traces also contain a correction factor to account for the change in the fluorescence 
intensity resulting from the reduced transmitted light (280 nm) due to absorbance by 
substrate (1, 280 = 110 M
-1 cm-1) and product (2, 280 ~ 27 M
-1 cm-1).  The reduced light 
intensity (I) is provided by the logarithmic function, 
( /2)10 c lrefI I
   , where is the 
extinction coefficient at 280 nm, c is the concentration of the species, and l is the path 
length of the cell (0.5 cm). The average light intensity across the full fluorescence 




3.3 RESULTS  
3.3.1 Inhibition and Binding of Bromide to Y60W-CaaD 
The mode of inhibition of bromide was investigated by monitoring the changes in 
the initial rate of the Y60W-CaaD-catalyzed reaction using 1 (35-200 µM) in the 
presence of various concentrations of bromide (0-50,000 µM).  The inhibition pattern 
observed in the Dixon plot is consistent with competitive inhibition where the Ki value is 
~10 mM (Figure 3.1).12,13 Full time courses (300 s) were also monitored using the 
Y60W-CaaD mutant at a fixed concentration of 1 (300 µM) in the presence of various 
concentrations of bromide ion (Figure 3.2).  A reduction in the rate of the reaction can 
only be observed at very high bromide concentration, consistent with the observed weak 
inhibition constant.  Stopped-flow binding experiments were conducted using bromide 
ion and the Y60W-CaaD mutant (Figure 3.3, filled circles).  At all bromide 
concentrations examined, the fluorescence change reached equilibrium within the dead 
time of the instrument (1.3 ms).  Stopped-flow fluorescence remains constant over the 1 s 
collection.  Therefore, the data for each trace were fit to a horizontal line yielding a single 
fluorescence value for each concentration.  These single fluorescence values were plotted 
against the bromide ion concentration.  The data in the resultant plot was fit to Eq. 3.4 
using Grafit (Figure 3.4). Based on the saturation of the fluorescence signal, the Y60W-
CaaD mutant binds bromide with a predicted Kd of 7.4 mM (similar to the Ki observed in 





Figure 3.1:  Dixon Plot of Bromide Inhibition of Y60W-CaaD 
A plot of the initial reciprocal velocities (1/v) against bromide (5, 10, 15, 30 
and 50 mM) at six concentrations of 1 (35, 50, 75, 120, 160, and 200 µM).12  
The KI for inhibiton of Y60W-CaaD by bromide is determined by the 
intersection point of the lines resulting from a linear fit to the data (shown 
above as solid lines). The Ki of bromide (dashed lined extrapolation) was 





Figure 3.2:  Bromide Inhibition of Y60W-CaaD.    
Full progress curve kinetic traces observed at 300 µM of 1 with Y60W-
CaaD in the presence of five concentrations of bromide (0, 5, 10, 20, 30, and 









Figure 3.3: Bromide Binding to Y60W-CaaD.  
A) The stopped-flow fluorescence traces (340 nm) of Y60W-CaaD with 
bromide (0-50000 µM) over 1 s.  Each trace was fit to a line (slope = 0) and 
resulting constant values (C) were further analyzed as shown in Figure 3.4.  
Solid lines correspond to the fit by simulation.  Results of the fit by 










 In addition to conventional fitting of data, the stopped-flow binding data were fit 
by simulation using KinTek Global Kinetic Explorer (Figure 3.3, solid lines).5  Due to 
rapid equilibration between the Y60W-CaaD mutant and bromide ion (<1.3 ms), the koff 
was held fixed at an arbitrarily fast rate (200 s-1) where it didn't affect the simulated traces 
and fitting was based upon finding the optimal value for kon. Accordingly, the data only 
define the equilibrium constant (Kd) for bromide binding to free enzyme, but not the 
individual on and off rate constants.    Fitting by simulation also defined the fluorescence 
factor of 1.17 for enzyme-bound bromide, and a kon affording calculation of a Kd of 12 
mM. The values of koff and the fluorescence factor for enzyme-bound bromide were used 
as constraints for subsequent global fitting of the reactions of 1 with Y60W-CaaD.  A 





Table 3.1. Summary of the Conventional Analysis and Individual Fit by Simulation of 
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3.95f 0.67 ± 0.12c 1.17 ± 0.03 
aThe value for f/f0
 







 .   Error 
ranges on these values were calculated using standard propagation of errors.   bThe first 
row is based upon the conventional analysis.  The second row (shaded) is based from 
the individual fits to the data by simulation.  cError ranges were calculated from 
FitSpace analysis of the individual fit by simulation with a  threshold of 5% deviation 
from the minimal SSE.  dDue to the rapid equilibrium (<1.3 ms) between bromide ion 
and the Y60W mutant of CaaD, the data only defines the Kd for bromide binding to 
free E.  This kon affords the calculation of the defined Kd when the koff  is assumed to be 
200 s-1.  eThis value was calculated by dividing koff / kon.  
fThese values were held fixed 





3.3.2 Binding of Malonate Semialdehyde (2) to the Y60W-CaaD  
 Stopped-flow binding experiments were conducted with malonate semialdehyde, 
2, (0-5000 µM after mixing) and the Y60W-CaaD mutant (Figure 3.5, filled circles).  
Upon mixing Y60W-CaaD with 2, a 16% increase in the fluorescence signal was 
observed (Figure 3.6), similar in magnitude to that observed for bromide.  However, in 
contrast to the bromide binding (fast equilibration within the dead time), the binding of 2 
occurs more slowly and requires ~100 ms to reach equilibrium.  After approximately 0.5 
s, the fluorescence signal decays, which is attributed to the instability of 2 and subsequent 
degradation to a chromophoric species, which absorbs strongly at 280 nm, thereby 
reducing the fluorescence signal (W.H. Johnson, Jr., G.K. Schroeder, J.P. Huddleston, 
and C.P. Whitman, unpublished observations, 2012).  Data were fit using both 
conventional analysis (fitting to equations, Figure 3.5A) and simulation-based methods 
(fitting based on numerical integration of the rate equations, Figure 3.5B, solid lines). For 
the conventional fit, the initial phase of the time course (250 ms) for each trace was fit to 
a single exponential (Figure 3.5A, solid lines).  A plot of the resulting first order rate 
constants versus the concentration of 2 is nearly linear and fitting to Eq 3.5 gave values 
of kon = 0.025 µM
-1s-1 and koff = 28
 s-1 (Figure 3.6A).  These values provide an estimate of 
the Kd (koff / kon) for 2
 of 1100 µM.  Based on the end-point fluorescence titration fit to 
Eq. 3.1, the Kd for 2 was predicted to be 380 µM (Figure 3.6B).  Fitting the data (250 ms) 
by simulation (Figure 3.5B, solid lines) gave a kon of 0.028 µM
-1s-1 and a koff of 17
 s-1 




enzyme-bound to 2.  All values listed above are summarized in Table 3.2.  The values for 
kon and the fluorescence factor for enzyme bound to 2 were used as constraints for 
subsequent global fitting of the reactions of 1 with Y60W-CaaD, yielding refined 




Figure 3.5:  The Stopped-Flow Fluorescence Traces (250 ms) of Y60W-CaaD with 
Malonate Semialdehyde (2).   
A) Solid lines represent a single exponential fit to the data.  Resultant rate  
vs. concentration plots are shown in Figure 3.6.  B) Solid lines represent the 
fit to the data by simulation.  Rate constant values resulting from the fit by 





Figure 3.6:  Conventional Analysis of the Binding of Malonate Semialdehyde (2) to the 
Y60W-CaaD Mutant.  
A) Plot of the kobs vs. [2] with fit to Eq 3.5 (solid line). B) Plot of constant 
values (C) vs. [2] with fit to Eq 3.4 (solid line).  A summary of fitting results 





Table 3.2.  Rates from the Conventional Analysis and Individual Fit by Simulation of 
























aThe value for f/f0
 







 .   Error 
ranges on these values were calculated using standard propagation of errors.   bThe first 
row is based upon the conventional analysis.  The second row (shaded) is based from the 
individual fits to the data by simulation.  cKd is calculated  by dividing koff / kon using the 
values from the conventional analysis of the binding of 2 to Y60W-CaaD in a stopped-
flow experiment (Figure 3.6A).  dKd is calculated from the conventional analysis of the 
saturation of the fluorescence signal in the stopped-flow experiment monitoring the 
binding of 2 to Y60W-CaaD (Figure 3.6B).  eError ranges were calculated from 
FitSpace analysis of the individual fit by simulation with a  threshold of 5% deviation 
from the minimal SSE.   fThis value was calculated by dividing koff / kon.  
gThis value was 




3.3.3 Global Fitting of the Data 
 Kinetic Model Development.  A kinetic model was developed to allow global 
fitting of the full data set (KinTek Global Kinetic Explorer) in order to provide a more 
comprehensive test of the model.  Conventional analysis (i.e. fitting to equations and 
plotting the observed rates versus concentration) was used to provide the initial kinetic 
model and estimates for some of the rate constants.6 We initially fit the stopped-flow 
fluorescence data to a two-step model because the time dependence appeared to be 
adequately fit to a single exponential function, but showed a concentration dependence 
reaching a maximum rate of ~10 s-1. However, the rate of the pre-steady state burst was 
approximately 100 s-1 (as shown in Chapter 2, Table 2.5), which defines the sum of the 
rates of chemistry and subsequent steps leading to release of product. These data imply 
that the chemistry step precedes the fluorescence change, and predicts that the 
fluorescence data should show a brief lag phase. Closer inspection of the stopped-flow 
fluorescence data revealed the data could be fit to a double exponential function (Figure 
3.7A,B), but resolution of the lag phase was unreliable due to the large errors stemming 
from the low amplitude of the lag phase, and the inherent difficulties in fitting kinetic 
data to double exponential functions with arbitrary amplitude terms. In Figure 3.7C, we 
show a fit to the same data set based on computer simulation using the full kinetic model 
described below.  The predicted lag phase is most prominent at the intermediate substrate 
concentrations (labeled with *).  The simulated traces show the rate and the amplitude of 
the lag phase are consistent with the measured rates of the chemistry step, resulting in a 









Figure 3.7:  Fitting a Lag in the Stopped-Flow Fluorescence Data. 
 A) The stopped-flow fluorescence traces (0.5 s) of Y60W-CaaD with 1 
were fit to a double exponential (Eq 3.1 with n = 2) yielding the solid lines 
shown.  The concentrations of 1 are: 0, 50, 100, 150, 250, 550, 1000, 2000, 
3000, 4000, 5000, 6000, 8000, 10000 µM.  B) The observed rate constants 
(1 and 2) from the fit to Eq 3.1 to the first 0.5 s of the stopped-flow data 
for the Y60W-CaaD are plotted versus the concentration of 1.  The faster 
rate constants are shown in green while the slower rate constants are shown 
in red.  Shown in gray lines are the error bars on the first observable rate 
values.  Note that some of these rates are off the y-axis and some of the error 
values exceed the rate constants values. Values for the slower rate constants 
and errors are similar to the rates observed from the single exponential fits 
shown in Chapter 2, Figure 2.6B.   C) The stopped-flow fluorescence traces 
(0.5 s) of Y60W-CaaD with 1 fit by global simulation are shown in solid 
lines.  The simulation lines are able to account for the lag phase significantly 
better than conventional methods.  The concentrations are the same as listed 




 These results suggest a minimal model shown in Scheme 3.6, with a fluorescence 
change occurring after the chemistry step. Product release is proposed to follow a biased 
random pathway with kinetic preference for the upper branch of the pathway (see 
Discussion). Three distinct fluorescence states (E, E* and E**) were proposed based upon 
quantitative analysis of the kinetic and equilibrium titration data. Fitting of the data set 
using this model, and the features of the data requiring each element of the model will be 
discussed below.   
Scheme 3.6: Minimal Kinetic Model Used for Global Fit  
 
 
 Global Fitting of Kinetic Data.  The complete data set for the Y60W-CaaD 
mutant reacting with 1 was subjected to global data fitting using KinTek Global Kinetic 
Explorer5 in order to rigorously test the model and provide a more comprehensive 
analysis of the lag phase in the stopped-flow fluorescence data relative to the observed 
rate of the pre-steady state burst. The global fit of the data according to Scheme 3.6 is 
shown in Figures 3.8A-I, where the smooth lines represent the global fit to the entire data 
set based upon Scheme 3.6 with the rate constants summarized in Table 3.3.  The 




3.8A-E.  Figures 3.8A-B (see also Figure 3.7C) show the initial portion (100 ms) and first 
1 s of the stopped-flow data, respectively, while Figure 3.8C shows the first 12 s of the 
reaction.  Figures 3.8D-E (see also Figure 2.4C) show the change in fluorescence over the 
full-time course of the reaction (120 s and 300 s, respectively).  Figure 3.8F (see also 
Figure 2.7B) shows the pre-steady state burst of bromide formation (using 1) at various 
concentrations of Y60W-CaaD (250-600 µM). Figure 3.8G shows the time dependence 
for the binding of 2 to Y60W-CaaD (data from Figure 3.5A-B).  This data set was not 
included explicitly in the global fit. However, the fit to this data by conventional analysis 
and simulation-based fitting of the single data set yielded a binding rate constant of 
~0.025 s-1 (vida supra, Table 3.2 and Figure 3.6A); and this value was used for k6 
(Scheme 3.6) and held fixed during global fitting. Figure 3.8H (data from Figure 3.2) 
shows the dehalogenation of 1 by Y60W-CaaD in the presence of various 
concentrations of bromide (0-50,000 µM). Figure 3.8I (data from Figure 2.3) shows the 
full progress curves of the dehalogenation of 1. A single fluorescence factor for enzyme 
bound product species (E**P and E**Q in Scheme 3.6) was defined based upon the 
conventional analysis and fits by simulation of the individual data sets; because these 
data were not included in the global analysis, the fluorescence factor was held constant at 
a value of 1.13 during global fitting, a value within the error ranges of each estimate 
















Figure 3.8:  Global Fitting of Data Collected with Y60W-CaaD.  
The Y60W-CaaD kinetic data with 1 and bromide (A-I) globally fit by 
simulation (solid lines) to the mechanism shown in Scheme 3.6 and (G) 
Y60W-CaaD kinetic data with 2 fit by simulation (solid lines) to give 
constraints on rates defined in Scheme 3.6 and Table 3.3.5  (A-E) Stopped-
flow fluorescence traces (0.1-300 s) for 1 (0-10000 µM) and Y60W-CaaD.  
Concentrations of 1 are: 0, 50, 100, 150, 250, 550, 1000, 2000, 3000, 4000, 
5000, 6000, 8000, 10000 µM. Colors corresponding to the concentrations of 
1 are maintained for graphs A-E. (F) Rapid-quench of Y60W-
CaaD200,400and 600 µM) with 1. (G) Stopped-flow fluorescence traces 
for 2 (100, 200, 300, 400, 500, 750, 1500, and 2000 µM) and Y60W-
CaaD. (H) Full time progress curves following 300 µM of 1 at 224 nm with 
increasing concentrations of bromide (0, 5000, 10000, 20000, 30000, and 
50000 µM).  (I) Full time progress curves following the decrease of 1 (18, 




 Data were not sufficient to define all of the rate constants in Scheme 3.6, so the 
less well-defined rate constants were assigned nominal values in order to fit the data to 
the full model. Because of the nature of the chemistry, we propose that the chemical 
reaction at the active site is essentially irreversible (k-2 = 0). The proposed conformational 
change occurring after chemistry (vida infra), was allowed to be reversible with the value 
of k-3 set at 1 s
-1, which represents a upper limit for k-3 based upon analysis by computer 
simulation; that is, in fitting the data we noted that any rate greater than 1 s-1 begins to 
affect the simulated traces, but rate constants below 1 s-1 have no effect, so any value less 
than or equal to 1 s-1 accounts for the data. The rate of bromide release from E**P appears 
to be rapid and therefore was held fixed at an arbitrarily fast rate (k5 = 200 s
-1) during 
global fitting.  Accordingly, the data only define the Kd for bromide, not the individual 
rate constants for binding and release.  
 Fitting with the constraints described above provides individual rate constants for 
each step in the model shown in Scheme 3.6 with error ranges shown in Table 3.3. Error 
ranges were provided by FitSpace8 confidence contour analysis (Figure 3.9) and represent 
the upper and lower limits of a 3% threshold on the 2.8   Global simulation of the data to 
the model shown in Scheme 3.6 with the constraints described above accounts for all 
aspects of the data and yields well-bounded rate constants.  The final model with our best 
estimates for each rate constant is shown in Scheme 3.7. Numbers in parentheses 
represent rate constant values that were assigned nominal values and held fixed during 
fitting.  Stacked values, 3 over 10 and 10 over 3, represent ambiguity in assigning these 










Table 3.3. Rates Constants Derived from the Global Analysis of the αY60W-CaaD 








































3.3 s-1  
(9.2  s-1) f 
k-1g 2600 4700 32% 3300 s
-1  Kd,Brh 9100 20000 43% 12500 µM 
k2 65 100 22% 78 s-1  k-6i 20 33 26% 25  s-1 
aThe data were fit globally to the mechanism shown in Scheme 3.6. Chemistry and the initial release of 2 
were assumed to be irreversible with reverse rates fixed at zero during global fitting. bThe upper and lower 
limits reflect a threshold of 3% deviation from the minimal 2
 
in the confidence contours.   FitSpace error 
confidence contours are shown in Figure 3.8.8  cThe percentage range was calculated by dividing the mean 
of the range by the best fit value as (upper-lower) / (2*best fit).  This reflects the allowable variation of 
each best fit value as a percentage. dThe fluorescence scaling factor is shown as the fractional change in 
enzyme fluorescence (see text). eFormation of E*PQ was modeled as a reversible step associated with a 
conformational change in the enzyme.  The value of k-3 was held fixed at 1 s-1 during global fitting (see 
text).   fRates for the alternate fit are provided (See Discussion 3.4).  gThe value for k1 (substrate binding) 
was assumed to be fast and held fixed at 1 µM-1 s-1, so fitting to derive k-1 defined only Kd,S (see text).  
hThe value for k5 (release of bromide ion) was assumed to be fast (Figure 3.3) and held fixed at 200 s-1 
(see text).  As bromide binding is in rapid equilibrium with free enzyme, the data only defines the Kd for 
bromide   iThe value for k6 was defined by fitting the binding of 2 to free enzyme (Figure 3.5 and Table 
3.2) and held fixed at 0.025 µM-1 s-1 during global fitting (see text).  Errors for this value estimated by 
FitSpace results to the binding of 2 to free enzyme can be found in Figure 3.8 inset. The value f/f0 for the 
product bound enzyme species (E**) was determined by fitting the products, 2 and bromide, binding to 





Figure 3.9.  FitSpace Confidence Contours for the Global Fit. 
FitSpace confidence contours for the global fit of the kinetic data shown in 
Figure 3.8A-I (αY60W-CaaD and 1) to the model in Scheme 3.6.8  The inset 
shows the FitSpace confidence contours for the fit by simulation of 2 
binding to Y60W-CaaD (Figure 3.8G).  The fluorescence factor of E** was 
held fixed at 1.13.  The letters B, C, and D (shown in white) refer to select 





Based on the kinetic similarities between the Y60W- and wild-type-CaaD 
enzymes, an in-depth analysis of the Y60W-CaaD data was pursued.  Global fitting of 
the Y60W-CaaD data provided values for individual rate constants without many of the 
additional assumptions and deconvolution of complex rate functions required for 
conventional analysis.5  Prior to global fitting (KinTek Global Kinetic Explorer), a 
minimal kinetic model was proposed based upon conventional analysis of the data.5  The 
kinetic model (Scheme 3.6) used to account for the data was developed as follows. 
Observation of a pre-steady state burst in the rapid quench experiments implies that a step 
after chemistry is at least partly rate limiting.  Fitting the burst data as shown in Chapter 2 
(Section 2.3.4) defines the rate of the burst (≈ 85 s-1) and the rate of steady state turnover, 
governed by kcat (≈ 3 s
-1).  Analysis of the pre-steady state stopped-flow data provided 
estimates for the rate constants governing a possible conformational change occurring at 
a rate slower than chemistry.6,7  The stopped-flow fluorescence data could be fit to a 
double exponential decay with a fast phase (lag) occurring with a rate comparable to the 
rate of the pre-steady state burst of product formation. Although conventional analysis 
failed to provide reliable estimates for the rate constant governing the lag phase, 
simulation-based fitting supported the existence of a lag phase consistent with duration of 
the rate of chemistry.  It is useful to note that the lag will be most noticeable when the 
rates governing the fast and slow phases are comparable, which should occur at a 




is evident in the data, as marked by an asterisk (*) in Figures 3.7A and C.  At higher 
concentrations of substrate, the lag phase becomes less distinct. This makes resolution of 
the lag by conventional fitting difficult, but the trend is included as part of the global 
fitting, which reinforces confidence in the results.     
 The slower phase of the fluorescence transients occurred at a maximum rate of 
~10 s-1, which defines the sum of all rate constants contributing to the final approach to 
the steady state,6 including the rate constant that limits steady state turnover. Because 
chemistry is irreversible, the actual reverse of the fluorescence change occurs via the 
release of products to return the enzyme to the free E state.  Accordingly, fitting the 
concentration dependence of the rate of the fluorescence change as shown in Chapter 2 
(Section 2.3.3) gives kfor = k3 = 8 s
-1 and krev = kcat = k4 = 3 s
-1. 
 Estimation of the equilibrium constant (Kd,S) for substrate binding was based on a 
rapid equilibrium assumption (k-1 >> k2) in globally fitting the entire data set. In 
particular, the Kd,S (1/K1) was defined by the concentration dependence of the 
fluorescence transients and the need to account for kcat and Km values derived from the 
full time course kinetic traces.  Although there was no observable lag in the burst data, 
suggesting a rapid equilibrium binding of the substrate prior to chemistry, this conclusion 
is inexact, but reasonable given the relatively weak apparent Kd (~ 400 µM).  By 
assigning a second order rate constant of k1 = 1 µM
-1 s-1, where k-1 >> k2, fitting the data 
to derive k-1 affords a simplistic calculation of the Kd,S = k-1/1 µM
-1 s-1. This value k1 is 





 Because the rate of the fluorescence change is slower than chemistry, the 
formation of species E*PQ is proposed to occur after chemistry so that the binding and 
chemistry steps occur without a change in fluorescence. That is, the lag phase in the 
fluorescence transients can be accurately accounted for in the simulated traces by 
assigning the same fluorescence to all enzyme species through the chemistry step (i.e., E, 
ES, and EPQ). The maximum burst rate (≈ 85 s-1) provides an initial estimate of the rate 
for chemistry (k2), but is actually the sum of the rate constants governing formation and 
decay of the EPQ complex.  
 Two product release steps are required to regenerate free enzyme, which is 
suggested to occur by a biased, random release pathway with kinetic preference for the 
upper branch of the pathway. This assignment was made as follows.  As described above, 
bromide (P) is a competitive inhibitor (Ki ~ 12 mM).  This might suggest an ordered 
product release pathway with loss of Q preceding the release of P.15  However, malonate 
semialdehyde (Q, 2) was shown to bind to free enzyme 20-fold more tightly than bromide 
(Table 3.2, Kd ~ 600 µM), perhaps suggesting a random pathway as shown in Scheme 
3.6.  Although a random pathway predicts a mixed inhibition pattern for both products, 
the apparent competitive inhibition pattern for P could be explained if the binding of P to 
E**•Q is too weak to have an observable effect.  However, the data suggest a kinetic 
preference for the upper pathway.  This can be illustrated using thermodynamic box 
arguments based on the available product binding measurements.  
 The global fitting model shown in Scheme 3.6 incorporates two assumptions 




release from E*PQ is largely irreversible, and 2) binding of P to E**Q is too weak or too 
slow to generate E*PQ (i.e., shows competitive inhibition, not mixed).  The validity of 
these two assumptions can be demonstrated in the product release model shown in 
Scheme 3.8.  
Scheme 3.8: Product Release Model  
 
In Scheme 3.8, K4 is the dissociation constant for release of Q from E
*PQ, K5 is the 
dissociation constant for release of P from E**Q , K6 is the dissociation constant for 
release of Q from E**P, and K7 is the dissociation constant for release of P from E
*PQ.  
The product of all equilibrium constants contained in a thermodynamic cycle must be 
equal to unity.  In other words, the product of constants on one side of the pathway must 
be equal to the product of the constants on the other side (Eq. 3.6):   
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Rearrangement of Eq. 3.6 to make the binding of Q to E**P versus E equal to the binding 








         Eq. 3.7  
Experimental data provide approximations of the values for
6
DK (~0.6 mM) and 5
DK  (~12 





          Eq. 3.8 
Rearranging Eq. 3.8 yields Eq. 3.9: 
7 420
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proportional.  As a result, Eq. 3.9 shows that Q binds to species E**P ( 4
DK ) approximately 
20 times tighter than P binds to species E**Q (
7
DK ).  Therefore, the assumptions 
associated with the product release and rebinding in Scheme 3.6 are consistent with a 




Unfortunately, the product, Q (2) is too unstable to carry out more accurate product 
inhibition studies to probe product release in detail.   
 The preceding analysis also agrees with the docking results of 1 to CaaD, which 
indicate that substrate appears to bind with the halide oriented toward the back of the 
active site pocket (Figure 2.2A), suggesting that the physical release of bromide would 
occur second.  In addition, an ordered product release model, with halide release as the 
final step, was proposed previously for the related enzyme cis-CaaD based on similar 
experimental observations.7  Therefore, we prefer a biased-random product release 
pathway favoring the release of  Q (2) first (slow) followed by bromide (fast), but 
accounting for the rebinding of Q to free enzyme as one leg of a random pathway.  There 
is no direct evidence for the release of P from E*PQ or the binding of P to E**•Q, so this 
reaction step is shown in gray in Scheme 3.6. 
 In Scheme 3.6, the formation of a new fluorescent state of the enzyme (E*PQ) 
occurs after chemistry (k2).  Comparable rates of formation for E
*PQ were observed for 
wild-type (Chapter 2, Figures 2.5 and 2.6B) and Y60W, suggesting that the slow 
formation for E*PQ is not an artifact caused by the Y60W mutation.  The E**•P and 
E**•Q states accounted for an increase in the fluorescence endpoint (~13%) relative to 
that of the free enzyme when either product (i.e., 2 or bromide) was bound to the enzyme 
(Tables 3.1 and 3.2).   
 Global fitting to the model shown in Scheme 3.6, constrained by the above 
information, yielded estimates for the individual rates constants for each step of the 




individual rate constants was obtained using FitSpace8, which indicates that all of the 
rates are constrained as shown in Figure 3.9. Moreover, the kinetic parameters derived by 
global simulation provide reasonable estimates in agreement with the Michaelis-Menten 
parameters obtained from steady state initial velocity measurements.  Using the numbers 
in Table 3.3 and Scheme 3.6, we calculate kcat = 2.2 s
-1 and Km = 95 µM. The 
experimentally determined values for kcat and Km are 3.0 s
-1 and 70 µM, respectively.  
Additionally, the calculated Kd values for bromide and 2 binding to free enzyme are in 
good agreement with those predicted from the individual fits by simulation and 
conventional analysis (Tables 3.1, 3.2, and 3.3).   
 Inspection of the FitSpace confidence contours (Figure 3.9) highlights various 
limitations of the data set and provides a more realistic estimation of errors on the rate 
constants (~20%, Table 3.3) compared to conventional data analysis.6,8 For example, 
conventional analysis of the stopped-flow fluorescence data based upon fitting to 
exponential functions yields two rate constants for k3 and k4 (Scheme 3.6), which are ~8 s
-
1 and ~3 s-1, respectively. Global fitting using these values as initial estimates for the rate 
constants k3 and k4, respectively, results in a fit shown in Figure 3.8 (with normal error 
estimates on all rate constants of <1%).  However, FitSpace analysis revealed that an 
equivalent fit to the data can be obtained when the values of k3 and k4 are reversed (i.e. k3 
= 3 s-1 and k4 = 10 s
-1), with a corresponding adjustment of the fluorescence scaling factor 
(f/f0) to compensate for changes in the predicted transient concentration of E
*PQ.  This is 
illustrated in Figure 3.10A, which depicts the parameter variation among k3, k4, and f/f0 




minimum).  Figure 3.10A shows that as the value for k3 increases from 3 s
-1 to 12 s-1, the 
value of k4 decreases from 12 s
-1 to 3 s-1, following a hyperbolic relationship.  
Conversely, as the value for k3 increases from 3 s
-1 to 12 s-1, the value for f/f0 increases 
from 0.15 to 0.70 following an inverse hyperbolic relationship in which k4 decreases.  
This suggests that the data can be fit equally well (maintaining an acceptably small  2) 
when k3 and k4 are defined as any appropriate combination of rates (i.e., following the 
hyperbolic relationship) from 3 s-1 to ~12 s-1 by proper adjustment of the fluorescence 
factor value (f/f0).  However, when comparing k3 or k4 to other rate constants, (e.g., k3 vs. 
d,BrK , Figure 3.10B or k2 vs. k4, Figure 3.10C) two sets of rates centered around ~3 s
-1 and 
~10 s-1 emerge as acceptable values.  Therefore, all FitSpace confidence contours 
describing k3 or k4 in relation to other rate constants have two regions of minimum 
2 (red 
spots) centered around 3 s-1 and 10 s
-1.  In the direct comparison of k3 vs. k4, (Figure 
3.10D) the hyperbolic relationship in the parameter variation is apparent, with two 
primary regions of a minimum 2 occurring when k3 and k4 are defined as 10 s
-1 and 3 s-1, 
or 3 s-1 and 10 s-1, respectively (dashed lines in Figure 3.10D).  Also, Figure 3.10D shows 
that when k3 and k4 divert from these rate constants (i.e., the hyperbolic relationship), the 





Figure 3.10: Selected Confidence Contour Plots.   
Selected FitSpace confidence contours for the global fit to the kinetic data shown 
in Figure 3.7 (Y60W-CaaD and 1).  (A) Parameter variation for k4 (, left axis) 
and f/f0 (, right axis) plotted as a function of the value of k3 required to maintain 
an SSE value within 3% of the minimum 2.  FitSpace confidence contours for 
(B) k3 vs. d,BrK  (C) k2 vs. k4, and (D) k3 vs. k4.  The dashed lines illustrate two sets 
of values for k3 and k4 that yield equivalent fits to the data (within 3% of the 






 The uncertainty in the order of these two rate constants is primarily due to the fact 
that the data lack explicit information to quantify the fluorescence factor for the species, 
E*PQ.  For example, a fast/slow sequence predicts a higher concentration of E*PQ 
requiring a lower scaling factor to achieve the same fluorescence amplitude, compared to 
the slow/fast sequence of rate constants.  This observation emphasizes the inability of 
kinetic analysis to provide the order of the two sequential rates in the absence of data to 
define the absolute amplitude of the intermediate species (E*PQ in this case). 
Conventional methods of determining standard error drastically underestimate the error 
ranges for these rate constants because error analysis is based upon only exploring the 
area around a local minimum and the covariance analysis fails to reveal nonlinear 
relationships between fitted parameters.8  The global fit to all the data with the confidence 
contour analysis reveals two acceptable fits to the data.   
Although the data cannot define the order for k3 and k4, they do provide strict 
lower and upper limits for both rate constants.  The lower limit for both k3 and k4 is 2.5 s
-1 
defined by kcat and depicted in the FitSpace confidence contours by a rapid increase in 
2 
at rate constants below 2.5 s-1.  The upper limits for these rate constants are controlled by 
the range of allowable adjustments in the fluorescence factor values (f/f0) (Figure 3.10A).  
The upper limit for k3 is ~13 s
-1 and is well constrained (Figure 3.10B).   As k3 increases, 
f/f0 increases and begins to approach unity yielding a smooth, well defined upper limit 
(Figure 3.10B). Conversely, like the lower limits, the upper limit on k4 is strictly defined.  




k4 is ~12 s
-1.  At all values above 12 s-1, the 2 drastically increases, resulting in a strict 
upper limit for k4 in the FitSpace confidence contours (Figure 3.10C).  However, even at 
these limits, the values of k3 and k4 are within 5-fold of one another.  This suggests that 
both the formation of E*PQ and release of Q (2) are partially rate limiting. 
  A previous report indicated that product release is not rate limiting.16    Horvat et 
al. based this conclusion on the observation that increasing solvent viscosity with 
trehalose did not decrease the values of kcat
 or kcat/Km, based upon the simplistic analysis 
where viscosity effects probe the extent to which diffusion limits the observed rate.16  At 
first glance, the observation of a burst of product formation appears at odds with this 
conclusion.  However, the observation of a burst only implies that a step after chemistry, 
not necessarily product release per se (e.g., a conformational change), is rate limiting.6    
In the case of CaaD, product release appears to be only partially rate limiting, which may 
have produced the observed results of the viscosity experiments. Moreover, the release of 
Q from the E*PQ state is accompanied by a change in enzyme state (to E**P) as indicated 
by the different fluorescence level. Although the structural basis for the fluorescence 
change is not known with certainty, it is reasonable to propose that a change in enzyme 
structure precedes and limits the net rate of release of Q, defining kcat. Therefore, the 
viscosity effect would have failed to reveal the rate-limiting product release, governed by 
a change in enzyme structure. It is reasonable to suppose that many slow product release 
steps are governed by rate-limiting conformational change steps that lead to rapid product 
release and weaken product rebinding. Such conformational change steps occurring 




experimental results also provide a more accurate estimate of the rate enhancement for 
the CaaD reaction (k2/knon = 3.6 x 10
13), a value that is an order of magnitude greater than 
previously reported.16  Our analysis also suggest caution in interpreting the implications 
of viscosity effects.  
 Our results raise the question about the nature of the partially rate-limiting 
conformational change steps following chemistry.   One possible explanation is gleaned 
from the crystal structures and reproduced in the docking results (presented in Chapter 2, 
Section 2.3.1), which provide molecular details for the observed conformational change.  
In the crystal structure of covalently modified CaaD (1S0Y), Glu52 is observed in this 
“closed” conformation, while in another structure of CaaD (3EJ3) without a ligand, 
Glu52 is found in the “open” conformation.18,19  In the docking poses with 1, Glu52 is 
reproduced in these two positions (Figures 3.11A and B, respectively).20  It is reasonable 
that Glu52 might have to rotate out of the active site after participating in the chemistry 
in order to facilitate product release.  A possible conformational change, with measurable 
changes in fluorescence (E*PQ), might rotate Glu52 out of the active site so the 
products, 2 followed by bromide, can be released from the enzyme. This proposed 
conformational change could partially limit the rate of turnover.  It is also reasonable to 
speculate that the efficiency of this enzymes can be optimized (perhaps by evolution) by 
accelerating the rate of the conformational change.     
Mutation of a nearby asparagine residue (Asn39to Ala39) had an unexpected, 




essentially no catalytic activity (kcat < 0.01 s
-1) with 1, despite being located more than 5 
Å away from the amino-terminal proline.20  One possibility for this observation is 
suggested by the docking study.  Although Asn39 is far from the amino-terminal 
proline, it is within hydrogen bonding distance to Glu52.  As suggested above, 
movement of Glu52 might play a key role in both chemistry and product release.  
Regardless of the position of Glu52, “open” or “closed”, Asn39 remains within 
hydrogen bonding distance of Glu52 (dotted lines in Figures 3.11A and B, 
respectively).  Based on the results of the kinetic from the N39A mutant of CaaD, it 
appears that Asn39 may be critical in guiding and positioning the Glu52 residue for 
chemistry.20   The breaking of the hydrogen bond formed in the “closed” conformation 
(Figure 3.11B) to allow for product release further supports the observed partially rate 





Figure 3.11: Results of the Docking Studies of CaaD with trans-3-bromoacrylate (1). 
A) The “open” conformation pose where the carboxylate of Glu52 points 
out of the active site.  B) The “closed” conformation pose where the 
carboxylate group of Glu52 is positioned to carry out the proposed 
chemistry.  In both cases, the Asn39 is within hydrogen bonding distance 
(shown in dotted lines) to the carboxylate moiety of Glu52.  The “open” 
conformation is predicted to be slightly favored conformation over the 




The results reported here largely parallel those found for cis-CaaD.  The kinetic 
data for the cis-CaaD reaction using cis-3-bromoacrylate are best accommodated by a 
five-step kinetic model11 in which substrate binding is followed by a rapid isomerization 
to a new fluorescent state.  Chemistry occurs next yielding an enzyme complex 
containing both products with no further change in fluorescence.  Subsequent product 
release from the complex is ordered and rate-limiting: malonate semialdehyde is released 
first (and is rate-limiting), followed by the rapid release of bromide.  The model 
suggested only two states for the enzyme, which could be associated with an open state 
and a closed state observed in the absence or presence of ligands, respectively. A 
comparison of the unliganded and liganded cis-CaaD structures provides a structural 
basis for this hypothesis.11,21    
 The similarities between CaaD and cis-CaaD include the ordered product release 
of malonate semialdehyde followed by bromide. Bromide appears to be a competitive 
inhibitor for both enzymes and the dissociation of malonate semialdehyde is at least 
partially rate determining for each enzyme.  The only differences are the nature of the 
conformational change (movement of an active site group in CaaD after chemistry vs 
open and closed states in cis-CaaD) and in the product inhibition. Malonate semialdehyde 
binds more tightly to CaaD than bromide (~10-fold), whereas bromide binds more tightly 
to cis-CaaD than malonate semialdehyde ( >10-fold).  These differences do not explain 
the greater economy of the CaaD-catalyzed reaction (compared with that of the cis-CaaD 
reaction). This remains an active area of investigation, which can now be pursued based 
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3.6.1 Introduction  
Global fitting by simulation of the data generated by the Y60W mutant using 
trans-3-bromoacrylate (1) yielded a kinetic mechanism with six individual rate constants 
(Scheme 3.7).  However, certain features of the model were not well defined.  For 
example, the data doesn’t explicitly define the fluorescence factor for the enzyme species 
designated as E*PQ.  This is mostly due to the similar magnitudes of the rate constants 
that govern its formation and decay.  These rates are designated as k3 and k4, respectively, 
in Scheme 3.7.  As a result, ambiguous values are obtained for the rates constants, k3 and 
k4, as discussed in Section 3.4, although limits on these values could be defined.  This 
problem is inherent to this system.   
One potential strategy to circumvent this problem is to find an alternate system 
where the fluorescence factor for E*PQ can be defined.  Studying the reaction with other 
CaaD mutations or with alternate substrates could generate data that define the 
fluorescent factor.  With the fluorescence factor in hand, the ambiguity in the rate 
constants for the Y60W mutant of CaaD with 1 can be resolved.  One problem with 











Scheme S3.1: Reactions of CaaD 
 
As discussed in Chapter 1, Section 1.5 (Scheme S3.1), 3-bromopropiolate (3) is a 
mechanism-based inhibitor of CaaD that covalently labels Pro-1.  Although the exact 
mechanism of action is unclear, it is proposed that 3 undergoes hydration to form an acyl 
bromide (Path A) or ketene (Path B).  Either species can result in covalent modification 
of Pro-1 (Scheme S3.2).  It was shown that CaaD is inactivated by 3 in less than 10 s 
when mixed in stoichiometric amounts.2  Moreover, the inhibition of CaaD was shown to 
be protected by the addition of 2-oxo-3-pentynoate (2-OP).  To increase our knowledge 
about the inactivation of CaaD by 3, the reaction of the Y60W mutant of CaaD with 3 
was followed using stopped-flow enzyme fluorescence. The resulting data were fit by 
both conventional methods and computer simulation.    






Following the same methodology outlined in Chapter 2, Section 2.2.6, various 
concentrations of 3 (80, 160, 240, 400, 1000, 2000, 4000, 10000 µM, initial 
concentrations) were mixed 1:1 with 20 µM (initial concentration) of the Y60W mutant 
of CaaD in 100 mM Na2HPO4 buffer, pH 8.1.  The reaction was followed for 1 and 10 s.  
The 1 s data shows a decrease in the fluorescence signal followed by a slow rise to a 
fluorescent signal higher than free enzyme alone.  After 10 s, the fluorescence signal 
remains unchanged at all concentrations.  The resulting traces were initially fit to the 
double exponential function shown in Eq. 3.2 with n = 2.  The resulting rates (1 and 2) 
were plotted versus the concentration of 3.  These concentration-dependence plots were 
fit using conventional methods.  The initial rate (1) linearly increases with increasing 
concentrations of 3.  The second rate (2) shows a hyperbolic dependence as defined by 
Eq. 2.3 (Figure S3.1).  These results suggest a minimal irreversible two-step model with 
k1 = 0.014 ± .0002
 mM-1 s-1 and k2 = 2.43 ± 0.2 s
-1 (Scheme S3.3).  There are two 
observable fluorescent species during the course of the reaction, designated here as E*PR 
and E!PR.  In this model, we designate P as bromide product and R as the reactive species 
that covalently labels the enzyme (Scheme S3.2).  This is the model (Scheme S3.3) used 
for fitting of the data by computer simulation.  The result of the fit by computer 
simulation is shown in Figure S3.2.  The FitSpace results suggests that all the parameters, 
including the two fluorescent factors are well-constrained by the data set (Figure S3.3).    
The resultant rate constants, fluorescent factors and error ranges are summarized in Table 






Figure S3.1: Conventional Analysis of Stopped Flow Fluorescence Transients Observed 
After Mixing 3-Bromopropiolate (3) with Y60W-CaaD.   
A) Plot of 1 vs. 3 with fit to a line (Eq. 3.5).  B) Plot of 2 vs. 3 fit to Eq 2.3 
(solid line).  The norminal values from these fits are described in the text.  
 
 









Figure S3.2: Global Data Fitting of 3-Bromopropiolate (3) with Y60W-CaaD. 
The Y60W-CaaD kinetic data with 3 globally fit by simulation to the 
mechanism shown in Scheme S3.3) Stopped-flow fluorescence traces (1 s) 
for 3 (0-5000 µM) and Y60W-CaaD.  B) Stopped-flow fluorescence traces 
(10 s) for 3 (0-2000 µM) and Y60W-CaaD.  Concentrations of 3 are 
shown in the legend.  Colors corresponding to the concentrations of 3 are 
maintained across both graphs.  Solid lines are the fits to the data by 







Figure S3.3: FitSpace Confidence Contours for the Global Fit for Y60W-CaaD and 3-
Bromopropiolate (3) 
FitSpace confidence contours for the global fit of the kinetic data shown in 
Figure S3.2 (Y60W-CaaD and 3) to the model in Scheme S3.3.  Included 
in the FitSpace are the two observed fluorescence factors for enzyme species 





 Table S3.1. Rate Constants and Fluorescence Factors Derived from the Fit by 








Rate a Lower Limitb Upper Limitb % Rangec Best fit 
k1 0.0124 0.0136 4.6% 0.013  M -1 s-1 
k2 1.74 1.82 2.2% 1.78  s-1 
E*(f/f0)d 0.700 0.716 1.1% 0.706  
E!(f/f0) d 1.220 1.224 0.17% 1.22 
aThe data are fit globally to the model shown in Scheme S3.3.  bThe upper and lower limits reflect a 
threshold of 5% deviation from the minimal 2 in the confidence contours.   FitSpace error confidence 
contours are shown in Figure S3.3  cThe percentage range was calculated by dividing the mean of the range 
by the best fit value as (upper-lower) / (2*best fit).  This reflects the allowable variation of each best fit 





If it is assumed that the observed fluorescent factor for enzyme species designated 
E*PR in the reaction with 3, is the same as E*PQ in the reaction with trans-3-
bromoacrylate (1), the rate ambiguities of k3 and k4 can be resolved.  Given that the f/f0 
value for E*PQ is 0.706 (the best fit value using 3) and re-fitting the dataset with 1, the 
best fit values for k3 and k4 are determined to be 9.05 s
-1 and 3.36 s-1, respectively.  The 
resulting FitSpace is shown in Figure S3.4.  This can be directly compared to the 
FitSpace shown in Figure 3.9.  Visually, the fit by simulation is the same as shown in 
Figure 3.8.  The numerical values and error ranges are shown in Table S3.2.  Under the 
same assumptions outlined for fitting in Chapter 3, Section 3.3.3, all the fitted parameters 










Figure S3.4: Refined FitSpace Confidence Contours for the Global Fit of Y60W-
CaaD and trans-3-bromoacrylate (1) 
FitSpace confidence contours for the global fit of the kinetic data shown in 
Figure 3.8A-I (Y60W-CaaD and 1) to the model in Scheme 3.7 with the 
fluorescence factor for the enzyme species E*PQ held fixed at 0.706, the 
value determined above (Table S3.1). Visually, the fit remains unchanged 






Table S3.2.  Rates Constants Derived after Refinement of the Collected trans-3-


















% Rangec Best fit 
k-1d 2600 5000 36% 3340 s-1 
 
k4 3.3 3.5 3% 3.37 s-1 
k2 62 117 35% 78 s-1 Kd,Brf 7200 22000 55% 13333 µM 
k3e 8.44 9.78 7% 9 s-1  k-6g 17 27 23% 22  s-1 
aThe data are fit globally to the model shown in Scheme 3.7. Chemistry and the initial release of malonate 
semialdehyde were assumed to be irreversible with reverse rates fixed at zero during global fitting. bThe 
upper and lower limits reflect a threshold of 5% deviation from the minimal 2 in the confidence contours.   
FitSpace error confidence contours are shown in Figure S3.4.  cThe percentage range was calculated by 
dividing the mean of the range by the best fit value as (upper-lower) / (2*best fit).  This reflects the 
allowable variation of each best fit value as a percentage.   dThe value for k1 (substrate binding) was 
assumed to be fast and held fixed at 1 µM-1 s-1, so fitting to derive k-1 defined only Kd,S  eFormation of 
E*PQ was modeled as a reversible step associated with a conformational change in the enzyme.  The value 
of k-3 was held fixed at 1 s-1 during global fitting.  fThe value for k5 (release of bromide ion) was assumed 
to be fast (Figure 3.3) and held fixed at 200 s-1.  As bromide binding is in rapid equilibrium with free 
enzyme, the data only define the Kd for bromide.  gThe value for k6 was defined by fitting the binding of 
malonate to free enzyme (Figure 3.5 and Table 3.2) and held fixed at 0.025 µM-1 s-1 during global fitting.  
Errors for this value estimated by FitSpace results to the binding of malonate semialdehyde to free enzyme 
can be found in Figure 3.8 inset. The value f/f0 for the product bound enzyme species (E**) was determined 
by fitting the products, malonate semialdehyde and bromide, binding to free enzyme,  individually, (Table 
3.1 and 3.2) and held fixed at 1.13 during global fitting (see text).   The value f/f0 for the enzyme species 




The number of assumptions (i.e., fixing of values) can be further reduced by 
combining both datasets (1 and 3) into a single global fit.  The model used for fitting is 
shown in Scheme S3.5.  In this model we designate S1 to be 1, S2 to be 3, P to be 
bromide, Q to be 2, and R to be the reactive species that covalently binds Pro1.  There are 
three observed fluorescent species of the enzyme E*, E**, and E
!.  The values shown in 
Scheme S3.5 in parenthesis were held fixed at the shown values during fitting.  A 
forward only arrow assumes that the reverse arrow was held fixed at a value of “zero”.  
This model results in well-constrained values for nine rate constants and all three 
fluorescent factors.  The FitSpace and summary of numerical values are shown in Figure 
S3.5 and Table S3.3, respectively.   
 
 
Scheme S3.5: Complete Model Used for Simultaneous Fitting of Both Datasets 
















Figure S3.5: FitSpace Confidence Contours for the Simultaneous Global Fit of 
Y60W-CaaD with trans-3-Bromoacrylate (1) and 3-Bromopropiolate (3) 
FitSpace confidence contours for the global fit of the kinetic data shown in 
Figure 3.8A-I (Y60W-CaaD and 1) and Figure S3.1 (Y60W-CaaD and 
3) to the model in Scheme S3.5.   Visually, the fits (not shown) only 
change slightly from Figure 3.8 and remain unchanged from the fits shown 




















Table S3.3.  Rate Constants and Fluorescence Factors Resulting from a Comprehensive 






















k-1d 2180 3830 30% 2765 s-1 k-6 19.9 61.6 66% 31.5 s-1 
k2 68 102 22% 79 s-1 k7 0.014 0.016 6.6% 
0.015   
µM-1 s-1 
k3e 7.1 8.9 12% 7.8 s-1 k8 1.54 1.7 5% 1.62 s-1 
k4 3.13 3.53 6% 3.3 s-1 (f/f0)* 0.683 0.708 1.7% 0.695 
Kd,Brf 4850 10050 35% 
7460 
µM 
(f/f0)** 1.12 1.15 1.3% 1.13 
k6g 0.032 0.066 40% 
0.042   
µM-1 s-1 
(f/f0)! 1.200 1.203 0.1% 1.202 
aThe data are fit globally to the model shown in Scheme S3.5.  The assumptions used in the fitting are 
discussed in the text.  bThe upper and lower limits reflect a threshold of 3% deviation from the minimal 2 
in the confidence contours.   FitSpace error confidence contours are shown in Figure S3.5.  cThe percentage 
range was calculated by dividing the mean of the range by the best fit value as (upper-lower) / (2*best fit).  
This reflects the allowable variation of each best fit value as a percentage.   dThe value for k1 (substrate 
binding) was assumed to be fast and held fixed at 1 µM-1 s-1, so fitting to derive k-1 defined only Kd,S  
eFormation of E*PQ was modeled as a reversible step associated with a conformational change in the 
enzyme.  The value of k-3 was held fixed at 1 s-1 during global fitting.  fThe value for k5 (release of bromide 
ion) was assumed to be fast (Figure 3.3) and held fixed at 200 s-1.  As bromide binding is in rapid 




Scheme S3.6: Final Complete Kinetic Model with Rate Constants and Fluorescence 
Factors for A) Caad with trans-3-bromoacrylate (1) and B) CaaD 




Previously, 3-bromopropiolate (3) was identified as a mechanism-based inhibitor 
of CaaD, which covalently labels the enzyme at Pro-1.  The inactivation process was not 
well-defined.  For example, at a concentration of 300 µM of 3, the detectable activity of 
CaaD is less than 10% in 10 s.  Due to the very fast inactivation, it is difficult to monitor 
the reaction using conventional methodology (e.g. UV spectrophotometry, NMR, etc).  
However, the reaction of 3 with the validated fluorescent mutant can be monitored using 
stopped-flow by following changes in enzyme fluorescence over the course of the 
reaction.  The collected data were fit using both conventional methods and computational 
simulation.  The stopped-flow data of Y60W-CaaD with 3 follows a two-step 
irreversible kinetic model.  Fitting the data resulted in well-constrained rate constants for 
both steps as well as fluorescence factors for two enzyme species.  The two fitted rate 




inactivation (kinact) and inhibitor potency (kinact/KI).  The values of kinact and kinact/KI are 
1.8 ± 0.04 s-1 and 0.013 ± 0.0006 µM-1 s-1, respectively.  With these values, an apparent 
KI can be determined (KI, app = 140 ± 7
 µM).   
The result of this fit, specifically the fluorescence factor for E*PR, can be used to 
re-fit the data of Y60W-CaaD with 1.  By assuming the fluorescence factor for enzyme 
species E* is the same in both systems the ambiguity in the rate constants of k3 and k4 can 
be resolved.  This results in well-constrained values for all the fitted parameters in 
Scheme S3.6.  Moreover, combining the two sets of data results in a complete global fit 
with well-constrained values for nine rate constants and three fluorescents factors with a 
reasonable estimation of errors for each (Scheme S3.6 and Table S3.3).    
These results are contingent on the assumption that E* is the same in both systems 
(Y60W-CaaD with 1 and Y60W-CaaD with 3).  In the Y60W-CaaD with 1, the 
proposed model has two florescence species, one occurring after chemistry and other 
occurring with initial product release.   This conclusion is primarily based on the rate 
observed in the burst experiment (~80 s-1) versus the observed rate in the stopped flow 
experiments (~10 s-1).  Further support for this conclusion comes from observation of a 
brief lag phase in the stopped-flow data which is comparable to that of the burst rate.  The 
fitting results for the Y60W-CaaD data with 3 suggest that the fluorescence change 
occurs with chemistry or the rate of chemistry occurs so fast that it is not observed.  Due 
to the reactivity of 3, we expect the rate of chemistry to be as fast as or faster than that 
observed with 1.  Upon closer inspection of the stopped-flow data with 3, there might be 
a very brief lag phase (<5 ms).  For comparison, the lag phase in the Y60W-CaaD with 
1 is around 20-30 ms.  This suggests that the fluorescence change with 3 may also occur 
after chemistry, as was concluded with Y60W-CaaD and 1.  In fact, the Y60W-CaaD 




for chemistry (kchem equal to ~500 s
-1), a value that is about 5-fold greater than that 
observed for Y60W-CaaD with 1.  Unfortunately, the lack of data in this region 
precludes further error analysis on this rate provided by during the fitting optimization 
routines.  The lower limit of 500 s-1 is provided by visual inspection only.  In Figure S3.6, 
the fit of the first 10 ms is shown.  In the light, colored lines is the fit to Scheme S3.3.  
Shown in the solid, lines is the fit to Scheme S3.7 with the rate of chemistry set to 500 s-1. 
 













Figure S3.6: Fit of the First 10 ms of Y60W-CaaD with 3-Bromopropiolate (3) 
Shown in filled circles are the data.  The light colored lines are the result of 
the fit by simulation to Scheme S3.3.  The solid colored lines are the fit by 
simulation to Scheme S3.7.  The concentration series of 3 is the same as 
listed in Figure S3.2. 
  
In the expanded model (Scheme S3.7), the product, P, bromide, is shown to be 
released at a very slow rate.  There are no stopped-flow data to support the slow release 
of product.  In fact, a model that allows P to be released from E*PR to form E!R + P, fits 
the stopped-flow data equally as well.  However, previous work showed that bromide 
release occurs very slowly with an observed rate of approximately kobs = 0.01 ± 003 s
-1
 
(Figure S3.7).2  This rate is at least 100-fold less than the observed rate of inactivation 
(kinact = 1.8 s
-1) determined in the stopped-flow experiment.  The “fast” rate for kinact is 
supported by the enzyme activity versus time plots presented elsewhere.2  The bromide 




the enzyme to be inactivated “fast” to form species E! followed by a very slow release of 
bromide to form species E!R as shown in Scheme S3.7.  By including the bromide release 
data in the global fit of Y60W-CaaD with 3 and allowing for some background bromide 
(about 20 µM), the release rate for bromide is determined to be 0.004 s-1.   
 
 
Figure S3.7: Fit of the Bromide Release Data with 3-Bromopropiolate (3) and wild-type 
CaaD 
Shown in the filled circles are selected points from the data presented in 
Wang et al.2 The lines are the result of the fit by simulation using Scheme 
S3.7.  Including this data with the stopped-flow data and fitting using the 
expanded model does not change the fits from Figure S3.2.     






At first glance this rate seems to contradict the rapid bromide release rate 
observed with Y60W-CaaD and 1.  However, in the model with 1, we concluded that 
product release occurs in a biased random release with a preference for the upper 
pathway (Scheme S3.6A) where the release of 2 occurs first at a slow rate (k4 = 3.3 s
-1), 
and is followed by rapid release of bromide.  It was assumed that the bottom pathway 
(release of bromide followed by 2) in Scheme S3.6A is not significant (shown in gray 
arrows).  In the case of Y60W-CaaD and 3, bromide release must occur “first” because 
the reactive intermediate is not released into solution.  In effect, the enzyme is forced to 
follow the lower pathway of Scheme S3.6A.  This forced release of bromide first is 
approximately 3-orders of magnitude slower than when 2 is released first (upper pathway 
of Scheme S3.6A) during the catalysis of 1 (3.3 s-1) and, at least, 4-orders of magnitude 
slower than when bromide is released from the enzyme second.  Interestingly, the upper 
limit of release of bromide first during the catalysis of 1 (lower pathway Scheme S3.6A) 
is about 0.01 s-1, as predicted by inspection of the fit.  These observations are consistent 
with the previous proposal that CaaD preferentially releases 2 followed by bromide in the 
dehalogenation of 1.   
As a final check, docking was carried out with the putative intermediates formed 
during the catalysis of 3 and 1, designated as 4 and 5 (Scheme S3.8), respectively.  These 
results for both intermediates suggest the bromide ion cannot be released from CaaD first 
without significant movement, because it is predicted to be buried at the back of the 
active site (Figure S3.8A and B).   The 3-bromoenolate intermediate in Figure S3.8A is 
the trans-3-bromoenolate intermediate.  The exact face of addition to 3 is unknown, 
however, the cis-3-bromoenolate intermediate docks very poorly into the active site of 





Scheme S3.8: Putative Intermediates, 4 and 5, Formed the During Catalysis of 3-







Figure S3.8: Docking of the Intermediates, 4 and 5, into the Active Site of CaaD 
A) Shown in light blue spheres is the docked 3-bromoenolate intermediate, 
4.  The bromide moiety is shown in maroon spheres.  B) Shown in purple 
spheres/sticks is the docked enolate intermediate formed during the catalysis 
of 1.  The bromide moiety is shown in maroon spheres.  It is positioned 
almost directly behind C3 of 5. Shown in blue and green spheres are the 
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Chapter 4: Reactions of Cg10062 with Acetylene and Allene Substrates: 
Evidence for a Hydration-dependent Decarboxylation  
4.1 INTRODUCTION 
Cg10062 is a 149-amino acid protein from Corynebacterium glutamicum with 
unknown biological function(s).1,2 It is a cis-3-chloroacrylic acid dehalogenase (cis-
CaaD) homologue (~34% pairwise sequence identity and 53% similarity), and is 
categorized in the cis-CaaD family, one of the five known families in the tautomerase 
superfamily.3-5 Members of this superfamily share a characteristic fold and a 
catalytic amino-terminal proline.  
 In contrast to Cg10062, cis-CaaD from Pseudomonas pavonaceae 170 carries out 
a known reaction in an established pathway.3,6-8 The enzyme catalyzes the hydrolytic 
dehalogenation of cis-3-chloroacrylate (2, Scheme 4.1) to produce malonate 
semialdehyde (4).3  A related enzyme, trans-3-chloroacrylic acid dehalogenase (CaaD), 





malonate semialdehyde decarboxylase (MSAD) yields acetaldehyde (5), which is 
presumably shuttled to the Krebs cycle.10 These reactions are two of the five steps that 
convert the isomeric mixture of the nematicide, 1,3-dichloropropene (1), to 
acetaldehyde.6-8  
Scheme 4.1: The Enzyme-catalyzed Reactions of the 1,3-Dichloropropene Catabolic 
Pathway 
 
 Cg10062 and cis-CaaD share common features.1,2,11,12 Both are homotrimers 
where each monomer is composed of 149 amino acids. Six residues critical for cis-CaaD 
activity (Pro-1, His-28, Arg-70, Arg-73, Tyr-103, and Glu-114) are also present in 
Cg10062.1 Moreover, the structures and active site regions are largely superimposable 








Figure 4.1: Overlay of Cg10062 and cis-CaaD Active Sites 
An overlay of the active sites of Cg10062 (blue, PDB code: 3N4G) and cis-
CaaD (grey, PDB code: 2FLZ).  Shown in sticks are the six key residues 
(Pro-1, His-28, Arg-70 Arg-73, Tyr-103, and Glue-114).   
 
 However, Cg10062 is not a very efficient cis-CaaD: there is a significant 
reduction in kcat/Km (~1000-fold using cis-3-bromoacrylate) and it processes both the cis 
and trans isomers of 3-chloroacrylate with a preference for the cis isomer.1,2,11  In 
contrast, cis-CaaD and CaaD are highly specific for their respective isomers.1,3,13  
 The basis for these differences is not known. The substantial increase in Km 
(~687-fold) observed for Cg10062 using (cis-3-bromoacrylate) suggests that it might 
originate in the elements that govern substrate specificity.11,12 Two possibilities include 





closed down on the active site in the crystal structure of the enzyme that has been 
inactivated by an irreversible inhibitor.11 A similar feature has not been observed in 
Cg10062. Both possibilities have been explored, but the results of these studies did not 
provide a definite explanation.11   
 Scheme 4.2: A) The Enzyme-catalyzed Conversion of 2-oxo-3-Pentynoate (6) to 
Acetopyruvate (7).  B) The Acetylene and Allene Substrates Used in 
this Work   
 
 In the course of our work on cis-CaaD, CaaD, and Cg10062, we desired a halide-
free solution of 4, which could only be generated with halide from 2 or 3 using the 
appropriate dehalogenase.10 It is known that all three enzymes hydrate the acetylene 
compound, 2-oxo-3-pentynoate (6, Scheme 4.2A), to produce acetopyruvate (7) with 
varying degrees of efficiency (CaaD >> Cg10062 > cis-CaaD).1,3,13 This observation 
prompted us to incubate cis-CaaD with propiolate (8, Scheme 4.2B), which was 
anticipated to produce 4 upon hydration. Indeed, 8 is a reasonably good substrate for cis-
CaaD (kcat/Km = 6.4 × 10
3 M-1s-1), but an even better one for Cg10062. Interestingly, an 





Instead, a mixture of 4 and 5 was obtained (25% and 75%, respectively), suggesting that 
Cg10062 functions as both a hydratase and decarboxylase (Scheme 4.3).  
Scheme 4.3: The Cg10062-catalyzed Conversion of Propiolate (8) to a Mixture of 
Malonate Semialdehyde (4) and Acetaldehyde (5).   
 
 
 These findings prompted a detailed investigation of this reaction with the wild 
type enzyme and active site mutants and confirmed that the hydration and 
decarboxylation reactions take place at the same active site. The reactions also appear to 
occur sequentially using the initial substrate (i.e., 8), because the enzyme does not 
decarboxylate exogenously added 4. The reactions of Cg10062 with 2,3-butadienoate (9) 
and 2-butynoate (10), as well as those of Cg10062 with 2 and 3, were also examined.  
For 3, 9, and 10, Cg10062 functions as a hydratase. With 2, Cg10062 is a 
hydratase/decarboxylase, but it is not as efficient as with 8 (as assessed by the kcat/Km 
values). A mutational analysis of two water-activating residues (Glu-114 and Tyr-103) 
provided an interesting array of results. There was a reduction in wild type activity for 
some mutant/substrate combinations, as would be expected, but other combinations 
switched activities (hydratase to hydratase/decarboxylase or vice-versa). Moreover, the 
likely intermediates of the hydration and decarboxylation products can be trapped (using 





Y103F mutant with 10. Three mechanisms are proposed to account for these 
observations. One mechanism involves a direct attack of water on the substrate followed 
by the decarboxylation of some of the hydration products. In a second mechanism, the 
substrate undergoes hydration, which is followed in some cases, by the formation of a 
Schiff base between the hydration product and Pro-1. Decarboxylation and hydrolysis of 
the Schiff base complete the reaction. A third mechanism involves the partitioning of the 
different substrates between covalent catalysis through Pro-1 and the direct attack of 
water. The route might be determined by the substrate’s orientation in the active site with 
respect to Pro-1 and two water-activating residues (i.e., Glu-114 and Tyr-103). Finally, 
the possible biological relevance of the reaction of Cg10062 with 8, the best substrate for 





4.2 MATERIALS AND METHODS 
 Materials.  Chemicals, biochemicals, buffers, and solvents were purchased from 
Sigma-Aldrich Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Pittsburgh, PA), 
Fluka Chemical Corp. (Milwaukee, WI), or EMD Millipore, Inc. (Billerica, MA).  
Sodium phosphate buffer salts were at least 99.99% pure or greater, as indicated by the 
manufacturer. Propiolic acid (98%, 8) and 2-butynoate (10) were purchased from Sigma-
Aldrich. Both were purified further prior to use by distillation (8) or re-crystallization 
(10).  2,3-Butadienoate (9) was synthesized according to published methods.14 The 
DEAE-Sepharose and Phenyl-Sepharose 6 Fast Flow resins used for protein purification 
were obtained from Sigma-Aldrich Chemical Co. (St Louis, MO).  The Econo-Column® 
chromatography columns were obtained from BioRad (Hercules, CA).  The Amicon 
stirred cell concentrators and the ultrafiltration membranes (10000 Da, MW cutoff) were 
purchased from EMD Millipore Inc. Malonate semialdehyde decarboxylase (MSAD) 
was purified as described previously.10 
 Bacterial Strains, Plasmids, and Growth Conditions.  Escherichia coli strain 
BL21-Gold(DE3) was obtained from Agilent Technologies (Santa Clara, CA).  The E. 
coli DH5 cells were obtained from Invitrogen (Carlsbad, CA).   Cells were grown at 37 
°C overnight in Luria-Bertani (LB) media that contained ampicillin (Ap, 100 µg/mL).   
General Methods.  The PCR amplification of DNA sequences was conducted in a 
GeneAmp 2700 thermocycler (Applied Biosystems, Carlsbad, CA).   Techniques for 
restriction enzyme digestion, transformation, and other standard molecular biology 





performed in the DNA Core Facility in the Institute for Cellular and Molecular Biology 
(ICMB) at the University of Texas at Austin.   Electrospray ionization mass spectrometry 
(ESI-MS) was carried out on an LCQ electrospray ion-trap mass spectrometer (Thermo, 
San Jose, CA).   Peptide fragment masses were determined using Voyager-DE Pro 
matrix-assisted laser desorption/ionization (MALDI) mass spectrometer run in the linear 
mode.   Both instruments are housed in the ICMB Protein and Metabolite Analysis 
Facility at the University of Texas.   Steady-state kinetic assays were performed on an 
Agilent 8453 diode-array spectrophotometer at 22 °C.   Non-linear regression data 
analysis was performed using the program Grafit (Erithacus Software Ltd., Staines, 
U.K.).   Protein concentrations were determined by the Waddell method.16 Sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out on 
denaturing gels containing 12% polyacrylamide.17 Nuclear magnetic resonance (NMR) 
spectra were recorded on a Varian INOVA-500 or a Varian DirectDrive 600 MHz 
spectrometer (Palo Alto, CA).   NMR signals were analyzed using the software program 
SpinWorks 3.1.6 (Copyright © 2009 Kirk Marat, University of Manitoba).    
4.2.1 Construction of the Cg10062 Mutants and Expression, Purification of Wild-
type and Cg10062 Mutants 
 The expression vectors for Cg10062 and the P1A, R70A, and E114Q mutants of 
Cg10062 were constructed as described elsewhere.1,18 The remaining Cg10062 mutants 
were constructed using the QuikChange Site-Directed Mutagenesis Kit (Agilent 
Technologies) following the manufacturer's instructions.   Oligonucleotide primers 





reverse primers used to introduce the Y103F mutation were 5'-
CCAATGAAGAAGTATGGGTATTTATAACGGAGATTCCTGGTTC-3' and 5'-
GAACCAGGAATCTCCGTTATAAATACCCATACTTCTTCATTGG-3', respectively.  
The forward and reverse primers used to introduce the E114D mutation were 5'-
GGTTCCAATATGACGGATTATGGCCGTCTCCTCAT-3' and 5'-
ATGAGGAGACGGCCATAATCCGGTCATATTGGAACC-3', respectively.  The 
codon used to introduce the mutation is underlined in each primer.   The E114Q/Y103F 
double mutant of Cg10062 was constructed by the QuikChange method using the E114Q-
pET3b plasmid as template DNA and the primers used for the Y103F mutant.   Wild-type 
Cg10062 and the mutants were grown and expressed in E. coli BL21-Gold(DE3) cells 
and purified by previously published protocols.1,2,18  
 Mass Spectral Analysis of Cg10062 and the Cg10062 Mutants.  The monomer 
molecular masses of Cg10062 and mutants were determined by ESI-MS.   Samples for 
analysis were made 1 mg/mL, as described elsewhere.13 The observed molecular masses 
(MH+) for the wild-type enzyme, and the E114Q-, E114D-, Y103F-, and P1A-Cg10062 
mutants are: 17100 Da, 17098 Da, 17085 Da, 17085 Da, and 17072 Da, respectively.  
These masses agree with the calculated masses (within experimental error). 
4.2.3 Steady-State Kinetics  
 The assays were carried out at 22 °C in 100 mM Na2HPO4 buffer, pH 8.1, using 
various concentrations of enzyme (0.02–2 µM) depending on the kcat of the enzyme with 
the substrate.   A stock solution of 8 (~400 mg/mL, 5.71 M) was made up by pipetting 





phosphate buffer (0.5 mL).  Subsequently, a 100 mM propiolate solution was made up in 
100 mM phosphate buffer from this stock solution.  The final pH was adjusted to 8.1.  
Diluted enzyme solutions were equilibrated for 1 h before the assays.   Initial rates were 
plotted vs.  substrate concentration and fit to the Michaelis-Menten equation using Grafit 
to determine kcat
 and Km.  The reported errors are calculated from the standard errors of 
the fit to the data by nonlinear regression.  If saturation kinetics were not observed, the 
data were fit to a straight line where the slope is equal to kcat/Km.
19 The reactions of 2, 3, 
and 8 were monitored by a coupled assay described elsewhere, where the reduction of 
acetaldehyde by alcohol dehydrogenase is coupled to the oxidation of NADH.1,10,11 
Cg10062 processes cis-3-bromoacrylate with comparable kinetic parameters and product 
ratios to those determined for 2 (data not shown). The hydration of 9 to acetoacetate (11) 
was followed by monitoring the decrease in absorbance at 224 nm (ε224 = 1125 µM
-1 cm-
1), as described previously.11 The hydration of 10 to acetoacetate (11, Scheme 4.4) was 
followed by monitoring the decrease in absorbance at 220 nm (ε220 = 624 µM
-1 cm-1).  
The decarboxylase activity of Cg10062 and the mutants with 2, 3, or 8 (yielding 5), was 
determined using the coupled assay described above where MSAD was excluded from 
the mixture and by 1H NMR spectroscopy.   The decarboxylase activity of Cg10062 and 








Scheme 4.4: The Cg10062-catalyzed Conversion of 2-Butynoate (10) to a Mixture of 
Acetoacetate (11) and Acetone (12) 
 
 Decarboxylation of 4 and 11 by Cg10062 and Mutants. Malonate semialdehyde 
(4, ~ 10 mM) was generated using cis-CaaD and cis-3-chloroacrylate (2), as previously 
reported.10,20  The decarboxylation of exogenous 4 by Cg10062 and the mutants was 
monitored by the coupled assay (above) without MSAD and by 1H NMR spectroscopy.   
4.2.4 Identification of the Products of the Cg10062- and Mutant-catalyzed 
Reactions by 1H NMR Spectroscopy   
 The protocol for monitoring the reaction of Cg10062 with 2 or 3 by 1H NMR 
spectroscopy is described elsewhere.1 The same procedure was used with the following 
modifications for monitoring the reaction of Cg10062 with 8, 9, or 10.  Accordingly, an 
amount of 8, 9, or 10 (4 mg, ~95 mM for 8 and ~80 mM for 9 and 10) was added to 100 
mM Na2HPO4 buffer (pH 9.2) containing 30 µL of DMSO-d6 (final total volume of 600 
µL). The final pH of the solution is adjusted 8.0. Subsequently, a 7-µL aliquot of enzyme 
(wild-type or the E114Q, E114D, Y103F, Y103F/E114Q, and P1A mutant of Cg10062, 
from 18 mg/mL, 15 mg/mL, 17 mg/mL, 28 mg/mL, 16 mg/mL, or 17 mg/mL stock 
solutions, respectively) was added to the mixture and product formation was monitored 





d6 was used as the lock signal and for the standardization of the chemical shifts (at 2.49 
ppm). The chemical shifts for 4, 5, their hydrates, 11, and 12 are reported elsewhere.13,21 
The approximate amount of product in the mixtures was determined by integration, as 
described previously.1    
4.2.5 ESI-MS Analysis of NaCNBH3-treated Mixtures Containing the Y103F or 
E114D Mutants of Cg10062 with 9 or 10.  
 Six reaction mixtures (300 µL) were made up containing 100 mM Na2HPO4 
buffer (37 µL, pH 8.0), NaCNBH3 (50 µL of a 1.6 M solution in 100 mM Na2HPO4, pH 
~9.5) and the Y103F or E114D mutant of Cg10062 (20 µL) (3 reaction mixture each).   
After a 10-min incubation period, 9 or 10 (193 µL from a 14 mg/mL stock solution in 
100 mM Na3PO4 buffer with the pH adjusted to 8.0 using a 50% NaOH solution) was 
added to the mixtures containing the Y103F- or E114D-Cg10062 (accounting for four of 
the six reaction mixtures).  The remaining two mixtures (one with the Y103F mutant and 
one with the E114D mutant) served as controls where the substrate is replaced with 100 
mM Na2HPO4 buffer, pH 8.0 (193 µL).  The reaction mixtures incubated overnight at 
room temperature.  Subsequently, the remaining hydratase activity in each sample (using 
9 as substrate) was determined by the UV assay described previously.11 The activities of 
three of the four reaction mixtures (9 with E114D-Cg10062 and 10 with Y103F- and 
E114D-Cg10062) were reduced 10-100-fold from those observed in the control reaction 
mixtures.  The incubation of 9 with Y103F-Cg10062 results in no reduction of activity 
from that observed in the control sample.  The mixtures with reduced activity (i.e., 9 with 





MS analysis, as described elsewhere.3,21  Four additional reaction mixtures were set up 
that contained the Y103F and E114D mutants of Cg10062 along with exogenous 11 or 
12.   Following the protocol described above, an aliquot (230 µL) of 11 or 12 (from a 
0.14 M stock solution, 14.95 mg/mL and 8.02 mg/mL, respectively) was added to 70 µL 
of pre-incubated solution containing enzyme (20 µL of the Y103F or E114D mutant of 
Cg10062) and NaCNBH3 (50 µL).  There was no reduction in the activity of these 
samples, as assessed by an assay using 9 (compared with that of control), so that ESI-MS 
analysis was not carried out on these samples. 
4.2.6 Peptide Mapping and MALDI-MS Analysis.   
The covalently modified Y103F and E114D mutants of Cg10062 (by their 
incubation with 9 and 10 and treatment with NaCNBH3) were treated with a solution of 
Staphylococcus aureus endoproteinase Glu-C (protease V-8), following a previously 
published protocol.3,21 After a 48-h incubation period, the resulting peptide mixture was 






4.3.1 Kinetic Parameters of Cg10062 with 8 and 10.  
 The steady-state kinetic parameters were measured for Cg10062 with the 
acetylene compounds, 2, 8, and 10, and are summarized with those previously measured 
for Cg10062 with 3 and 9 in Table 4.1.1,11,18 Cg10062 shows the highest kcat and lowest 
Km values with propiolate (8), yielding a kcat/Km value of 1.8 × 10
5 M-1s-1.  This kcat/Km is 
12,000-fold and 6000-fold higher than those measured respectively for 2 and 2-butynoate 
(10), and 35-fold higher than the one measured for 2,3-butadienoate (9). The kcat/Km 
values for Cg10062 with 2 and 10 are comparable.  Cg10062 has the poorest activity and 
lowest efficiency with 3. However, the ability of Cg10062 to process 3 is interesting in 
light of the inability of cis-CaaD to process 3 coupled with the many similarities between 




























Table 4.1. Steady-state Kinetic Parameters for the Cg10062-catalyzed Reactions__ 
4.3.2 1H NMR Characterization of Products Resulting from Reactions Catalyzed 
by Cg10062. 
 1H NMR spectroscopic analysis of the reaction of Cg10062 with 8 showed that 5 
is the major product (~75%) of the reaction along with a small amount of 4 (~25%) 
(Figure 4.2A). The reaction is complete in less than 3 min, indicating that 5 does not 
result from the non-enzymatic decarboxylation of 4. The same kinetic parameters are 
obtained with and without MSAD in the coupled assay, which is also consistent with 5 
being the major product. The subsequent incubation of Cg10062 with exogenously 






8,500 1 ± 0.1 14 ± 2 
3b 
78,000 ± 
36,000 0.06 ± 0.01  0.8 ± 0.4 
8 33 ± 5  6 ± 0.2 (1.8 ± 0.2) × 105 
9c 780 ± 120 4 ± 0.1 (5.1 ± 0.8) × 103 
10d - - 30 ± 2 
aThe kinetic parameters for 8 and 10 were 
measured by the assay described in the text in 100 
mM Na2HPO4 buffer (pH 8) at 22 °C. 
bReported in 
refs 1 and 18. cReported in ref 11.  dSaturation 
kinetics could not be achieved with 10.  The initial 
rates were plotted versus [10] and fit to a straight 
line to provide a value for kcat/Km.





generated 4 (10-80 mM) did not produce 5 at a rate faster than that observed for the non-
enzymatic rate, as assessed by UV and 1H NMR spectroscopy. Based on these 
observations, the Cg10062 catalyzes the hydration-dependent decarboxylation of 8.   
 These observations prompted a closer examination of the reactions of Cg10062 
with 2 and 3 by 1H NMR spectroscopy.  Cg10062 converts 2 to both 4 (7%) and 5 (33%) 
after 48 min with 60% of 2 remaining (Figure 4.2B). (Two doublets corresponding to the 
protons of 2 appear at 6.11 and 6.19 ppm, which are outside the range shown in the 
figure.3) Although 3 is converted to 4 (2.9%) by Cg10062, 4 is not processed to 5 by the 
enzyme after 48 min (Figure 4.2C). A small amount of acetaldehyde, 5, is observed 
(1.5%), but this is due to the non-enzymatic decarboxylation of 4 in the course of the 48-
min incubation time. This was confirmed by the UV assay (data not shown). A large 
amount of unreacted substrate (95.6%) is also present. (Two doublets for the protons of 3 
appear at 6.09 and 6.89 ppm, which are outside the range shown in the figure.13) The 
presence of 5 in the reaction of Cg10062 with 2 was noted previously, but was attributed 
to a non-enzymatic process or a promiscuous decarboxylase activity of Cg10062.1  
 With 9 and 10, Cg10062 functions as a hydratase.11 The reaction of Cg10062 with 
9 is complete in less than 3 min and the 1H NMR spectrum shows mostly 11, which 
results from the hydration of 9 (Figure 4.2D). The reaction of 10 with Cg10062 yields a 
similar result, but over a longer time period:  it is complete after 39 min and 11 is the 
major product observed (Figure 4.2E).  There is a small amount of 12 present (~2.5% 





decarboxylation of 11. Hence, Cg10062 functions primarily as a hydratase with this 











Figure 4.2: 1H NMR Spectroscopic Product Analysis of the Reaction of Cg10062 with 
2, 3, 8, 9, or 10.   
A) Products of Cg10062 with 8 (~95 mM) after 3 min. B) Products of 
Cg10062 with 2 (~63 mM) after 48 min. The signals for the unreacted 2 are 
not shown.  C) Products of Cg10062 with 3 (~63 mM) after 48 min.  The 
signals for the unreacted 3 are not shown. The small amount of 5 present is 
consistent with non-enzymatic decarboxylation of 4. D) Products of 
Cg10062 with 9 (~80 mM) after 3 min.  The small amount of 12 present is 
consistent with the non-enzymatic decarboxylation of 11.  E) Products of 
Cg10062 with 10 (~80 mM) after 39 min.  The amount of 12 present (2.5%) 
is more than expected for non-enzymatic decarboxylation.   All reactions 
contained ~12.3 µM Cg10062 and 30 µL of DMSO-d6. The reactions are 
individually scaled to show the products of the reactions.  The scale can be 
assessed by the height of the DMSO peak (labeled in the spectra). The 
hydrates of 4 and 5 are also present: the signal at ~2.3 ppm corresponds to 
the methyl group of the hydrate of 4 and the signal at ~1.1 ppm corresponds 








4.3.3 Incubation of the P1A, R70A, and Y103F/E114Q Mutants of Cg10062 with 2, 
8, 9, and 10 
 In order to assess whether the reactions are taking place at the active site of 
Cg10062 (or another site), various active site mutants were examined with 2, 8, 9, and 10.  
The P1A mutant was examined with 2, 8, and 10.   The R70A mutant was examined with 
2, 8, and 9.  The Y103F/E114Q mutant was examined with 8 and 9.  (The reactions of the 
P1A and R73A mutants of Cg10062 with 3 were previously reported.1) In all cases, the 
signals were greatly reduced in the 1H NMR spectra (data not shown).  These 
observations suggest that the reactions take place in the same active site. 
4.3.4 Kinetic Parameters of E114Q-Cg10062 with 2, 8, and 9 
 The steady-state kinetic parameters for the E114Q mutant of Cg10062 with 2, 8, 
and 9 are summarized in Table 4.2.   With 8, the E114Q mutant of Cg10062 shows a 7.5-
fold reduction in kcat (vs. wild type) and an 11-fold reduction in Km.  As a result, there is a 
slight increase in the value of kcat/Km.   With 9, the kcat/Km value increases ~5-fold, which 
is due to an increase in the kcat.  Like 8, the E114Q mutant of Cg10062 shows a reduction 
in both the kcat and Km values using 2, and results in a slightly higher kcat/Km (vs. wild 
type).  The steady-state kinetic parameters for the E114Q mutant using 3 or 10 could not 
be determined with the coupled assay because the reactions are too slow.  Although the 
kcat/Km values for the E114Q mutant with 2 and 8 are comparable with the respective ones 
for wild type, the E114Q mutant does not carry out a decarboxylation reaction with the 
hydration product and MSAD must be present in the assay mixture in order to monitor 













Table 4.2. Steady-state Kinetic Parameters for the E114Q-Cg10062-catalyzed 
Reactions 
 
4.3.5 1H NMR Characterization of the E114Q-Cg10062-catalyzed Reaction with 2, 
3, 8, 9 and 10 
 1H NMR analysis of the five E114Q-Cg10062-catalyzed reactions uncovered 
some intriguing contrasts to the wild type reactions. With 8, the E114Q-Cg10062 
apparently functions as a hydratase because 4 is now the major product (8.5%) of the 
reaction after 18 min (Figure 4.3A).  A small amount of 5 (0.5%) is observed in the NMR 
spectrum, but it is similar to that observed for the non-enzymatic decarboxylation of 4. 
(This was confirmed by the UV assay using MSAD.) There is also a large amount of 
unreacted substrate present (91%), indicated by the singlet at ~2.9 ppm.  A similar result 
is observed when 2 is incubated with E114Q-Cg10062 (Figure 4.3B). After 18 min, the 
mixture consists of unreacted substrate (80%), 4 (19%), and a small amount of 5 (1%). 




2 4,000 ± 800 0.4 ± 0.05 100 ± 25 
8 3 ± 0.25  0.80 ± 0.02 (2.7 ± 0.2) × 105 
9 660 ± 75 16 ± 1 (2.4 ± 0.3) × 104 
aThe kinetic parameters were measured using the 
assay described in the text in 100 mM Na2HPO4 





The E114Q mutant of Cg10062 does process 3 to any significant extent after 90 min 
(Figure 4.3C).   
 With 9 and 10, the 1H NMR analysis suggests that the E114Q mutant of Cg10062 
functions as a hydratase/decarboxylase. With 9, the E114Q-Cg10062-catalyzed reaction 
is complete after 12 min, and yields mostly 11 (83%) with a significant amount of 12 
present (~17%) (Figure 4.3D).  Moreover, there is no further change in the amounts of 11 
or 12 after the reaction mixtures incubate for an additional 15 min. This suggests that the 
E114Q mutant does not catalyze the decarboxylation of 11 when added exogenously, just 
as wild-type does not catalyze the decarboxylation of 4 (at a rate faster than non-
enzymatic) when added exogenously. With 10, the E114Q-Cg10062-catalyzed reaction 
produces 12 (2.2%, which is 73% of the total products observed) as the major product 
and 11 as the minor product (0.8%, which is 27% of the total products observed) after 90 
min (Figure 4.3E). A large amount of unreacted substrate remains (97%), as indicated by 
the singlet at ~1.7 ppm. These results suggest that the E114Q mutant catalyzes a 
decarboxylation reaction (preceded by a hydration reaction), but only using 9 and 10 

















Figure 4.3:  1H NMR Spectroscopic Product Analysis of the Reaction of E114Q-
Cg10062 with 2, 3, 8, 9, or 10.   
A) Products of E114Q-Cg10062 with 8 (~95 mM) after 18 min.  The small 
amount of 5 present is consistent with non-enzymatic decarboxylation of 4.  
The reaction is not complete with a significant amount of 8 present 
(identified by the singlet at 2.90 ppm).  B)  Products of E114Q-Cg10062 
with 2 (~63 mM) after 18 min.  The small amount of 5 present is consistent 
with non-enzymatic decarboxylation of 4. The reaction is not complete with 
a significant amount of 2 still present (NMR signals not shown). C) Products 
of E114Q-Cg10062 with 3 (~63 mM) after 90 min. There are no observable 
signals for 4 or 5. D) Products of E114Q-Cg10062 with 9 (~80 mM) after 12 
min. The signal at 2.03 ppm corresponds to the methyl group of 12. The 
signals at 2.08 and 3.23 ppm correspond to the methyl and methylene 
groups respectively of 11.21 E) Products of E114Q-Cg10062 with 10 (~80 
mM) after 90 min. All reactions contained ~12.3 µM E114Q-Cg10062 and 
30 µL of DMSO-d6. The reactions are individually scaled to show the 
product reaction.  The scale can be assessed by the height of the DMSO 







4.3.6 Kinetic Parameters of E114D-Cg10062 with 2, 8, 9, and 10 
 The steady state kinetic parameters for the E114D mutant of Cg10062 with 2, 8, 
9, and 10 are summarized in Table 4.3.   Using 8, there is a 6-fold reduction in kcat and a 
2.7-fold increase in Km (vs. wild type), which results in a 16-fold decrease in the kcat/Km. 
The resulting kcat/Km (1.1 × 10
4 M-1s-1) is an order of magnitude less than that measured 
for wild type. With 2, the E114D-Cg10062 exhibits poor activity.  With 3, the activity is 
so poor that it is not possible to measure kinetic parameters. The kcat/Km for the E114D 
mutant of Cg10062 using 9 increased slightly from that observed for wild type. The 
kcat/Km for the E114D mutant of Cg10062 with 10 is 14-fold higher than that for wild 
type.  The kcat is low (0.5 s
-1), but a Km value can be measured unlike the wild type 










Table 4.3. Steady-state Kinetic Parameters for the E114D-Cg10062-catalyzed 
Reactions 






10,000 0.1 ± 0.02 2.5 ± 0.8  
8 90 ± 10  1 ± 0.05 (1.1 ± 0.2) × 104 
9 480 ± 90 3.2 ± 0.4 (6.6 ± 1.5) × 103 
10 1400 ± 200 0.5 ± 0.03 (4.1 ± 0.5) × 102 
aThe kinetic parameters were measured by the 
assay described in the text in 100 mM Na2HPO4 






4.3.7 1H NMR Characterization of the E114D-Cg10062-catalyzed Reaction with 8, 
9 and 10  
 The reactions of the E114D mutant of Cg10062 with 8, 9 and 10 were monitored 
by 1H NMR spectroscopy.  The major product of the reaction with 8 is 4 (22%), and not 5 
(1%) after 3 min (Figure 4.4A). A significant amount of unreacted substrate (77%) 
remains (i.e., singlet at ~2.9 ppm). The E114D mutant of Cg10062 with 9 yields mostly 
11 (97.2%) and a small amount of 12 (2.8%) after 3 min (Figure 4.4B).  Similar 
observations are made for the reaction of 10 with the E114D mutant of Cg10062 (i.e., 
91.5% of 11 and 2.5% of 12 and 8.2% unreacted substrate) after 3 min (Figure 4.4C). 
These results indicate that the E114D mutant of Cg10062 functions mostly as a hydratase 










Figure 4.4: 1H NMR Spectroscopic Product Analysis of the Reaction of E114D-
Cg10062 with 8, 9, or 10.  
A) Products of E114D-Cg10062 with 8 (~95 mM) after 3 min. B)  Products 
of E114D-Cg10062 with 9 (~80 mM) after 3 min. C) Products of E114D-
Cg10062 with 10 (~80 mM) after 3 min.  All reactions contained ~10.2 µM 
E114D-Cg10062 and 30 µL of DMSO-d6. The reactions are individually 
scaled to show the product reaction.  The scale can be assessed by the height 





4.3.8 Kinetic Parameters of Y103F-Cg10062 with 2, 8, 9, and 10  
 The steady-state kinetic parameters for the reactions of 2, 8, 9, and 10 with the 
Y103F mutant of Cg10062 are summarized in Table 4.4.   With 8, there was a 12-fold 
decrease in kcat and a 6-fold decrease in Km (vs wild type), resulting in a slight decrease in 
the kcat/Km.   With 9, the Y103F mutant of Cg10062 shows an 2-fold increase in the 
kcat/Km, which is due mostly to the 3.2-fold increase in kcat.  These observations parallel 
those made for the E114Q mutant of Cg10062.   With 2, there was a reduction in both kcat 
and Km (vs. wild-type) resulting in a slightly higher kcat/Km value (~4.3-fold) but lower 
than that for E114Q-Cg10062 (~1.7-fold).  With 10, there was a significant increase 
(~106-fold) in the value of kcat/Km.  The Y103F mutant of Cg10062 showed very little 










Table 4.4. Steady-state Kinetic Parameters for the Y103F-Cg10062-catalyzed 
Reactions 




2 4,700 ± 300 0.3 ± 0.04 60 ± 10 
8 5 ± 2  0.5 ± 0.01 (1.0 ± 0.3) × 105 
9 1200 ± 200 13 ± 2.5 (1.1 ± 0.3) × 104 
10 700 ± 100 2.1 ± 0.2 (3.2 ± 0.8) × 103 
aThe kinetic parameters were measured by appropriate 





4.3.9 1H NMR Characterization of the Y103F-Cg10062-catalyzed Reaction with 2, 
3, 8, 9, and 10.   
 The reactions of the Y103F mutant of Cg10062 with 2, 3, 8, 9 and 10 were 
monitored by 1H NMR spectroscopy (Figure 4.5). The results with 8 and the Y103F 
mutant are comparable to those observed for the wild type, although slower. Accordingly, 
the reaction of 8 with the Y103F mutant yields 4 (0.7%) and 5 (2.1%), along with 
unreacted substrate (97.2%) after 27 min (Figure 4.5A), (as indicated by the singlet at 
~2.9 ppm). The reaction of the Y103F mutant of Cg10062 with 2 yields 4 (1%) and 5 
(8%) and unreacted substrate (91%) after 18 min (Figure 4.5B).  The reaction with 3 is 
very slow although a small signal for 4 (~ 2.30 ppm) can be observed after 18 min 
(Figure 4.5C). The reaction of 9 with the Y103F mutant shows that 11 is the major 
product (99.5%) after 3 min (Figure 4.5D). A small amount of 12 (0.5%) is also present, 
which is slightly more than is expected for the non-enzymatic decarboxylation of 11.  
The reaction of 10 with the Y103F mutant shows that the major product is 11 (84%), 
along with a significant amount of 12 (16%) after 6 min (Figure 4.5E). Hence, the Y103F 
mutant has hydratase/decarboxylase activity using 2, 8, and 10 as substrates. With 9, it is 

















Figure 4.5: 1H NMR Spectroscopic Product Analysis of the Reaction of Y103F-
Cg10062 with 2, 3, 8, 9, or 10.   
A) Products of Y103F-Cg10062 with 8 (~95 mM) after 27 min. The reaction 
is not complete with 8 still present (~2.9 ppm).  B)  Products of  Y103F-
Cg10062 with 2 (~63 mM) after 18 min. The reaction is not complete with 2 
still present (NMR signals not shown). C) The reaction of Y103F-Cg10062 
with 3 (~63 mM) after 18 min. There are no observable signals for products 
except for a trace of 4 in the baseline.  D) Products of Y103F-Cg10062 with 
9 (~80 mM) after 3 min. The small amount of 12 present is consistent with 
non-enzymatic decarboxylation of 11. E) Products of Y103F-Cg10062 with 
10 (~80 mM) after 6 min. All reactions contained ~19.1 µM Y103F 
Cg10062 and 30 µL of DMSO-d6. The reactions are individually scaled to 
show the product reaction.  The scale can be assessed by the height of the 











4.3.10 Incubation of the E114D and Y103F mutants of Cg10062 with 9 and 10 in the 
Presence of NaCNBH3.   
 Compounds 9 and 10 were incubated with the E114D and Y103F mutants 
overnight in the presence of NaCNBH3 and the residual activity was determined using 9.  
Three of the four mixtures had less than 10% remaining activity compared to the control 
(E114D and 9 or 10 and Y103F and 10).   The sample containing the Y103F mutant and 
9 showed no loss in activity (vs the control).  The ESI mass spectra of the three samples 
with reduced activities all showed two major signals: one at 17,083-17,085 Da and the 












Figure 4.6: ESI-MS Spectra of the E114D Mutant of Cg10062 Incubated with 9 and 10 
in the Presence of NaCNBH3.  
The signals at 17,085 Da and 17,084 Da (in A and B, respectively) 
correspond to the unlabeled E114D-Cg10062. The signals at 17,126 Da 
correspond to E114D-Cg10062 covalently modified by the reduced imine of 
12. The smaller signals at 17,166 Da and 17,168 Da (in A and B, 
respectively) correspond to E114D-Cg10062 covalently modified by the 






Figure 4.7: ESI-MS Spectra of the Y103F Mutant of Cg10062 Incubated with 10 in the 
Presence of NaCNBH3.  
The signal at 17,083 Da corresponds to the unlabeled Y103F-Cg10062.  The 
signals at 17,125 Da and 17,165 Da correspond to Y103F-Cg10062 











 The first signal corresponds to the expected mass for the unlabeled Cg10062 
(calc, 17,085 Da) and the other signal corresponds to the mass of the covalently modified 
enzyme.   The difference in mass is 42 Da, which is consistent with the mass of the 
reduced imine of acetone (12), one of the expected products of the reactions.   In all 3 
spectra, there is also a smaller signal at 17,165-17,168 Da.   The difference in mass from 
that of control is 81-84 Da, which is consistent with the mass of the reduced imine of 
acetoacetate (11), the other expected product of these reactions.  (It is important to note 
that there is no loss in activity when the E114D or Y103F mutants are incubated with 
exogenous 11 or 12 in the presence of NaCNBH3.)   
4.3.11  Peptide Mapping and MALDI-MS Analysis  
 The location of the covalent modification was determined by proteolytic digestion 
using endoproteinase Glu-C (protease V-8), followed by MALDI-MS of the peptide 
fragments.1,21 The spectra for the proteolytic digest of the E114D mutant with 9 or 10, 
and the Y103F mutant with 10 are shown respectively in Figures 4.8A and 4.8B, and 
Figure 4.9.   All three spectra show a signal corresponding to the unmodified peptide Pro-
1-Glu-15 (1896.2-1896.4 Da) as well as second signal corresponding to the same peptide 
modified by an adduct with a mass 42 Da (1938.3-1938.5 Da).  This mass difference is 
consistent with the addition of the reduced imine of acetone (12) to the fragment.  An 
examination of the sequence indicates that Pro-1 is the only chemically reasonable site 
for imine formation and subsequent covalent modification by reduction with NaCNBH3.  
A signal for the reduced imine of acetoacetate (11) was not detected.  The spectra show 





E114D mutant and three major peptide fragments for the Y103F mutant).  However, none 
of these peptide fragments is modified by a covalent adduct.   
 Protease V-8 hydrolyzes peptides at the carboxylate side of glutamate and 
aspartate residues with a preference for the glutamyl residues.22,23 Proteolysis is 
dependent on the buffer conditions as well as the residues adjacent to the site of 
hydrolysis.   Interestingly, the E114D mutant shows a slightly different pattern than that 
for the Y103F mutant.  The protease doesn’t hydrolyze the protein at Asp-114 in the 
E114D mutant, but does hydrolyze at Glu-114 in the Y103F mutant.  This observation 









   
Figure 4.8: MALDI-MS of Spectra of Fragments from the Proteolytic Digest of the 
E114D Mutant of Cg10062 Incubated with 9 and 10 and Treated with 
NaCNBH3.  
The signals for the six major peptide fragments are labeled and are assigned 
as follows:  985.4 Da, Leu-81 to Glu-88; 1422.2 Da, Tyr-115 to Glu-126; 
1768.3 Da, Asn-61 to Glu-75; 1896.2/1896.4 Da, Pro-1 to Glu-15; 1938.3 
Da, Pro-1 to Glu-15 (+ 42 Da); and 2238.2/2238.4 Da, Ile-107 to Glu-126. 
The mass difference of 42 Da on the Pro-1 to Glu-15 fragment is consistent 
with the covalent modification of the fragment by the reduced imine of 12.  







Figure 4.9: MALDI-MS of Spectra of Fragments from the Proteolytic Digest of the 
Y103F Mutant of Cg10062 Incubated with 10 and Treated with NaCNBH3.  
The signals for the five major peptide fragments are labeled and are 
assigned as follows:  985.4 Da, Leu-81 to Glu-88; 1422.4 Da, Tyr-115 to 
Glu-126; 1768.5 Da, Asn-61 to Glu-75; 1896.4 Da, Pro-1 to Glu-15; and 
1938.5 Da, Pro-1 to Glu-15 (+ 42 Da). The mass difference of 42 Da on the 
Pro-1 to Glu-15 fragment is consistent with the covalent modification of the 
fragment by the reduced imine of 12.  Only the Pro-1 to Glu-15 fragment 






4.4  DISCUSSION 
 The mechanism of cis-CaaD has been studied extensively3,11,12,21,24-27, and the 
results of these studies provide the context for the reactions of Cg10062 with 8, 9, and 10. 
Sequence analysis first linked cis-CaaD to the tautomerase superfamily and identified 
four of the six residues (Pro-1, Arg-70, Arg-73, and Glu-114) now known to be required 
for activity.3 Mutagenesis showed that three of these residues are critical for cis-CaaD 
activity: the P1A, R70A, and R73A mutants of cis-CaaD lacked any detectable activity. 
However, the E114Q mutant retained some activity (8-fold reduction in kcat/Km using 2), 
which hinted that an additional residue(s) might be involved in the activation of a water 
molecule (later identified at Tyr-103). This initial characterization also showed that cis-
CaaD catalyzed the hydration of the acetylene compound 6 to produce 7 with a 582-fold 
reduction in kcat/Km (compared with that measured for the CaaD-catalyzed reaction). 
 Analysis of a crystal structure of cis-CaaD covalently modified at Pro-1 by (R)-2-
hydroxypropanoate (14, Scheme 4.5) identified a second water-activating residue (Tyr-
103) and a sixth residue (His-28).24,25 Covalent modification resulted from the incubation 
of cis-CaaD with the (R)-isomer of oxirane-2-carboxylate (13).24  Mutagenesis confirmed 
the importance of these two residues for cis-CaaD activity. The structure also suggested 








Scheme 4.5: The Irreversible Inactivation of cis-CaaD by (R)-Oxirane-2-carboxylate 
(13). 
 
 In the course of this study, a pH rate profile of the wild-type reaction identified a 
protonated group with a pKa of ~9.3 that is required for activity.
24 The group is proposed 
to be Pro-1, which is consistent with the observed hydration of 6 to 7 involving a cationic 
Pro-1.4 
 Based on all of these observations, the mechanism shown in Scheme 4.6 was 
formulated for cis-CaaD (using 2). In this mechanism, the carboxylate group interacts 
with the three positively charged residues (Arg-70, Arg-73, and His-28).25,27 The 
interactions serve to bind and polarize the substrate. Polarization of the substrate 
generates a partial positive charge at C-3 and sets up the substrate for a Michael addition 
of water.  Glu-114 and Tyr-103 activate the water molecule for attack at C-3 to produce 
the aci-carboxylate species 15. This species undergoes one of the two fates shown in 
paths A and B.  In path A, Pro-1 provides a proton at C-2 to produce 16. Expulsion of 
HCl from 16 affords 4. In path B, 15 undergoes an -elimination reaction to produce 






Scheme 4.6: Proposed Mechanism of cis-CaaD and cis-3-Chloroacrylate (2)._ 
 
 
 In addition to 6, compounds 8, 9, and 10 were examined as substrates for cis-
CaaD. Both compounds are reasonably good substrates for cis-CaaD with kcat/Km values 
of 6.4 × 103 M-1s-1 (8)28 and 8.7 × 103 M-1s-1 (9).11,21 Compound 10 is not processed to 
any appreciable extent.28 For both of the substrates (8 and 9) with cis-CaaD, the 
decarboxylation products (5 or 12, respectively) are not observed (above non-enzymatic 
background) nor are the hydration products (4 or 11, respectively) decarboxylated by the 
enzyme.  
 It was anticipated that cis-CaaD would catalyze the direct addition of water to C-3 
of 8 and 9, paralleling the reaction mechanism for the enzyme with 6 (Scheme 4.2A).  
However, in the presence of 9 and NaCNBH4, cis-CaaD was irreversibly inactivated by 
the covalent modification of the prolyl nitrogen of Pro-1.21 This prompted a detailed 
investigation into the mechanism of cis-CaaD with 9.  As a result, cis-CaaD was shown 
to catalyze the hydration of 9 almost exclusively through a covalent intermediate 
(Scheme 4.7).  The proposed mechanism for covalent catalysis is the result of 





the covalent mechanism, 9 becomes covalently attached to Pro-1 by nucleophilic (or 
electrophilic) addition at the  
C-3 positon.  This forms an unstable enolate intermediate (18), which cis-CaaD 
stereospecifically incorporates a proton at C-2 yielding an 3,4-enamine intermediate (19). 
Hydrolysis of 19 generates acetoacetate (11) and free enzyme.  This is proposed to be the 
kinetically preferred pathway of catalysis.  Alternatively, 19 can tautomerize to give the 
imine species (20).  This is also subject to hydrolysis, or 20 can tautomerize to the 
theromodynamically favored 2,3 enamine (21).  Hydrolysis of 21 yields 11.  This step is 
proposed to be the rate-limiting step in turnover.  This is the first example of covalent 

















Scheme 4.7: Proposed Nucleophilic Mechanism of cis-CaaD and Allene (9)._ 
 
 A database search for cis-CaaD family members identified Cg10062.1 The 
conserved six active site residues, the sequence similarity, and the nearly identical active 
site region suggested that the activity and mechanism would be comparable to those of 
cis-CaaD, even though the genomic context did not show the presence of any enzymes in 
the 1,3-dichloropropene catabolic pathway or homologues of these enzymes.1 
Characterization of Cg10062 showed that this assumption was not correct.   
 Our studies uncovered three striking differences. First, Cg10062 is a poor 
dehalogenase using 2, and is a non-specific dehalogenase in that it will process 3 
(although poorly).1 Second, the enzyme is inactivated by both isomers of 13, with the 





both 2 and 3. Finally, Cg10062 catalyzes the direct addition of water to the allene (9), 
whereas cis-CaaD uses covalent catalysis to hydrate the compound (Scheme 4.7). A 
stereochemical analysis of the two enzymes (using 9) shows that they incorporate a 
deuteron on opposite faces. The different stereochemical consequences could be a result 
of the different mechanisms, binding modes, proton sources, or some combination of the 
three.21      
Frequently, two closely related enzymes do not have comparable levels of activity 
using the same substrate(s) or even the same activities.29-31 This observation can be due to 
subtle changes in the active site that alter the positions of catalytic and/or binding 
residues. It can also result from elements outside the active site where the sequence 
similarities are not as high.30,31 These elements might include a mobile loop or 
conformational dynamics.11,30,31 Finally, the two enzymes might have different substrates 
or entirely different activities. The work presented here shows that Cg10062 has a 
different activity than cis-CaaD using the same substrate.  
 The reaction of cis-CaaD and 8 produces only 4. In contrast, the reaction of 8 and 
Cg10062 produces a small amount of 4 (25%) and mostly 5 (75%). Hence, Cg10062 
functions as a hydratase/decarboxylase, whereas cis-CaaD functions only as a hydratase. 
The unique feature of the Cg10062-catalyzed reaction is that the decarboxylation reaction 
depends on the hydration reaction. In other words, Cg10062 does not catalyze the 
decarboxylation of 4 when added exogenously.  It is known that the exogenously added 4 
binds at the active site with a Kd of about 25 mM.  Moreover, although 4 is a reasonable 





intermediate. Understanding how Cg10062 catalyzes the decarboxylation reaction of this 
hydration-dependent reaction is critical for elucidating the enzyme’s mechanism.  
 Several mechanisms have been reported for the decarboxylation of -keto 
acids.32-34 For a start, the hydration-dependent decarboxylation reaction reported here is 
coenzyme and metal ion independent (as is the hydration reaction), eliminating 
mechanisms that require a cofactor. Cofactor-independent -ketoacid decarboxylases 
have been described that use a Schiff base mechanism (e.g., acetoacetate 
decarboxylase32) or an oxyanion hole (e.g., MSAD10,20,33 and methylmalonyl CoA 
decarboxylase34). For Cg10062, the Schiff base would form between Pro-1 and substrate. 
These mechanisms might not be directly applicable to Cg10062 because the 
decarboxylation reaction is entirely dependent on the hydration reaction. This suggests 
that Cg10062 might proceed by an unprecedented mechanism.             
In view of these considerations, three mechanisms can be envisioned for the 
hydratase/decarboxylase activity of Cg10062 where the interaction of the substrate 
carboxylate group with Arg-70, Arg-73, and His-28 most likely positions it in the active 
site.  The first mechanism involves the Cg10062-catalyzed hydration of 8 to produce 4, 
followed by the decarboxylation of 4 to yield 5 (Scheme 4.8). Water is activated by the 
combination of Glu-114 and Tyr-103 and 8 is polarized by the combination of Arg-70, 
Arg-73, and His-28 (analogous to the roles assigned to these residues in Scheme 4.6).  
Water is added to the C-3 of 8 resulting in an unstable allene intermediate that is 
immediately protonated at C-2.  This results in 17, which tautomerizes to 4.  Pro-1 (with 





(to form 17) or in the tautomerization step.  A small amount of 4 (~25%) is released from 
the active site and the remaining 4 is decarboxylated to give 22 by an unknown 
mechanism.  After decarboxylation, Glu-114 and Tyr-103 could be in a favorable 
protonation state to facilitate decarboxylation.  22 can be tautomerized to give 5.  An 
analogous mechanism can be envisioned for the hydration/decarboxylation of 2.   
This mechanism is at odds with the observation that exogenously added 4 is not 
decarboxylated by the enzyme and argues against it. However, if this mechanism is 
operative, one could argue that the hydration of 8 positions 4 in an orientation for 
decarboxylation. The positioning of 4 in the active site appears to be an important factor 
for its decarboxylation. The hydration of 3 also produces 4, but 4 is not decarboxylated. 
Hence, the hydration of 8 (and 2) could place 4 in a favorable state for decarboxylation, 
which is not achieved by the hydration of 3 or by exogenously added 4. Another 
possibility is that 4 is not generated as a distinct entity in the hydration-dependent 














Scheme 4.8: The Cg10062-catalyzed Hydration of Propiolate (8) by Direct Attack of 
Water Followed by Decarboxylation 
 
 
 In a second mechanism, the hydration step is followed by the formation of a 
covalent intermediate between Pro-1 (now nucleophilic because the proton was removed 
in the hydration step) and C-3 of 4 (i.e., a Schiff base) (Scheme 4.9). The reactivity of the 
aldehyde could facilitate the process.  This would form an unstable intermediate, 23, 
which could undergo dehydration to give 24 (or 25, depending on the proton 
elimination).  Decarboxylation of the Schiff base (25) generates the enamine, 26, which 
can tautomerize to 27.   Hydrolysis of 27 generates 5 and free enzyme.  A small amount 
of 4 could escape from the active site and not form a Schiff base (accounting for the 25% 
of 4 in the final mixture). In this mechanism, the exogenously added 4 might not be 





base intermediate. The hydration reaction must necessarily occur first in order to put Pro-
1 into the correct state. The same sequence of events could process 2.    
Scheme 4.9: The Cg10062-catalyzed Hydration of Propiolate (8) by Direct Attack of 
Water Followed by Decarboxylation via a Schiff Base.  
 
 The third mechanism involves covalent catalysis using Pro-1 (Scheme 4.10). 
Accordingly, Pro-1 adds to C-3 of 8 followed by a proton transfer to form 24, which can 
rearrange to 25.  The occasional hydrolysis of 24 (or 25) produces the small amount 





tautomerizes to 27.  Hydrolysis of 27 yields 5 and free enzyme.  An analogous 
mechanism is not likely for 2.  
 
Scheme 4.10: The Cg10062-catalyzed Hydration of Propiolate (8) by Covalent 
Catalysis Mechanism. 
 
 One potential drawback to this third mechanism is that the apparent pKa of Pro-1 
(~9.2), inferred again from the pH rate profile of cis-CaaD, suggests that the prolyl 
nitrogen is largely cationic and unable to function as a nucleophile. If this mechanism is 





not reflect the actual pKa of the prolyl nitrogen in Cg10062 or the reaction proceeds using 
the small amount of enzyme with the prolyl nitrogen in the uncharged form. (For the third 
mechanism, the small amount of enzyme in the uncharged form would readily react with 
the aldehyde moiety of exogenously added 4 and result in decarboxylation.  This does not 
happen.  A satisfactory explanation is not apparent.) 
It is unknown how Cg10062 catalyzes the decarboxylation reaction in the 
hydration-dependent decarboxylation sequence in the first mechanism (Scheme 4.8). The 
Schiff base in the second and third mechanisms (Schemes 4.9 and 4.10) lends itself to 
decarboxylation (although it is not known which residues and other features of the active 
site are involved). Obviously, delineating the decarboxylation mechanism would narrow 
the mechanistic possibilities. 
 The reactions of 9 and 10 with Cg10062 produce only the hydration product (11 
for both substrates). Hence, for these substrates, Cg10062 functions as a hydratase. The 
most obvious difference between 8 and these substrates is length (3 vs. 4 carbons). These 
observations could suggest that the positioning of substrate in the active site plays an 
important role in the outcome (hydration vs hydration/decarboxylation). In addition, the 
hydration product, 11, is a ketone with an extra methyl group (vs 4). These features could 
further contribute to the reaction outcome. However, there still remains any number of 
explanations without knowing how Cg10062 catalyzes the decarboxylation part of the 
hydration-dependent decarboxylation of 8.     
 In an effort to understand the Cg10062 reaction mechanism, the two water-





reactions with 8, 9, and 10 characterized (Table 4.5, Figure 4.10). This analysis produced 
a range of results, which are mostly perplexing and not obviously explained. The easier 
results to rationalize are those that involve a reduction in wild type activity (e.g., Y103F 
with 8). In these cases, the mutation could disrupt binding, the catalytic machinery, or 









































aActivity is not detected by UV or 1H NMR spectroscopy.  bTrace amounts 
of 12 (~0.3-2.8%) are present in the 1H NMR spectra, but these enzymes 






Figure 4.10:   Visual Summary of Activities for the Wild Type, E114Q-, E114D-, and 
Y103F-Mutants of Cg10062 with 2, 8, 9, and 10.   
Shown in shades of green, blue, yellow, and red columns (bars) are the 
activities for the four substrates (2, 8, 9, and 10) with the wild-type, 
E114Q-, E114D-, and Y103F-mutants of Cg10062, respectively.  Bars in 
front of the double line (i.e. in the white panel, lighter shades of color) 
represent enzyme and substrate combinations that showed 
hydratase/decarboxylase activity.  Bars behind the double line (i.e. in the 
gray panel, darker shades of color) represent enzyme and substrate 
combinations that showed hydratase only activity.   The height of the bars 





It is more difficult to explain the switch in activities where the 
hydratase/decarboxylases lose decarboxylase activity or the hydratases gain 
decarboxylase activity. With 2 and 8, the E114 mutants (E114Q and E114D) lose 
decarboxylase activity and function only as hydratases. With 2, the E114D mutant is a 
poor hydratase, whereas with 8, it has more significant activity. This is based on the 1H 
NMR analysis, which shows that the mutant generates product at a faster rate using 8. 
The same analysis shows that the E114Q mutant is a better hydratase with 2 than it is 
with 8 (but not as effective as the E114D mutant with 10). The other switch in activity is 
the gain of function. With 9 and 10, the E114Q mutant functions as a 
hydratase/decarboxylase as does the Y103F mutant with 10. 1H NMR analysis also 
suggests that the Y103F mutant (with 10) and the E114Q mutant (with 9) have significant 
hydratase/decarboxylase activity, (but not comparable to the hydratase/decarboxylase 
activity of the wild type with 8). Several factors could be responsible for the gain of 
function ranging from a longer time in the active site to a more roomy, less constrained 
active site resulting in accessibility to C-3 of the substrate.  Again, understanding how 
Cg10062 and the mutants catalyze the decarboxylation part of the hydration-dependent 
decarboxylation of 8 shortens the list of possibilities.       
 For two of the mutant enzymes (E114D and Y103F), it was possible to trap the 
equivalent of the hydration product (11 from 9 or 10 processed by E114D and 11 from 10 
processed by the Y103F mutant) and the decarboxylation product (12) as the reduced 
imine covalently attached to Pro-1 (using NaCNBH3). It is not possible to trap the 





result is tantalizing, and seems to suggest that covalent catalysis is operative (Schemes 
4.9 or 4.10). However, there are concerns.  First, it is not possible to trap any imine when 
the same experiment is carried out with the E114Q mutant and 9. This enzyme has a 
pronounced hydratase/decarboxylase activity (after 12 min, the mixture consists of 83% 
of 11 and 17% of 12).  Second, it is not clear why the imine of 12 is trapped when the 
E114D mutant is incubated with 9 and 10 because 12 is not present in very large amounts 
(~2.5%). These observations raise the possibility that the trapping results are 
experimental artifacts.  Other experiments (not shown) with E114Q with 10 suggests that 
the presence of NaCNBH3 alters the course of the reaction (i.e. more 11 is present than in 
the absence of NaCNBH3, where 12 is observed to be the primary product).     
 Although 8 is clearly the “best” substrate identified for Cg10062 thus far (as 
suggested by the high kcat/Km of 1.8  10
5 M-1 s-1), the biological relevance of the 
hydratase/decarboxylase activity with this substrate is not clear. Acetylene-bearing 
natural products are well known (e.g., the enediyne antibiotics) and there are various 
reports about the bacterial catabolism of acetylenes, but not in C. glutamicum.35-37 The 
genomic context for Cg10062 is not informative because the adjacent genes have 
unknown functions or annotated functions that are not useful.1 There are, however, two 
reports about the bacterial transformation of 8 that could have implications for the 
biological relevance. First, a strain of Pseudomonas putida that was isolated from rotting 
fruit was shown to use 8 as a sole carbon source.36 1H NMR spectroscopy following the 
transformation of 8 in these P. putida cells showed the transformation of 8 to 4 and 5. 





of 4 to 5 is an enzyme-catalyzed reaction (or not) were not reported. The identification of 
the enzyme responsible for this transformation and any genomic context could shed light 
on the role of Cg10062. A second report in the KEGG database outlines a pathway for 
the conversion of 8 to 4, followed by the conversion of 4 to -alanine.37 The basis for this 
series of conversions is not entirely clear, but -alanine can be processed to pantothenic 
acid in C. glutamicum, which is known for the overproduction of pantothenic acid.38-40 
(-alanine can be routed to other pathways as well.41) This pathway doesn’t account for 
the production of 5 in any obvious way and the connection between Cg10062 and the 
pathway is tenuous at best, but it is an intriguing possibility.  
 Finally, the hydratase/decarboxylase activity of wild type Cg10062 with the cis-3-
haloacrylates has an intriguing evolutionary implication. The isomer-specific 
dehalogenases (cis-CaaD and CaaD) and MSAD are all tautomerase superfamily 
members that are found in the 1,3-dichloropropene catabolic pathway, where they 
catalyze successive reactions (Scheme 4.1).4,6,7 cis-CaaD and MSAD have additional 
similarities: both are homotrimers with comparably sized monomers (129 amino acids for 
MSAD and 149 amino acids for cis-CaaD)25,27,33 and both catalyze the hydration of 6 to 
yield 7 (Scheme 4.2).3,10,13 For these reasons, the dehalogenases and MSAD might have 
diverged from a common ancestral enzyme that catalyzed both reactions.1 Although 
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